KR20150002588A - 인터페론 및 면역글로불린 fc 섹션 융합 단백질 - Google Patents
인터페론 및 면역글로불린 fc 섹션 융합 단백질 Download PDFInfo
- Publication number
- KR20150002588A KR20150002588A KR20147022960A KR20147022960A KR20150002588A KR 20150002588 A KR20150002588 A KR 20150002588A KR 20147022960 A KR20147022960 A KR 20147022960A KR 20147022960 A KR20147022960 A KR 20147022960A KR 20150002588 A KR20150002588 A KR 20150002588A
- Authority
- KR
- South Korea
- Prior art keywords
- leu
- ser
- gln
- ala
- pro
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title claims abstract description 270
- 108010050904 Interferons Proteins 0.000 title claims abstract description 270
- 229940079322 interferon Drugs 0.000 title claims abstract description 258
- 108060003951 Immunoglobulin Proteins 0.000 title abstract description 19
- 102000018358 immunoglobulin Human genes 0.000 title abstract description 19
- 108020001507 fusion proteins Proteins 0.000 title abstract description 7
- 102000037865 fusion proteins Human genes 0.000 title abstract 6
- 241001465754 Metazoa Species 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 15
- 229940047124 interferons Drugs 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 239000003443 antiviral agent Substances 0.000 claims abstract description 3
- 230000004927 fusion Effects 0.000 claims description 101
- 210000004027 cell Anatomy 0.000 claims description 82
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 claims description 17
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 claims description 17
- 239000002609 medium Substances 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 12
- 239000012679 serum free medium Substances 0.000 claims description 11
- 108091033319 polynucleotide Proteins 0.000 claims description 8
- 239000002157 polynucleotide Substances 0.000 claims description 8
- 102000040430 polynucleotide Human genes 0.000 claims description 8
- 210000004962 mammalian cell Anatomy 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 14
- 108091028043 Nucleic acid sequence Proteins 0.000 description 91
- 108020004414 DNA Proteins 0.000 description 81
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 76
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 76
- 241000282898 Sus scrofa Species 0.000 description 72
- IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 68
- OMMDTNGURYRDAC-NRPADANISA-N Ala-Glu-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OMMDTNGURYRDAC-NRPADANISA-N 0.000 description 60
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 60
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 59
- NJWJSLCQEDMGNC-MBLNEYKQSA-N Ala-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C)N)O NJWJSLCQEDMGNC-MBLNEYKQSA-N 0.000 description 55
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 55
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 55
- KQFRUSHJPKXBMB-BHDSKKPTSA-N Ala-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 KQFRUSHJPKXBMB-BHDSKKPTSA-N 0.000 description 54
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 54
- QJUWBDPGGYVRHY-YUMQZZPRSA-N Leu-Gly-Cys Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N QJUWBDPGGYVRHY-YUMQZZPRSA-N 0.000 description 54
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 54
- ULNXMMYXQKGNPG-LPEHRKFASA-N Met-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCSC)N ULNXMMYXQKGNPG-LPEHRKFASA-N 0.000 description 54
- LJRPYAZQQWHEEV-FXQIFTODSA-N Asp-Gln-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O LJRPYAZQQWHEEV-FXQIFTODSA-N 0.000 description 53
- DSRVQBZAMPGEKU-AVGNSLFASA-N Gln-Phe-Cys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N DSRVQBZAMPGEKU-AVGNSLFASA-N 0.000 description 53
- GFHXZNVJIKMAGO-IHRRRGAJSA-N Pro-Phe-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O GFHXZNVJIKMAGO-IHRRRGAJSA-N 0.000 description 53
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 53
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 52
- 108010090461 DFG peptide Proteins 0.000 description 52
- WJZLEENECIOOSA-WDSKDSINSA-N Gly-Asn-Gln Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O WJZLEENECIOOSA-WDSKDSINSA-N 0.000 description 52
- ZYDYEPDFFVCUBI-SRVKXCTJSA-N His-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N ZYDYEPDFFVCUBI-SRVKXCTJSA-N 0.000 description 52
- REPPKAMYTOJTFC-DCAQKATOSA-N Leu-Arg-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O REPPKAMYTOJTFC-DCAQKATOSA-N 0.000 description 52
- KAFOIVJDVSZUMD-DCAQKATOSA-N Leu-Gln-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-DCAQKATOSA-N 0.000 description 52
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 52
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 52
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 52
- SHOMROOOQBDGRL-JHEQGTHGSA-N Thr-Glu-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SHOMROOOQBDGRL-JHEQGTHGSA-N 0.000 description 52
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 52
- ZEVNVXYRZRIRCH-GVXVVHGQSA-N Val-Gln-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N ZEVNVXYRZRIRCH-GVXVVHGQSA-N 0.000 description 52
- 108010011559 alanylphenylalanine Proteins 0.000 description 52
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 52
- PXAFZDXYEIIUTF-LKTVYLICSA-N Ala-Trp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O PXAFZDXYEIIUTF-LKTVYLICSA-N 0.000 description 51
- BLGNLNRBABWDST-CIUDSAMLSA-N Cys-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N BLGNLNRBABWDST-CIUDSAMLSA-N 0.000 description 51
- GQNZIAGMRXOFJX-GUBZILKMSA-N Cys-Val-Met Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O GQNZIAGMRXOFJX-GUBZILKMSA-N 0.000 description 51
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 51
- SWCOXQLDICUYOL-ULQDDVLXSA-N Phe-His-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SWCOXQLDICUYOL-ULQDDVLXSA-N 0.000 description 51
- NKUGCYDFQKFVOJ-JYJNAYRXSA-N Tyr-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NKUGCYDFQKFVOJ-JYJNAYRXSA-N 0.000 description 51
- 108010012058 leucyltyrosine Proteins 0.000 description 51
- 108010070643 prolylglutamic acid Proteins 0.000 description 51
- RBXSZQRSEGYDFG-GUBZILKMSA-N Glu-Lys-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O RBXSZQRSEGYDFG-GUBZILKMSA-N 0.000 description 50
- MYXNLWDWWOTERK-BHNWBGBOSA-N Gly-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN)O MYXNLWDWWOTERK-BHNWBGBOSA-N 0.000 description 50
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 50
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 50
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 50
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 50
- SYFHQHYTNCQCCN-MELADBBJSA-N Tyr-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O SYFHQHYTNCQCCN-MELADBBJSA-N 0.000 description 50
- PAPWZOJOLKZEFR-AVGNSLFASA-N Val-Arg-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N PAPWZOJOLKZEFR-AVGNSLFASA-N 0.000 description 50
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 50
- 108010090894 prolylleucine Proteins 0.000 description 50
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 49
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 49
- SYTFJIQPBRJSOK-NKIYYHGXSA-N Gln-Thr-His Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 SYTFJIQPBRJSOK-NKIYYHGXSA-N 0.000 description 48
- JQEBITVYKUCBMC-SRVKXCTJSA-N Met-Arg-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JQEBITVYKUCBMC-SRVKXCTJSA-N 0.000 description 48
- 150000001413 amino acids Chemical group 0.000 description 48
- 108010018006 histidylserine Proteins 0.000 description 48
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 47
- PZSDPRBZINDEJV-HTUGSXCWSA-N Thr-Phe-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PZSDPRBZINDEJV-HTUGSXCWSA-N 0.000 description 46
- QJHOOKBAHRJPPX-QWRGUYRKSA-N Asp-Phe-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 QJHOOKBAHRJPPX-QWRGUYRKSA-N 0.000 description 44
- PDSUIXMZYNURGI-AVGNSLFASA-N His-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CN=CN1 PDSUIXMZYNURGI-AVGNSLFASA-N 0.000 description 44
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 43
- IPFKIGNDTUOFAF-CYDGBPFRSA-N Ile-Val-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IPFKIGNDTUOFAF-CYDGBPFRSA-N 0.000 description 42
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 42
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 40
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 39
- MCAVASRGVBVPMX-FXQIFTODSA-N Gln-Glu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MCAVASRGVBVPMX-FXQIFTODSA-N 0.000 description 37
- BMGOFDMKDVVGJG-NHCYSSNCSA-N Val-Asp-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BMGOFDMKDVVGJG-NHCYSSNCSA-N 0.000 description 36
- 238000003752 polymerase chain reaction Methods 0.000 description 36
- CMHTUJQZQXFNTQ-OEAJRASXSA-N Phe-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O CMHTUJQZQXFNTQ-OEAJRASXSA-N 0.000 description 35
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 35
- DURWCDDDAWVPOP-JBDRJPRFSA-N Ile-Cys-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N DURWCDDDAWVPOP-JBDRJPRFSA-N 0.000 description 34
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 33
- 108010009298 lysylglutamic acid Proteins 0.000 description 31
- HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 30
- 230000000840 anti-viral effect Effects 0.000 description 28
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 27
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 27
- BTSPOOHJBYJRKO-CIUDSAMLSA-N Gln-Asp-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BTSPOOHJBYJRKO-CIUDSAMLSA-N 0.000 description 26
- SKHPKKYKDYULDH-HJGDQZAQSA-N Thr-Asn-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SKHPKKYKDYULDH-HJGDQZAQSA-N 0.000 description 26
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 25
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 24
- ALTQTAKGRFLRLR-GUBZILKMSA-N Cys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N ALTQTAKGRFLRLR-GUBZILKMSA-N 0.000 description 24
- UESYBOXFJWJVSB-AVGNSLFASA-N Gln-Phe-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O UESYBOXFJWJVSB-AVGNSLFASA-N 0.000 description 24
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 24
- QQFSKBMCAKWHLG-UHFFFAOYSA-N Ile-Phe-Pro-Pro Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(NC(=O)C(N)C(C)CC)CC1=CC=CC=C1 QQFSKBMCAKWHLG-UHFFFAOYSA-N 0.000 description 24
- PZWBBXHHUSIGKH-OSUNSFLBSA-N Ile-Thr-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PZWBBXHHUSIGKH-OSUNSFLBSA-N 0.000 description 24
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 24
- MDDUIRLQCYVRDO-NHCYSSNCSA-N Lys-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN MDDUIRLQCYVRDO-NHCYSSNCSA-N 0.000 description 24
- FWAHLGXNBLWIKB-NAKRPEOUSA-N Met-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCSC FWAHLGXNBLWIKB-NAKRPEOUSA-N 0.000 description 24
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 24
- CJAHQEZWDZNSJO-KKUMJFAQSA-N Phe-Lys-Cys Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CS)C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 CJAHQEZWDZNSJO-KKUMJFAQSA-N 0.000 description 24
- CZQZSMJXFGGBHM-KKUMJFAQSA-N Phe-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O CZQZSMJXFGGBHM-KKUMJFAQSA-N 0.000 description 24
- LAFLAXHTDVNVEL-WDCWCFNPSA-N Thr-Gln-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O LAFLAXHTDVNVEL-WDCWCFNPSA-N 0.000 description 24
- SSSDKJMQMZTMJP-BVSLBCMMSA-N Trp-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CC=C(O)C=C1 SSSDKJMQMZTMJP-BVSLBCMMSA-N 0.000 description 24
- QYSBJAUCUKHSLU-JYJNAYRXSA-N Tyr-Arg-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O QYSBJAUCUKHSLU-JYJNAYRXSA-N 0.000 description 24
- 239000013604 expression vector Substances 0.000 description 24
- 108010049041 glutamylalanine Proteins 0.000 description 24
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 24
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 23
- FVBZXNSRIDVYJS-AVGNSLFASA-N Arg-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N FVBZXNSRIDVYJS-AVGNSLFASA-N 0.000 description 23
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 23
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 23
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 23
- PABFFPWEJMEVEC-JGVFFNPUSA-N Gly-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)CN)C(=O)O PABFFPWEJMEVEC-JGVFFNPUSA-N 0.000 description 23
- WEWCEPOYKANMGZ-MMWGEVLESA-N Ile-Cys-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N WEWCEPOYKANMGZ-MMWGEVLESA-N 0.000 description 23
- 241000880493 Leptailurus serval Species 0.000 description 23
- DLAFCQWUMFMZSN-GUBZILKMSA-N Met-Arg-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CCCN=C(N)N DLAFCQWUMFMZSN-GUBZILKMSA-N 0.000 description 23
- RKIIYGUHIQJCBW-SRVKXCTJSA-N Met-His-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RKIIYGUHIQJCBW-SRVKXCTJSA-N 0.000 description 23
- GDXZRWYXJSGWIV-GMOBBJLQSA-N Pro-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 GDXZRWYXJSGWIV-GMOBBJLQSA-N 0.000 description 23
- ASJDFGOPDCVXTG-KATARQTJSA-N Thr-Cys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ASJDFGOPDCVXTG-KATARQTJSA-N 0.000 description 23
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 23
- ZIGZPYJXIWLQFC-QTKMDUPCSA-N Val-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C(C)C)N)O ZIGZPYJXIWLQFC-QTKMDUPCSA-N 0.000 description 23
- DXVOKNVIKORTHQ-GUBZILKMSA-N Glu-Pro-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O DXVOKNVIKORTHQ-GUBZILKMSA-N 0.000 description 22
- SJRQWEDYTKYHHL-SLFFLAALSA-N Phe-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O SJRQWEDYTKYHHL-SLFFLAALSA-N 0.000 description 22
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 22
- QVOGDCQNGLBNCR-FXQIFTODSA-N Ser-Arg-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O QVOGDCQNGLBNCR-FXQIFTODSA-N 0.000 description 22
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 22
- 108010064235 lysylglycine Proteins 0.000 description 22
- FYVHHKMHFPMBBG-GUBZILKMSA-N His-Gln-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N FYVHHKMHFPMBBG-GUBZILKMSA-N 0.000 description 21
- BWCZJGJKOFUUCN-ZPFDUUQYSA-N Pro-Ile-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O BWCZJGJKOFUUCN-ZPFDUUQYSA-N 0.000 description 21
- 108010081551 glycylphenylalanine Proteins 0.000 description 21
- 108010054155 lysyllysine Proteins 0.000 description 21
- RRIJEABIXPKSGP-FXQIFTODSA-N Cys-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS RRIJEABIXPKSGP-FXQIFTODSA-N 0.000 description 20
- 238000002965 ELISA Methods 0.000 description 20
- TUYWCHPXKQTISF-LPEHRKFASA-N Pro-Cys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N2CCC[C@@H]2C(=O)O TUYWCHPXKQTISF-LPEHRKFASA-N 0.000 description 20
- 206010057190 Respiratory tract infections Diseases 0.000 description 20
- QPPYAWVLAVXISR-DCAQKATOSA-N Ser-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QPPYAWVLAVXISR-DCAQKATOSA-N 0.000 description 20
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 20
- WFAUDCSNCWJJAA-KXNHARMFSA-N Thr-Lys-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(O)=O WFAUDCSNCWJJAA-KXNHARMFSA-N 0.000 description 20
- UKEVLVBHRKWECS-LSJOCFKGSA-N Val-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)N UKEVLVBHRKWECS-LSJOCFKGSA-N 0.000 description 20
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 20
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 19
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 19
- AQPZYBSRDRZBAG-AVGNSLFASA-N Gln-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N AQPZYBSRDRZBAG-AVGNSLFASA-N 0.000 description 19
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 19
- ARIORLIIMJACKZ-KKUMJFAQSA-N Glu-Pro-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ARIORLIIMJACKZ-KKUMJFAQSA-N 0.000 description 19
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 19
- WMKXFMUJRCEGRP-SRVKXCTJSA-N His-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N WMKXFMUJRCEGRP-SRVKXCTJSA-N 0.000 description 19
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 19
- RKIGNDAHUOOIMJ-BQFCYCMXSA-N Val-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 RKIGNDAHUOOIMJ-BQFCYCMXSA-N 0.000 description 19
- SBJCTAZFSZXWSR-AVGNSLFASA-N Val-Met-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SBJCTAZFSZXWSR-AVGNSLFASA-N 0.000 description 19
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 19
- 241000700605 Viruses Species 0.000 description 19
- 108010091871 leucylmethionine Proteins 0.000 description 19
- WQLDNOCHHRISMS-NAKRPEOUSA-N Ala-Pro-Ile Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WQLDNOCHHRISMS-NAKRPEOUSA-N 0.000 description 18
- BVBKBQRPOJFCQM-DCAQKATOSA-N Arg-Asn-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BVBKBQRPOJFCQM-DCAQKATOSA-N 0.000 description 18
- ZPWMEWYQBWSGAO-ZJDVBMNYSA-N Arg-Thr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZPWMEWYQBWSGAO-ZJDVBMNYSA-N 0.000 description 18
- SVABRQFIHCSNCI-FOHZUACHSA-N Asp-Gly-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SVABRQFIHCSNCI-FOHZUACHSA-N 0.000 description 18
- DHNWZLGBTPUTQQ-QEJZJMRPSA-N Gln-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N DHNWZLGBTPUTQQ-QEJZJMRPSA-N 0.000 description 18
- LURCIJSJAKFCRO-QWRGUYRKSA-N Gly-Asn-Tyr Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LURCIJSJAKFCRO-QWRGUYRKSA-N 0.000 description 18
- QAMMIGULQSIRCD-IRXDYDNUSA-N Gly-Phe-Tyr Chemical compound C([C@H](NC(=O)C[NH3+])C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C([O-])=O)C1=CC=CC=C1 QAMMIGULQSIRCD-IRXDYDNUSA-N 0.000 description 18
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 18
- BRQKGRLDDDQWQJ-MBLNEYKQSA-N His-Thr-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O BRQKGRLDDDQWQJ-MBLNEYKQSA-N 0.000 description 18
- ZGGWRNBSBOHIGH-HVTMNAMFSA-N Ile-Gln-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZGGWRNBSBOHIGH-HVTMNAMFSA-N 0.000 description 18
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 18
- PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 18
- DUTMKEAPLLUGNO-JYJNAYRXSA-N Lys-Glu-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DUTMKEAPLLUGNO-JYJNAYRXSA-N 0.000 description 18
- JOSAKOKSPXROGQ-BJDJZHNGSA-N Lys-Ser-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JOSAKOKSPXROGQ-BJDJZHNGSA-N 0.000 description 18
- LGSANCBHSMDFDY-GARJFASQSA-N Pro-Glu-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O LGSANCBHSMDFDY-GARJFASQSA-N 0.000 description 18
- TYMBHHITTMGGPI-NAKRPEOUSA-N Pro-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H]1CCCN1 TYMBHHITTMGGPI-NAKRPEOUSA-N 0.000 description 18
- FHZJRBVMLGOHBX-GUBZILKMSA-N Pro-Pro-Asp Chemical compound OC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(O)=O FHZJRBVMLGOHBX-GUBZILKMSA-N 0.000 description 18
- PMCMLDNPAZUYGI-DCAQKATOSA-N Ser-Lys-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMCMLDNPAZUYGI-DCAQKATOSA-N 0.000 description 18
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 18
- GZYNMZQXFRWDFH-YTWAJWBKSA-N Thr-Arg-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O GZYNMZQXFRWDFH-YTWAJWBKSA-N 0.000 description 18
- RIVVDNTUSRVTQT-IRIUXVKKSA-N Tyr-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O RIVVDNTUSRVTQT-IRIUXVKKSA-N 0.000 description 18
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 18
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 18
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 18
- 108010044940 alanylglutamine Proteins 0.000 description 18
- 108010060199 cysteinylproline Proteins 0.000 description 18
- 108010010147 glycylglutamine Proteins 0.000 description 18
- 108010053037 kyotorphin Proteins 0.000 description 18
- 108010051242 phenylalanylserine Proteins 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 108010080629 tryptophan-leucine Proteins 0.000 description 18
- 108010020532 tyrosyl-proline Proteins 0.000 description 18
- OHLLDUNVMPPUMD-DCAQKATOSA-N Cys-Leu-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N OHLLDUNVMPPUMD-DCAQKATOSA-N 0.000 description 17
- ZXCAQANTQWBICD-DCAQKATOSA-N Cys-Lys-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N ZXCAQANTQWBICD-DCAQKATOSA-N 0.000 description 17
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 17
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 17
- BWTKUQPNOMMKMA-FIRPJDEBSA-N Phe-Ile-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BWTKUQPNOMMKMA-FIRPJDEBSA-N 0.000 description 17
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 17
- PCWLNNZTBJTZRN-AVGNSLFASA-N Pro-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 PCWLNNZTBJTZRN-AVGNSLFASA-N 0.000 description 17
- QKWYXRPICJEQAJ-KJEVXHAQSA-N Pro-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2)O QKWYXRPICJEQAJ-KJEVXHAQSA-N 0.000 description 17
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 17
- RTXKJFWHEBTABY-IHPCNDPISA-N Ser-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CO)N RTXKJFWHEBTABY-IHPCNDPISA-N 0.000 description 17
- DSLHSTIUAPKERR-XGEHTFHBSA-N Thr-Cys-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(O)=O DSLHSTIUAPKERR-XGEHTFHBSA-N 0.000 description 17
- FIFDDJFLNVAVMS-RHYQMDGZSA-N Thr-Leu-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O FIFDDJFLNVAVMS-RHYQMDGZSA-N 0.000 description 17
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 17
- JXGWQYWDUOWQHA-DZKIICNBSA-N Val-Gln-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N JXGWQYWDUOWQHA-DZKIICNBSA-N 0.000 description 17
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 17
- 108010005233 alanylglutamic acid Proteins 0.000 description 17
- 108010065920 Insulin Lispro Proteins 0.000 description 16
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 16
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 16
- UCDOXFBTMLKASE-HERUPUMHSA-N Ala-Ser-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N UCDOXFBTMLKASE-HERUPUMHSA-N 0.000 description 15
- WAEDSQFVZJUHLI-BYULHYEWSA-N Asp-Val-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WAEDSQFVZJUHLI-BYULHYEWSA-N 0.000 description 15
- XJKAKYXMFHUIHT-AUTRQRHGSA-N Gln-Glu-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N XJKAKYXMFHUIHT-AUTRQRHGSA-N 0.000 description 15
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 15
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 15
- MGLBSROLWAWCKN-FCLVOEFKSA-N Phe-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MGLBSROLWAWCKN-FCLVOEFKSA-N 0.000 description 15
- FISHYTLIMUYTQY-GUBZILKMSA-N Pro-Gln-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 FISHYTLIMUYTQY-GUBZILKMSA-N 0.000 description 15
- 108010047857 aspartylglycine Proteins 0.000 description 15
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 15
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 14
- SFNFGFDRYJKZKN-XQXXSGGOSA-N Ala-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)N)O SFNFGFDRYJKZKN-XQXXSGGOSA-N 0.000 description 14
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 14
- ZJBUILVYSXQNSW-YTWAJWBKSA-N Arg-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ZJBUILVYSXQNSW-YTWAJWBKSA-N 0.000 description 14
- FTSAJSADJCMDHH-CIUDSAMLSA-N Asn-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FTSAJSADJCMDHH-CIUDSAMLSA-N 0.000 description 14
- IXFVOPOHSRKJNG-LAEOZQHASA-N Gln-Asp-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IXFVOPOHSRKJNG-LAEOZQHASA-N 0.000 description 14
- LWDGZZGWDMHBOF-FXQIFTODSA-N Gln-Glu-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O LWDGZZGWDMHBOF-FXQIFTODSA-N 0.000 description 14
- NPSWCZIRBAYNSB-JHEQGTHGSA-N Gly-Gln-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NPSWCZIRBAYNSB-JHEQGTHGSA-N 0.000 description 14
- PFPUFNLHBXKPHY-HTFCKZLJSA-N Ile-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)N PFPUFNLHBXKPHY-HTFCKZLJSA-N 0.000 description 14
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 14
- KNYPNEYICHHLQL-ACRUOGEOSA-N Phe-Leu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 KNYPNEYICHHLQL-ACRUOGEOSA-N 0.000 description 14
- FYKUEXMZYFIZKA-DCAQKATOSA-N Pro-Pro-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O FYKUEXMZYFIZKA-DCAQKATOSA-N 0.000 description 14
- LRZLZIUXQBIWTB-KATARQTJSA-N Ser-Lys-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRZLZIUXQBIWTB-KATARQTJSA-N 0.000 description 14
- 108010077245 asparaginyl-proline Proteins 0.000 description 14
- 108010003700 lysyl aspartic acid Proteins 0.000 description 14
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 14
- DLOHWQXXGMEZDW-CIUDSAMLSA-N Gln-Arg-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O DLOHWQXXGMEZDW-CIUDSAMLSA-N 0.000 description 13
- QYKBTDOAMKORGL-FXQIFTODSA-N Gln-Gln-Asp Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N QYKBTDOAMKORGL-FXQIFTODSA-N 0.000 description 13
- ZJICFHQSPWFBKP-AVGNSLFASA-N Glu-Asn-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZJICFHQSPWFBKP-AVGNSLFASA-N 0.000 description 13
- FOKISINOENBSDM-WLTAIBSBSA-N Gly-Thr-Tyr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O FOKISINOENBSDM-WLTAIBSBSA-N 0.000 description 13
- AHZNUGRZHMZGFL-GUBZILKMSA-N Met-Arg-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCNC(N)=N AHZNUGRZHMZGFL-GUBZILKMSA-N 0.000 description 13
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 13
- HWLKHNDRXWTFTN-GUBZILKMSA-N Pro-Pro-Cys Chemical compound C1C[C@H](NC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CS)C(=O)O HWLKHNDRXWTFTN-GUBZILKMSA-N 0.000 description 13
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 13
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 13
- 239000012634 fragment Substances 0.000 description 13
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 12
- ZGKVPOSSTGHJAF-HJPIBITLSA-N Ile-Tyr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)N ZGKVPOSSTGHJAF-HJPIBITLSA-N 0.000 description 12
- 239000012091 fetal bovine serum Substances 0.000 description 12
- 108010047761 Interferon-alpha Proteins 0.000 description 11
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 11
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 11
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 11
- XGFGVFMXDXALEV-XIRDDKMYSA-N Trp-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N XGFGVFMXDXALEV-XIRDDKMYSA-N 0.000 description 11
- 108010026333 seryl-proline Proteins 0.000 description 11
- DWINFPQUSSHSFS-UVBJJODRSA-N Ala-Arg-Trp Chemical compound N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O DWINFPQUSSHSFS-UVBJJODRSA-N 0.000 description 10
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 10
- NONSEUUPKITYQT-BQBZGAKWSA-N Arg-Asn-Gly Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N)CN=C(N)N NONSEUUPKITYQT-BQBZGAKWSA-N 0.000 description 10
- ILQCHXURSRRIRY-YUMQZZPRSA-N Asp-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)O)N ILQCHXURSRRIRY-YUMQZZPRSA-N 0.000 description 10
- VLOLPWWCNKWRNB-LOKLDPHHSA-N Gln-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O VLOLPWWCNKWRNB-LOKLDPHHSA-N 0.000 description 10
- HNAUFGBKJLTWQE-IFFSRLJSSA-N Gln-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N)O HNAUFGBKJLTWQE-IFFSRLJSSA-N 0.000 description 10
- LXAUHIRMWXQRKI-XHNCKOQMSA-N Glu-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O LXAUHIRMWXQRKI-XHNCKOQMSA-N 0.000 description 10
- ZNOHKCPYDAYYDA-BPUTZDHNSA-N Glu-Trp-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZNOHKCPYDAYYDA-BPUTZDHNSA-N 0.000 description 10
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 10
- GNPVTZJUUBPZKW-WDSKDSINSA-N Gly-Gln-Ser Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GNPVTZJUUBPZKW-WDSKDSINSA-N 0.000 description 10
- 102100040019 Interferon alpha-1/13 Human genes 0.000 description 10
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 10
- KZOHPCYVORJBLG-AVGNSLFASA-N Lys-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N KZOHPCYVORJBLG-AVGNSLFASA-N 0.000 description 10
- GHKXHCMRAUYLBS-CIUDSAMLSA-N Lys-Ser-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O GHKXHCMRAUYLBS-CIUDSAMLSA-N 0.000 description 10
- ZFVWWUILVLLVFA-AVGNSLFASA-N Phe-Gln-Cys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N ZFVWWUILVLLVFA-AVGNSLFASA-N 0.000 description 10
- JDMKQHSHKJHAHR-UHFFFAOYSA-N Phe-Phe-Leu-Tyr Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)CC1=CC=CC=C1 JDMKQHSHKJHAHR-UHFFFAOYSA-N 0.000 description 10
- ALJGSKMBIUEJOB-FXQIFTODSA-N Pro-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H]1CCCN1 ALJGSKMBIUEJOB-FXQIFTODSA-N 0.000 description 10
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 10
- PEYNRYREGPAOAK-LSJOCFKGSA-N Pro-His-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 PEYNRYREGPAOAK-LSJOCFKGSA-N 0.000 description 10
- UKBSDLHIKIXJKH-HJGDQZAQSA-N Thr-Arg-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UKBSDLHIKIXJKH-HJGDQZAQSA-N 0.000 description 10
- MQBTXMPQNCGSSZ-OSUNSFLBSA-N Thr-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N MQBTXMPQNCGSSZ-OSUNSFLBSA-N 0.000 description 10
- UHBPFYOQQPFKQR-JHEQGTHGSA-N Thr-Gln-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O UHBPFYOQQPFKQR-JHEQGTHGSA-N 0.000 description 10
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 10
- RRVUOLRWIZXBRQ-IHPCNDPISA-N Trp-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N RRVUOLRWIZXBRQ-IHPCNDPISA-N 0.000 description 10
- RYHUIHUOYRNNIE-NRPADANISA-N Val-Ser-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N RYHUIHUOYRNNIE-NRPADANISA-N 0.000 description 10
- 108010078144 glutaminyl-glycine Proteins 0.000 description 10
- 108010015792 glycyllysine Proteins 0.000 description 10
- 108010040030 histidinoalanine Proteins 0.000 description 10
- 108010012581 phenylalanylglutamate Proteins 0.000 description 10
- 108010077112 prolyl-proline Proteins 0.000 description 10
- 108010031719 prolyl-serine Proteins 0.000 description 10
- 108010029020 prolylglycine Proteins 0.000 description 10
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 9
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 9
- BIOCIVSVEDFKDJ-GUBZILKMSA-N Arg-Arg-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O BIOCIVSVEDFKDJ-GUBZILKMSA-N 0.000 description 9
- APHUDFFMXFYRKP-CIUDSAMLSA-N Asn-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N APHUDFFMXFYRKP-CIUDSAMLSA-N 0.000 description 9
- UBKOVSLDWIHYSY-ACZMJKKPSA-N Asn-Glu-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UBKOVSLDWIHYSY-ACZMJKKPSA-N 0.000 description 9
- JZLFYAAGGYMRIK-BYULHYEWSA-N Asn-Val-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O JZLFYAAGGYMRIK-BYULHYEWSA-N 0.000 description 9
- 108020004635 Complementary DNA Proteins 0.000 description 9
- LLZLRXBTOOFODM-QSFUFRPTSA-N Ile-Asp-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N LLZLRXBTOOFODM-QSFUFRPTSA-N 0.000 description 9
- VOCZPDONPURUHV-QEWYBTABSA-N Ile-Phe-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VOCZPDONPURUHV-QEWYBTABSA-N 0.000 description 9
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 9
- XNKDCYABMBBEKN-IUCAKERBSA-N Lys-Gly-Gln Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O XNKDCYABMBBEKN-IUCAKERBSA-N 0.000 description 9
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 9
- SCZJKZLFSSPJDP-ACRUOGEOSA-N Tyr-Phe-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O SCZJKZLFSSPJDP-ACRUOGEOSA-N 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 238000010804 cDNA synthesis Methods 0.000 description 9
- 238000004113 cell culture Methods 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 108010045383 histidyl-glycyl-glutamic acid Proteins 0.000 description 9
- 238000011534 incubation Methods 0.000 description 9
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- QHBMKQWOIYJYMI-BYULHYEWSA-N Asn-Asn-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O QHBMKQWOIYJYMI-BYULHYEWSA-N 0.000 description 8
- ZEXHDOQQYZKOIB-ACZMJKKPSA-N Cys-Glu-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZEXHDOQQYZKOIB-ACZMJKKPSA-N 0.000 description 8
- VIRYODQIWJNWNU-NRPADANISA-N Cys-Glu-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N VIRYODQIWJNWNU-NRPADANISA-N 0.000 description 8
- XSBGUANSZDGULP-IUCAKERBSA-N Gln-Gly-Lys Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O XSBGUANSZDGULP-IUCAKERBSA-N 0.000 description 8
- VXQOONWNIWFOCS-HGNGGELXSA-N Glu-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N VXQOONWNIWFOCS-HGNGGELXSA-N 0.000 description 8
- YOTHMZZSJKKEHZ-SZMVWBNQSA-N Glu-Trp-Lys Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CCC(O)=O)=CNC2=C1 YOTHMZZSJKKEHZ-SZMVWBNQSA-N 0.000 description 8
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 8
- TZCGZYWNIDZZMR-UHFFFAOYSA-N Ile-Arg-Ala Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(C)C(O)=O)CCCN=C(N)N TZCGZYWNIDZZMR-UHFFFAOYSA-N 0.000 description 8
- KBHYLOIVRVBBEB-JBDRJPRFSA-N Ile-Cys-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N KBHYLOIVRVBBEB-JBDRJPRFSA-N 0.000 description 8
- IGJWJGIHUFQANP-LAEOZQHASA-N Ile-Gly-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N IGJWJGIHUFQANP-LAEOZQHASA-N 0.000 description 8
- APDIECQNNDGFPD-PYJNHQTQSA-N Ile-His-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N APDIECQNNDGFPD-PYJNHQTQSA-N 0.000 description 8
- KYLIZSDYWQQTFM-PEDHHIEDSA-N Ile-Ile-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N KYLIZSDYWQQTFM-PEDHHIEDSA-N 0.000 description 8
- XMYURPUVJSKTMC-KBIXCLLPSA-N Ile-Ser-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N XMYURPUVJSKTMC-KBIXCLLPSA-N 0.000 description 8
- LVTJJOJKDCVZGP-QWRGUYRKSA-N Leu-Lys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LVTJJOJKDCVZGP-QWRGUYRKSA-N 0.000 description 8
- LUAJJLPHUXPQLH-KKUMJFAQSA-N Lys-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N LUAJJLPHUXPQLH-KKUMJFAQSA-N 0.000 description 8
- MDXAULHWGWETHF-SRVKXCTJSA-N Met-Arg-Val Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CCCNC(N)=N MDXAULHWGWETHF-SRVKXCTJSA-N 0.000 description 8
- 229930182555 Penicillin Natural products 0.000 description 8
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 8
- UEADQPLTYBWWTG-AVGNSLFASA-N Phe-Glu-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 UEADQPLTYBWWTG-AVGNSLFASA-N 0.000 description 8
- NHCKESBLOMHIIE-IRXDYDNUSA-N Phe-Gly-Phe Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 NHCKESBLOMHIIE-IRXDYDNUSA-N 0.000 description 8
- UPJGUQPLYWTISV-GUBZILKMSA-N Pro-Gln-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UPJGUQPLYWTISV-GUBZILKMSA-N 0.000 description 8
- QNZLIVROMORQFH-BQBZGAKWSA-N Pro-Gly-Cys Chemical compound C1C[C@H](NC1)C(=O)NCC(=O)N[C@@H](CS)C(=O)O QNZLIVROMORQFH-BQBZGAKWSA-N 0.000 description 8
- YUSRGTQIPCJNHQ-CIUDSAMLSA-N Ser-Arg-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YUSRGTQIPCJNHQ-CIUDSAMLSA-N 0.000 description 8
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 8
- WFUAUEQXPVNAEF-ZJDVBMNYSA-N Thr-Arg-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CCCN=C(N)N WFUAUEQXPVNAEF-ZJDVBMNYSA-N 0.000 description 8
- WNQJTLATMXYSEL-OEAJRASXSA-N Thr-Phe-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WNQJTLATMXYSEL-OEAJRASXSA-N 0.000 description 8
- MWHOLXNKRKRQQH-XIRDDKMYSA-N Trp-Asp-His Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O)N MWHOLXNKRKRQQH-XIRDDKMYSA-N 0.000 description 8
- PGQUDQYHWICSAB-NAKRPEOUSA-N Val-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N PGQUDQYHWICSAB-NAKRPEOUSA-N 0.000 description 8
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 8
- 108010047495 alanylglycine Proteins 0.000 description 8
- 238000003776 cleavage reaction Methods 0.000 description 8
- 229940049954 penicillin Drugs 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 229960005322 streptomycin Drugs 0.000 description 8
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 7
- XMPXVJIDADUOQB-RCOVLWMOSA-N Gly-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)CNC(=O)C[NH3+] XMPXVJIDADUOQB-RCOVLWMOSA-N 0.000 description 7
- 239000004471 Glycine Substances 0.000 description 7
- RIPJMCFGQHGHNP-RHYQMDGZSA-N Lys-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)N)O RIPJMCFGQHGHNP-RHYQMDGZSA-N 0.000 description 7
- UAYHMOIGIQZLFR-NHCYSSNCSA-N Pro-Gln-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O UAYHMOIGIQZLFR-NHCYSSNCSA-N 0.000 description 7
- AYCQVUUPIJHJTA-IXOXFDKPSA-N Thr-His-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O AYCQVUUPIJHJTA-IXOXFDKPSA-N 0.000 description 7
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 7
- LCHZBEUVGAVMKS-RHYQMDGZSA-N Val-Thr-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(O)=O LCHZBEUVGAVMKS-RHYQMDGZSA-N 0.000 description 7
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000001262 western blot Methods 0.000 description 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
- GXXWTNKNFFKTJB-NAKRPEOUSA-N Arg-Ile-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O GXXWTNKNFFKTJB-NAKRPEOUSA-N 0.000 description 6
- QXHVOUSPVAWEMX-ZLUOBGJFSA-N Asp-Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXHVOUSPVAWEMX-ZLUOBGJFSA-N 0.000 description 6
- LIVXPXUVXFRWNY-CIUDSAMLSA-N Asp-Lys-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O LIVXPXUVXFRWNY-CIUDSAMLSA-N 0.000 description 6
- LUGUNEGJNDEBLU-DCAQKATOSA-N Gln-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N LUGUNEGJNDEBLU-DCAQKATOSA-N 0.000 description 6
- XKPACHRGOWQHFH-IRIUXVKKSA-N Gln-Thr-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XKPACHRGOWQHFH-IRIUXVKKSA-N 0.000 description 6
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 6
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 6
- GWADARYJIJDYRC-XGEHTFHBSA-N Met-Thr-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GWADARYJIJDYRC-XGEHTFHBSA-N 0.000 description 6
- YYRCPTVAPLQRNC-ULQDDVLXSA-N Phe-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC1=CC=CC=C1 YYRCPTVAPLQRNC-ULQDDVLXSA-N 0.000 description 6
- MVIJMIZJPHQGEN-IHRRRGAJSA-N Phe-Ser-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@H](CO)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 MVIJMIZJPHQGEN-IHRRRGAJSA-N 0.000 description 6
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 6
- ZOPISOXXPQNOCO-SVSWQMSJSA-N Ser-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CO)N ZOPISOXXPQNOCO-SVSWQMSJSA-N 0.000 description 6
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 6
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 6
- 239000006180 TBST buffer Substances 0.000 description 6
- DOBIBIXIHJKVJF-XKBZYTNZSA-N Thr-Ser-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O DOBIBIXIHJKVJF-XKBZYTNZSA-N 0.000 description 6
- WPSYJHFHZYJXMW-JSGCOSHPSA-N Trp-Gln-Gly Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O WPSYJHFHZYJXMW-JSGCOSHPSA-N 0.000 description 6
- 108010068265 aspartyltyrosine Proteins 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 108010038320 lysylphenylalanine Proteins 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 108010005652 splenotritin Proteins 0.000 description 6
- 239000011534 wash buffer Substances 0.000 description 6
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 5
- KZYSHAMXEBPJBD-JRQIVUDYSA-N Asn-Thr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KZYSHAMXEBPJBD-JRQIVUDYSA-N 0.000 description 5
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 5
- YWLDTBBUHZJQHW-KKUMJFAQSA-N Asp-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N YWLDTBBUHZJQHW-KKUMJFAQSA-N 0.000 description 5
- GXHDGYOXPNQCKM-XVSYOHENSA-N Asp-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O GXHDGYOXPNQCKM-XVSYOHENSA-N 0.000 description 5
- 241000283707 Capra Species 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- PGPJSRSLQNXBDT-YUMQZZPRSA-N Gln-Arg-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O PGPJSRSLQNXBDT-YUMQZZPRSA-N 0.000 description 5
- PBYFVIQRFLNQCO-GUBZILKMSA-N Gln-Pro-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O PBYFVIQRFLNQCO-GUBZILKMSA-N 0.000 description 5
- CQGBSALYGOXQPE-HTUGSXCWSA-N Glu-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O CQGBSALYGOXQPE-HTUGSXCWSA-N 0.000 description 5
- DENRBIYENOKSEX-PEXQALLHSA-N Gly-Ile-His Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 DENRBIYENOKSEX-PEXQALLHSA-N 0.000 description 5
- NTRAGDHVSGKUSF-AVGNSLFASA-N Leu-Arg-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NTRAGDHVSGKUSF-AVGNSLFASA-N 0.000 description 5
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 5
- IDQFQFVEWMWRQQ-DLOVCJGASA-N Ser-Ala-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IDQFQFVEWMWRQQ-DLOVCJGASA-N 0.000 description 5
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 108010087924 alanylproline Proteins 0.000 description 5
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 5
- MXHCPCSDRGLRER-UHFFFAOYSA-N pentaglycine Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(O)=O MXHCPCSDRGLRER-UHFFFAOYSA-N 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 4
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 4
- DRCOAZZDQRCGGP-GHCJXIJMSA-N Asp-Ser-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DRCOAZZDQRCGGP-GHCJXIJMSA-N 0.000 description 4
- XIYWAJQIWLXXAF-XKBZYTNZSA-N Gln-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O XIYWAJQIWLXXAF-XKBZYTNZSA-N 0.000 description 4
- VAZZOGXDUQSVQF-NUMRIWBASA-N Glu-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)O VAZZOGXDUQSVQF-NUMRIWBASA-N 0.000 description 4
- OPAINBJQDQTGJY-JGVFFNPUSA-N Glu-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)O)N)C(=O)O OPAINBJQDQTGJY-JGVFFNPUSA-N 0.000 description 4
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 4
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 description 4
- HYLIOBDWPQNLKI-HVTMNAMFSA-N Ile-His-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HYLIOBDWPQNLKI-HVTMNAMFSA-N 0.000 description 4
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 4
- CDNPIRSCAFMMBE-SRVKXCTJSA-N Phe-Asn-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CDNPIRSCAFMMBE-SRVKXCTJSA-N 0.000 description 4
- XZQYIJALMGEUJD-OEAJRASXSA-N Phe-Lys-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XZQYIJALMGEUJD-OEAJRASXSA-N 0.000 description 4
- RCYUBVHMVUHEBM-RCWTZXSCSA-N Pro-Pro-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RCYUBVHMVUHEBM-RCWTZXSCSA-N 0.000 description 4
- KWQBJOUOSNJDRR-XAVMHZPKSA-N Thr-Cys-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N)O KWQBJOUOSNJDRR-XAVMHZPKSA-N 0.000 description 4
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 4
- DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 4
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 4
- XZLHHHYSWIYXHD-XIRDDKMYSA-N Trp-Gln-Arg Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XZLHHHYSWIYXHD-XIRDDKMYSA-N 0.000 description 4
- SGFIXFAHVWJKTD-KJEVXHAQSA-N Tyr-Arg-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SGFIXFAHVWJKTD-KJEVXHAQSA-N 0.000 description 4
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 4
- 108010036413 histidylglycine Proteins 0.000 description 4
- 108010079317 prolyl-tyrosine Proteins 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- WCBVQNZTOKJWJS-ACZMJKKPSA-N Ala-Cys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O WCBVQNZTOKJWJS-ACZMJKKPSA-N 0.000 description 3
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 3
- JLNFZLNDHONLND-GARJFASQSA-N Asn-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N JLNFZLNDHONLND-GARJFASQSA-N 0.000 description 3
- YUELDQUPTAYEGM-XIRDDKMYSA-N Asp-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)O)N YUELDQUPTAYEGM-XIRDDKMYSA-N 0.000 description 3
- XMKXONRMGJXCJV-LAEOZQHASA-N Asp-Val-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XMKXONRMGJXCJV-LAEOZQHASA-N 0.000 description 3
- UXUSHQYYQCZWET-WDSKDSINSA-N Cys-Glu-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O UXUSHQYYQCZWET-WDSKDSINSA-N 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- PODFFOWWLUPNMN-DCAQKATOSA-N Gln-His-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PODFFOWWLUPNMN-DCAQKATOSA-N 0.000 description 3
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 3
- SYMSVYVUSPSAAO-IHRRRGAJSA-N His-Arg-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O SYMSVYVUSPSAAO-IHRRRGAJSA-N 0.000 description 3
- LRAUKBMYHHNADU-DKIMLUQUSA-N Ile-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CC1=CC=CC=C1 LRAUKBMYHHNADU-DKIMLUQUSA-N 0.000 description 3
- ZDSNOSQHMJBRQN-SRVKXCTJSA-N Leu-Asp-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZDSNOSQHMJBRQN-SRVKXCTJSA-N 0.000 description 3
- ZTLGVASZOIKNIX-DCAQKATOSA-N Leu-Gln-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZTLGVASZOIKNIX-DCAQKATOSA-N 0.000 description 3
- YUTNOGOMBNYPFH-XUXIUFHCSA-N Leu-Pro-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YUTNOGOMBNYPFH-XUXIUFHCSA-N 0.000 description 3
- LMMBAXJRYSXCOQ-ACRUOGEOSA-N Lys-Tyr-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O LMMBAXJRYSXCOQ-ACRUOGEOSA-N 0.000 description 3
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 3
- WOIFYRZPIORBRY-AVGNSLFASA-N Pro-Lys-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O WOIFYRZPIORBRY-AVGNSLFASA-N 0.000 description 3
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- IJVNLNRVDUTWDD-MEYUZBJRSA-N Thr-Leu-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IJVNLNRVDUTWDD-MEYUZBJRSA-N 0.000 description 3
- WCTYCXZYBNKEIV-SXNHZJKMSA-N Trp-Glu-Ile Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)=CNC2=C1 WCTYCXZYBNKEIV-SXNHZJKMSA-N 0.000 description 3
- OJPRSVJGNCAKQX-SRVKXCTJSA-N Val-Met-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N OJPRSVJGNCAKQX-SRVKXCTJSA-N 0.000 description 3
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 3
- YQYFYUSYEDNLSD-YEPSODPASA-N Val-Thr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O YQYFYUSYEDNLSD-YEPSODPASA-N 0.000 description 3
- 238000004166 bioassay Methods 0.000 description 3
- 108010077515 glycylproline Proteins 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 3
- 108010078274 isoleucylvaline Proteins 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 3
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
- OTCJMMRQBVDQRK-DCAQKATOSA-N Arg-Asp-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OTCJMMRQBVDQRK-DCAQKATOSA-N 0.000 description 2
- SRUUBQBAVNQZGJ-LAEOZQHASA-N Asn-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SRUUBQBAVNQZGJ-LAEOZQHASA-N 0.000 description 2
- QIRJQYQOIKBPBZ-IHRRRGAJSA-N Asn-Tyr-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QIRJQYQOIKBPBZ-IHRRRGAJSA-N 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 241000450599 DNA viruses Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- IGNGBUVODQLMRJ-CIUDSAMLSA-N Gln-Ala-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IGNGBUVODQLMRJ-CIUDSAMLSA-N 0.000 description 2
- IHSGESFHTMFHRB-GUBZILKMSA-N Gln-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O IHSGESFHTMFHRB-GUBZILKMSA-N 0.000 description 2
- UTKICHUQEQBDGC-ACZMJKKPSA-N Glu-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N UTKICHUQEQBDGC-ACZMJKKPSA-N 0.000 description 2
- SAEBUDRWKUXLOM-ACZMJKKPSA-N Glu-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O SAEBUDRWKUXLOM-ACZMJKKPSA-N 0.000 description 2
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 2
- XXGQRGQPGFYECI-WDSKDSINSA-N Gly-Cys-Glu Chemical compound NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCC(O)=O XXGQRGQPGFYECI-WDSKDSINSA-N 0.000 description 2
- LLWQVJNHMYBLLK-CDMKHQONSA-N Gly-Thr-Phe Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLWQVJNHMYBLLK-CDMKHQONSA-N 0.000 description 2
- SYPULFZAGBBIOM-GVXVVHGQSA-N His-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N SYPULFZAGBBIOM-GVXVVHGQSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 102000006992 Interferon-alpha Human genes 0.000 description 2
- 208000007766 Kaposi sarcoma Diseases 0.000 description 2
- NEEOBPIXKWSBRF-IUCAKERBSA-N Leu-Glu-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O NEEOBPIXKWSBRF-IUCAKERBSA-N 0.000 description 2
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 2
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 2
- LINKCQUOMUDLKN-KATARQTJSA-N Leu-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N)O LINKCQUOMUDLKN-KATARQTJSA-N 0.000 description 2
- 108091036060 Linker DNA Proteins 0.000 description 2
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- 231100000002 MTT assay Toxicity 0.000 description 2
- 102000003505 Myosin Human genes 0.000 description 2
- 108060008487 Myosin Proteins 0.000 description 2
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 2
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 2
- KPEIBEPEUAZWNS-ULQDDVLXSA-N Phe-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 KPEIBEPEUAZWNS-ULQDDVLXSA-N 0.000 description 2
- IIEOLPMQYRBZCN-SRVKXCTJSA-N Phe-Ser-Cys Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O IIEOLPMQYRBZCN-SRVKXCTJSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- FKKHDBFNOLCYQM-FXQIFTODSA-N Pro-Cys-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O FKKHDBFNOLCYQM-FXQIFTODSA-N 0.000 description 2
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 2
- AJCRQOHDLCBHFA-SRVKXCTJSA-N Pro-His-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O AJCRQOHDLCBHFA-SRVKXCTJSA-N 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- WGDYNRCOQRERLZ-KKUMJFAQSA-N Ser-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N WGDYNRCOQRERLZ-KKUMJFAQSA-N 0.000 description 2
- KQNDIKOYWZTZIX-FXQIFTODSA-N Ser-Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KQNDIKOYWZTZIX-FXQIFTODSA-N 0.000 description 2
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- OFQGGTGZTOTLGH-NHCYSSNCSA-N Val-Met-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N OFQGGTGZTOTLGH-NHCYSSNCSA-N 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 108010084455 Zeocin Proteins 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000013553 cell monolayer Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 229960001235 gentian violet Drugs 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010092114 histidylphenylalanine Proteins 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 108010027338 isoleucylcysteine Proteins 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 2
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 230000009465 prokaryotic expression Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 238000009120 supportive therapy Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 1
- RUXQNKVQSKOOBS-JURCDPSOSA-N Ala-Phe-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RUXQNKVQSKOOBS-JURCDPSOSA-N 0.000 description 1
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 1
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 1
- FRBAHXABMQXSJQ-FXQIFTODSA-N Arg-Ser-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FRBAHXABMQXSJQ-FXQIFTODSA-N 0.000 description 1
- WONGRTVAMHFGBE-WDSKDSINSA-N Asn-Gly-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N WONGRTVAMHFGBE-WDSKDSINSA-N 0.000 description 1
- HFPXZWPUVFVNLL-GUBZILKMSA-N Asn-Leu-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFPXZWPUVFVNLL-GUBZILKMSA-N 0.000 description 1
- WIDVAWAQBRAKTI-YUMQZZPRSA-N Asn-Leu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O WIDVAWAQBRAKTI-YUMQZZPRSA-N 0.000 description 1
- IXIWEFWRKIUMQX-DCAQKATOSA-N Asp-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O IXIWEFWRKIUMQX-DCAQKATOSA-N 0.000 description 1
- TZOZNVLBTAFJRW-UGYAYLCHSA-N Asp-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N TZOZNVLBTAFJRW-UGYAYLCHSA-N 0.000 description 1
- DINOVZWPTMGSRF-QXEWZRGKSA-N Asp-Pro-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O DINOVZWPTMGSRF-QXEWZRGKSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000010667 Carcinoma of liver and intrahepatic biliary tract Diseases 0.000 description 1
- GGRDJANMZPGMNS-CIUDSAMLSA-N Cys-Ser-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O GGRDJANMZPGMNS-CIUDSAMLSA-N 0.000 description 1
- ALNKNYKSZPSLBD-ZDLURKLDSA-N Cys-Thr-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ALNKNYKSZPSLBD-ZDLURKLDSA-N 0.000 description 1
- NGOIQDYZMIKCOK-NAKRPEOUSA-N Cys-Val-Ile Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NGOIQDYZMIKCOK-NAKRPEOUSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- UZMWDBOHAOSCCH-ACZMJKKPSA-N Gln-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O UZMWDBOHAOSCCH-ACZMJKKPSA-N 0.000 description 1
- KVXVVDFOZNYYKZ-DCAQKATOSA-N Gln-Gln-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KVXVVDFOZNYYKZ-DCAQKATOSA-N 0.000 description 1
- NPTGGVQJYRSMCM-GLLZPBPUSA-N Gln-Gln-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NPTGGVQJYRSMCM-GLLZPBPUSA-N 0.000 description 1
- SHAUZYVSXAMYAZ-JYJNAYRXSA-N Gln-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SHAUZYVSXAMYAZ-JYJNAYRXSA-N 0.000 description 1
- HMIXCETWRYDVMO-GUBZILKMSA-N Gln-Pro-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O HMIXCETWRYDVMO-GUBZILKMSA-N 0.000 description 1
- DYVMTEWCGAVKSE-HJGDQZAQSA-N Gln-Thr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O DYVMTEWCGAVKSE-HJGDQZAQSA-N 0.000 description 1
- RONJIBWTGKVKFY-HTUGSXCWSA-N Gln-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O RONJIBWTGKVKFY-HTUGSXCWSA-N 0.000 description 1
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 1
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- SWRVAQHFBRZVNX-GUBZILKMSA-N Glu-Lys-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SWRVAQHFBRZVNX-GUBZILKMSA-N 0.000 description 1
- CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 1
- GZBZACMXFIPIDX-WHFBIAKZSA-N Gly-Cys-Asp Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)CN)C(=O)O GZBZACMXFIPIDX-WHFBIAKZSA-N 0.000 description 1
- 206010073069 Hepatic cancer Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- MWAJSVTZZOUOBU-IHRRRGAJSA-N His-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CN=CN1 MWAJSVTZZOUOBU-IHRRRGAJSA-N 0.000 description 1
- VHOLZZKNEBBHTH-YUMQZZPRSA-N His-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 VHOLZZKNEBBHTH-YUMQZZPRSA-N 0.000 description 1
- 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- KUIDCYNIEJBZBU-AJNGGQMLSA-N Leu-Ile-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O KUIDCYNIEJBZBU-AJNGGQMLSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- AUNMOHYWTAPQLA-XUXIUFHCSA-N Leu-Met-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AUNMOHYWTAPQLA-XUXIUFHCSA-N 0.000 description 1
- XWEVVRRSIOBJOO-SRVKXCTJSA-N Leu-Pro-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O XWEVVRRSIOBJOO-SRVKXCTJSA-N 0.000 description 1
- IDGZVZJLYFTXSL-DCAQKATOSA-N Leu-Ser-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IDGZVZJLYFTXSL-DCAQKATOSA-N 0.000 description 1
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 1
- LMDVGHQPPPLYAR-IHRRRGAJSA-N Leu-Val-His Chemical compound N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O LMDVGHQPPPLYAR-IHRRRGAJSA-N 0.000 description 1
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 1
- KWUKZRFFKPLUPE-HJGDQZAQSA-N Lys-Asp-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWUKZRFFKPLUPE-HJGDQZAQSA-N 0.000 description 1
- MWVUEPNEPWMFBD-SRVKXCTJSA-N Lys-Cys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCCN MWVUEPNEPWMFBD-SRVKXCTJSA-N 0.000 description 1
- YRNRVKTYDSLKMD-KKUMJFAQSA-N Lys-Ser-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YRNRVKTYDSLKMD-KKUMJFAQSA-N 0.000 description 1
- BDFHWFUAQLIMJO-KXNHARMFSA-N Lys-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N)O BDFHWFUAQLIMJO-KXNHARMFSA-N 0.000 description 1
- ZEDVFJPQNNBMST-CYDGBPFRSA-N Met-Arg-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZEDVFJPQNNBMST-CYDGBPFRSA-N 0.000 description 1
- ZIIMORLEZLVRIP-SRVKXCTJSA-N Met-Leu-Gln Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZIIMORLEZLVRIP-SRVKXCTJSA-N 0.000 description 1
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- KAGCQPSEVAETCA-JYJNAYRXSA-N Phe-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N KAGCQPSEVAETCA-JYJNAYRXSA-N 0.000 description 1
- IAOZOFPONWDXNT-IXOXFDKPSA-N Phe-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IAOZOFPONWDXNT-IXOXFDKPSA-N 0.000 description 1
- MRWOVVNKSXXLRP-IHPCNDPISA-N Phe-Ser-Trp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O MRWOVVNKSXXLRP-IHPCNDPISA-N 0.000 description 1
- IWNOFCGBMSFTBC-CIUDSAMLSA-N Pro-Ala-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IWNOFCGBMSFTBC-CIUDSAMLSA-N 0.000 description 1
- XQPHBAKJJJZOBX-SRVKXCTJSA-N Pro-Lys-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O XQPHBAKJJJZOBX-SRVKXCTJSA-N 0.000 description 1
- ULWBBFKQBDNGOY-RWMBFGLXSA-N Pro-Lys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O ULWBBFKQBDNGOY-RWMBFGLXSA-N 0.000 description 1
- 108010003201 RGH 0205 Proteins 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 1
- LWMQRHDTXHQQOV-MXAVVETBSA-N Ser-Ile-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LWMQRHDTXHQQOV-MXAVVETBSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- MQUZANJDFOQOBX-SRVKXCTJSA-N Ser-Phe-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O MQUZANJDFOQOBX-SRVKXCTJSA-N 0.000 description 1
- XQAPEISNMXNKGE-FXQIFTODSA-N Ser-Pro-Cys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CS)C(=O)O XQAPEISNMXNKGE-FXQIFTODSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 1
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 101000959787 Sus scrofa Interferon alpha-1 Proteins 0.000 description 1
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 1
- ZTPXSEUVYNNZRB-CDMKHQONSA-N Thr-Gly-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZTPXSEUVYNNZRB-CDMKHQONSA-N 0.000 description 1
- KRGDDWVBBDLPSJ-CUJWVEQBSA-N Thr-His-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O KRGDDWVBBDLPSJ-CUJWVEQBSA-N 0.000 description 1
- GFRIEEKFXOVPIR-RHYQMDGZSA-N Thr-Pro-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O GFRIEEKFXOVPIR-RHYQMDGZSA-N 0.000 description 1
- XVHAUVJXBFGUPC-RPTUDFQQSA-N Thr-Tyr-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XVHAUVJXBFGUPC-RPTUDFQQSA-N 0.000 description 1
- VXFXIBCCVLJCJT-JYJNAYRXSA-N Tyr-Pro-Pro Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O VXFXIBCCVLJCJT-JYJNAYRXSA-N 0.000 description 1
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 1
- PWKMJDQXKCENMF-MEYUZBJRSA-N Tyr-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O PWKMJDQXKCENMF-MEYUZBJRSA-N 0.000 description 1
- BYOHPUZJVXWHAE-BYULHYEWSA-N Val-Asn-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N BYOHPUZJVXWHAE-BYULHYEWSA-N 0.000 description 1
- TZVUSFMQWPWHON-NHCYSSNCSA-N Val-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N TZVUSFMQWPWHON-NHCYSSNCSA-N 0.000 description 1
- BNQVUHQWZGTIBX-IUCAKERBSA-N Val-His Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CN=CN1 BNQVUHQWZGTIBX-IUCAKERBSA-N 0.000 description 1
- QPPZEDOTPZOSEC-RCWTZXSCSA-N Val-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C(C)C)N)O QPPZEDOTPZOSEC-RCWTZXSCSA-N 0.000 description 1
- BZDGLJPROOOUOZ-XGEHTFHBSA-N Val-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N)O BZDGLJPROOOUOZ-XGEHTFHBSA-N 0.000 description 1
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 1
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 201000002250 liver carcinoma Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 동물 인터페론 및 동물 면역글로불린 Fc 섹션을 함유하는 융합 단백질을 제공한다. 융합 단백질은 인터페론 및 면역글로불린 Fc 섹션을 연결시키기 위한 링커를 추가로 포함한다. 본 발명은 융합 단백질을 인코딩하는 폴리리보뉴클레오티드, 융합 단백질을 제조하는 방법, 및 항바이러스 약물의 제조에서의 융합 단백질의 적용을 추가로 제공한다.
Description
본 발명은 재조합 융합 인터페론, 특히 동물 바이러스에 대한 항바이러스 활성을 갖는 재조합 융합 인터페론에 관한 것이다.
발명의 배경
1. 발명의 분야
본 발명은 동물용 재조합 융합 인터페론, 특히 동물 바이러스에 대한 항바이러스 활성을 갖는 재조합 융합 인터페론에 관한 것이다.
2. 관련 분야의 설명
인터페론(IFN)은 인플루엔자 바이러스의 연구중에 앨릭 이삭스(Alick Isaacs) 및 장 린덴만(Jean Lindenmann)에 의해 1957년에 최초로 발견되었다. 바이러스에 의해 감염된 후, 숙주 세포는 가까이의 다른 세포를 유도하는 사이토카인을 즉시 방출하여, 바이러스 복제를 방해하는 항바이러스 단백질을 생성시킨다. 이러한 사이토카인은 이후에 IFN으로 명명되었다. IFN의 항바이러스 효과는 주로 타입 I IFN(IFN-α 및 IFN-β)에 의해 제공된다. 항바이러스 활성에 더하여, IFN은 항-종양 활성을 가지며, 세포 분화를 유도하고, 면역 반응을 조절할 수 있다.
지금까지, 상업적 IFN의 대부분은 인간 질병, 예를 들어, 인간 B형 간염, 인간 C형 간염, 카포시 육종(KS), 및 악성 흑색종의 치료에 사용되어 왔다.
동물 바이러스를 예방하기 위한 효과적인 백신 없이는, 바이러스에 감염된 동물은 지지 요법으로만 치료될 수 있다. 그러나, 지지 요법은 보통 비효과적이고, 따라서 동물 바이러스의 감염은 가축 사육에서 큰 경제적 손실을 초래할 수 있다. 따라서, 동물 바이러스에 대한 항바이러스 활성을 갖는 IFN을 개발하는 것이 중요하다.
발명의 개요
본 발명의 첫번째 양태는 동물용 재조합 융합 IFN에 관한 것이다. IFN은 이의 작은 분자 크기로 인해 짧은 혈청 반감기(약 2 내지 8시간)를 갖는다. 한 구현예에서, 본 발명은 동물 IFN이 긴 혈청 반감기를 갖는 동물 면역글로불린 Fc 단편(IgG Fc)과 융합된 안정적인 동물용 재조합 융합 IFN을 제공한다. 한 바람직한 구현예에서, 동물 IFN 및 동물 IgG Fc는 글리신 및 세린 잔기를 포함하는 펩티드 링커에 의해 연결된다.
또 다른 구현예에서, 동물 IFN은 돼지 IFNα이다. 돼지 IFNα는 SEQ ID NO:2, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 및 47 중 적어도 하나의 서열과 적어도 80%, 바람직하게는 85%, 더욱 바람직하게는 90%, 또는 더욱 더 바람직하게는 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 또는 99%의 상동성을 갖는 아미노산 서열을 인코딩한다. 한 바람직한 구현예에서, 돼지 IFNα는 SEQ ID NO:2, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 및 47로 구성된 군으로부터 선택된 적어도 하나의 서열을 인코딩한다.
또 다른 구현예에서, 동물 IgG Fc는 돼지 면역글로불린 Fc 단편이다. 돼지 IgG Fc는 SEQ ID NO:4, 49, 51, 53, 및 55 중 적어도 하나의 서열과 적어도 80%, 바람직하게는 85%, 더욱 바람직하게는 90%, 또는 더욱 더 바람직하게는 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 또는 99%의 상동성을 갖는 아미노산 서열을 인코딩한다. 한 바람직한 구현예에서, 돼지 IgG Fc는 SEQ ID NO:4, 49, 51, 53, 및 55로 구성된 군으로부터 선택된 적어도 하나의 서열을 인코딩한다.
또 다른 구현예에서, 펩티드 링커는 SEQ ID NO:6의 서열과 적어도 80%, 바람직하게는 85%, 더욱 바람직하게는 90%, 또는 더욱 더 바람직하게는 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 또는 99%의 상동성을 갖는 아미노산 서열을 인코딩한다. 한 바람직한 구현예에서, 펩티드 링커는 SEQ ID NO:6의 아미노산 서열을 인코딩한다.
한 추가 구현예에서, 동물용 재조합 융합 IFN은 SEQ ID NO:8, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 및 223 중 적어도 하나의 서열과 적어도 80%, 바람직하게는 85%, 더욱 바람직하게는 90%, 또는 더욱 더 바람직하게는 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 또는 99%의 상동성을 갖는 아미노산 서열을 인코딩한다. 한 바람직한 구현예에서, 동물용 재조합 융합 IFN은 SEQ ID NO:8, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 및 223으로 구성된 군으로부터 선택된 적어도 하나의 서열을 인코딩한다.
본 발명의 두번째 양태는 본 발명의 동물용 재조합 융합 IFN을 인코딩하는 폴리뉴클레오티드에 관한 것이다. 동물 IFN을 인코딩하는 DNA 서열 및 동물 IgG Fc를 인코딩하는 DNA 서열은 발현 벡터로 클로닝되어, 동물용 재조합 융합 IFN을 인코딩하는 폴리뉴클레오티드가 수득된다. 동물용 재조합 융합 IFN을 인코딩하는 폴리뉴클레오티드를 함유하는 벡터는 이후 숙주 세포로 도입되고, 여기서 상기 동물용 재조합 융합 IFN이 발현될 수 있다.
한 바람직한 구현예에서, 동물 IFN을 인코딩하는 DNA 서열 및 동물 IgG Fc를 인코딩하는 DNA 서열을 발현 벡터로 클로닝하는 것에 더하여, 글리신 및 세린 잔기를 갖는 펩티드 링커를 인코딩하는 DNA 서열이 발현 벡터로 추가로 클로닝되어, 동물 IFN을 인코딩하는 DNA 서열 및 동물 IgG Fc를 인코딩하는 DNA 서열이 연결된다.
한 구현예에서, 동물 IFN을 인코딩하는 DNA 서열은 SEQ ID NO:1, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 및 46의 DNA 서열 중 적어도 하나와 적어도 80%, 바람직하게는 85%, 더욱 바람직하게는 90%, 더욱 더 바람직하게는 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%의 상동성을 갖는다. 한 바람직한 구현예에서, 동물 IFN을 인코딩하는 DNA 서열은 SEQ ID NO:1, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 및 46으로 구성된 군으로부터 선택된 적어도 하나의 DNA 서열이다.
한 구현예에서, 동물 IgG Fc를 인코딩하는 DNA 서열은 SEQ ID NO:3, 48, 50, 52, 및 54의 DNA 서열 중 적어도 하나와 적어도 80%, 바람직하게는 85%, 더욱 바람직하게는 90%, 더욱 더 바람직하게는 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%의 상동성을 갖는다. 한 바람직한 구현예에서, 동물 IgG Fc를 인코딩하는 DNA 서열은 SEQ ID NO:3, 48, 50, 52, 및 54로 구성된 군으로부터 선택된 적어도 하나의 DNA 서열이다.
한 구현예에서, 글리신 및 세린 잔기를 갖는 펩티드 링커를 인코딩하는 DNA 서열은 SEQ ID NO:5의 DNA 서열과 적어도 80%, 바람직하게는 85%, 더욱 바람직하게는 90%, 더욱 더 바람직하게는 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%의 상동성을 갖는다. 한 바람직한 구현예에서, 글리신 및 세린 잔기를 갖는 펩티드 링커를 인코딩하는 DNA 서열은 SEQ ID NO:5의 DNA 서열을 갖는다.
한 구현예에서, 동물용 재조합 융합 IFN을 인코딩하는 DNA 서열은 SEQ ID NO:7, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 및 222의 DNA 서열 중 적어도 하나와 적어도 80%, 바람직하게는 85%, 더욱 바람직하게는 90%, 더욱 더 바람직하게는 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%의 상동성을 갖는다. 한 바람직한 구현예에서, 동물용 재조합 융합 IFN을 인코딩하는 DNA 서열은 SEQ ID NO:7, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 및 222의 DNA 서열 중 하나를 갖는다.
발현 벡터는 원핵생물 발현 벡터 또는 진핵생물 발현 벡터일 수 있다. 원핵생물 발현 벡터는 pET, pGEX, 및 pDEST 발현 벡터를 포함하나, 이에 제한되지는 않는다. 진핵생물 발현 벡터는 pSecTag, pcDNA3, pCMV-Script, pCI, 및 pSV40b 발현 벡터를 포함하나, 이에 제한되지는 않는다.
숙주 세포는 원핵생물 세포, 예를 들어, 박테리아, 또는 진핵생물 세포, 예를 들어, 효모, 곤충 세포, 식물 세포, 및 포유동물 세포일 수 있다. 한 구현예에서, 숙주 세포는 에스케리키아 콜리(Escherichia coli)이다. 또 다른 구현예에서, 숙주 세포는 포유동물 세포이다. 본 발명의 동물용 재조합 융합 인터페론을 발현시키기 위해 사용될 수 있는 포유동물 세포는 3T3 세포, 차이니즈 햄스터(Chinese hamster) 난소 세포(CHO 세포), 새끼 햄스터 신장 세포(BHK 세포), 인간 자궁경부암 세포(예를 들어, Hela 세포), 및 인간 간 암종 세포(예를 들어, HepG2 세포)를 포함하나, 이에 제한되지는 않는다.
본 발명의 세번째 양태는 포유동물 숙주 세포 내에서 본 발명의 동물용 재조합 융합 인터페론을 생성시키기 위한 최적화된 방법에 관한 것이다. 한 구현예에서, 상기 방법은 (1) 혈청-함유 배지에서 본 발명의 동물용 재조합 융합 인터페론을 인코딩하는 폴리뉴클레오티드를 갖는 포유동물 숙주 세포를 배양하는 단계, (2) 세포가 안정적으로 성장한 후에 혈청-함유 배지를 혈청-비함유 배지로 대체하는 단계, (3) 1 내지 5일마다 본 발명의 동물용 재조합 융합 인터페론을 함유하는 혈청-비함유 배지를 수거하고, 새로운 혈청-비함유 배지를 세포에 첨가하는 단계를 포함한다.
포유동물 숙주 세포는 3T3 세포, 차이니즈 햄스터 난소 세포(CHO 세포), 새끼 햄스터 신장 세포(BHK 세포), 인간 자궁경부암 세포(예를 들어, Hela 세포), 및 인간 간 암종 세포(예를 들어, HepG2 세포)를 포함하나, 이에 제한되지는 않는다. 한 구현예에서, 포유동물 숙주 세포는 차이니즈 햄스터 난소 세포(CHO 세포)이다.
혈청은 소 혈청 및 말 혈청을 포함하나, 이에 제한되지는 않는다. 한 구현예에서, 혈청은 소 태아 혈청(FBS)이다. 배지 내의 혈청의 함량은 약 0.1 내지 10%(v/v)이다. 한 구현예에서, 혈청의 함량은 5%(v/v)이다.
본 발명의 네번째 양태는 동물용 항바이러스 약제의 제조를 위한 본 발명의 동물용 재조합 융합 인터페론의 용도에 관한 것이다. 본 발명에 제공된 시험은 본 발명의 동물용 재조합 융합 인터페론이 항바이러스 활성을 갖는 것을 나타낸다. DNA 바이러스(예를 들어, 거짓광견병(pseudorabies) 바이러스, PRV) 및 RNA 바이러스(예를 들어, 돼지 생식기 호흡기 증후군 바이러스, PRRSV)가 본 발명의 동물용 재조합 융합 인터페론의 항바이러스 활성을 평가하기 위해 각각 시험관내 실험에서 사용되었다. 결과는 본 발명의 동물용 재조합 융합 인터페론이 동물에서 바이러스 감염을 효과적으로 억제할 수 있고, 본 발명의 동물용 재조합 융합 인터페론이 동물용 비-융합 인터페론보다 큰 항바이러스 활성을 갖는 것을 나타낸다. 따라서, 본 발명의 동물용 재조합 융합 인터페론은 동물에서 바이러스 감염을 억제하는데 사용될 수 있다.
본원에 기재된 바와 같은 기술 및 과학 용어의 의미는 당업자에 의해 명백하게 이해될 수 있다.
본 발명은 하기 예시적 실시예에서 더욱 상세히 기재된다. 이러한 실시예는 단지 본 발명의 선택된 구현예만 기재하고 있으나, 하기 실시예는 예시적인 것으로 이로 제한되는 것이 아님이 이해되어야 한다.
도 1A는 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 함유하는 플라스미드로 트랜스펙션된 후, 제오신에 의해 스크리닝된 CHO 세포의 면역형광 검정(IFA) 검정을 도시한다. 도 1B는 pSecTag2(B)로 트랜스펙션된 후, 제오신에 의해 스크리닝된 CHO 세포의 IFA 검정을 도시한다.
도 2는 본 발명의 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 함유하는 플라스미드로 트랜스펙션된 후, 제오신에 의해 스크리닝된 CHO 세포, 및 pSecTag2(B)로 트랜스펙션된 후, 제오신에 의해 스크리닝된 CHO 세포의 ELISA 검정을 도시한다.
도 3은 본 발명의 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 포함하는 CHO 세포에서 발현된 단백질의 웨스턴 블롯을 도시한다. M: 단백질 마커; 레인 1: 단백질의 SDS-PAGE 분석; 레인 2: 마우스 항-IFNα 모노클로날 항체를 이용하여 검출된 웨스턴 블롯; 레인 3: 마우스 항-His 모노클로날 항체를 이용하여 검출된 웨스턴 블롯; 레인 4: 염소 항-돼지 IgG 항체를 이용하여 검출된 웨스턴 블롯.
도 4는 PRRSV 공격된 Marc-145 세포 및 PR 공격된 ST 세포에서의 본 발명의 돼지 재조합 융합 인터페론(P IFN-Fc 그룹) 및 돼지 면역글로불린 IgG-Fc 단편이 없는 돼지 인터페론(P IFN 그룹)에 대한 항바이러스 감염 검정의 결과를 도시한다.
도 2는 본 발명의 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 함유하는 플라스미드로 트랜스펙션된 후, 제오신에 의해 스크리닝된 CHO 세포, 및 pSecTag2(B)로 트랜스펙션된 후, 제오신에 의해 스크리닝된 CHO 세포의 ELISA 검정을 도시한다.
도 3은 본 발명의 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 포함하는 CHO 세포에서 발현된 단백질의 웨스턴 블롯을 도시한다. M: 단백질 마커; 레인 1: 단백질의 SDS-PAGE 분석; 레인 2: 마우스 항-IFNα 모노클로날 항체를 이용하여 검출된 웨스턴 블롯; 레인 3: 마우스 항-His 모노클로날 항체를 이용하여 검출된 웨스턴 블롯; 레인 4: 염소 항-돼지 IgG 항체를 이용하여 검출된 웨스턴 블롯.
도 4는 PRRSV 공격된 Marc-145 세포 및 PR 공격된 ST 세포에서의 본 발명의 돼지 재조합 융합 인터페론(P IFN-Fc 그룹) 및 돼지 면역글로불린 IgG-Fc 단편이 없는 돼지 인터페론(P IFN 그룹)에 대한 항바이러스 감염 검정의 결과를 도시한다.
바람직한 구현예의 상세한 설명
실시예 1 - 돼지 인터페론 α1의 분자 클로닝
말초 혈액 단핵 세포(PBMC)를 먼저 돼지(L×Y-D 계통)의 혈액으로부터 분리시켰다. 전체 RNA를 구아니딘 티오시아네이트(GTC) 방법에 의해 PBMC로부터 분리시킨 후, 역전사 중합효소 연쇄 반응(RT-PCT)에 사용하여 상보성 DNA(cDNA)를 생성시켰다. 간단히, 20 ㎕의 전체 RNA를 3분 동안 70℃에서 인큐베이션하고, 인큐베이션 후, 10 ㎕의 5x 완충액, 8 ㎕의 1.25mM dNTP, 1 ㎕의 올리고 dT 프라이머, 11 ㎕의 증류수, 0.5 ㎕의 RNasin, 및 0.5 ㎕의 AMV 역전사효소를 첨가하고, 30분 동안 42℃에서 인큐베이션하여 cDNA를 합성하였다. 이후, 합성된 cDNA를 DNA 주형으로 사용하여, 중합효소 연쇄 반응(PCR)에 의해 돼지 인터페론 α1(P IFNα1) 유전자를 클로닝하였다. 10 ㎕의 cDNA, 5 ㎕의 10x PCR 완충액, 8 ㎕의 1.25 mM dNTP, 1 ㎕의 정방향 프라이머, 1 ㎕의 역방향 프라이머, 24 ㎕의 가압증기멸균된 물, 및 1 ㎕의 Taq 중합효소를 함유하는 PCR 혼합물을 GeneAmp® PCR System 2400 반응기(Applied Biosystems)에 두었다. PCR 프로그램은 5분 동안 95℃의 1 주기, 95℃/1분, 55℃/30초, 72℃/30초의 30주기 후, 72℃/5분의 인큐베이션이었다. P IFNα1을 클로닝하기 위한 프라이머는 다음과 같다:
PCR 생성물의 크기를 아가로스 전기영동에 의해 검출하였다. 이후, PCR 생성물을 DNA 정제 키트(Protech Technology Enterprise, Taiwan)로 정제하였다. 정제 후, PCR 생성물을 pET20b 발현 벡터에 작제하였다. 정제된 PCR 생성물 및 pET20b 발현 벡터를 2개의 제한 효소 HindIII 및 Xho I로 각각 절단하였다. 제한 효소 절단 반응 후, 절단된 PCR 생성물 및 pET20b 발현 벡터를 DNA 정제 키트(Protech Technology Enterprise, Taiwan)로 각각 정제하였다. 정제된 PCR 생성물을 정제된 pET20b 발현 벡터와 라이게이션시켜 플라스미드 pET20b-IFNα1을 형성시켰고, 플라스미드를 숙주 세포(E. coli)에 형질전환시켰다. 형질전환주를 선택하고, 돼지 인터페론 α1(P IFNα1)의 DNA 서열을 DNA 시퀀싱에 의해 확인하였다. 돼지 인터페론 α1(P IFNα1)은 SEQ ID NO:1의 DNA 서열 및 SEQ ID NO:2의 아미노산 서열을 갖는다.
실시예
2 - 돼지 면역글로불린
Fc
4α 단편의 분자
클로닝
전체 RNA를 GTC 방법에 의해 돼지 비장으로부터 분리시킨 후, RT-PCR에서 사용하여 cDNA를 생성시켰다. 간단히, 20 ㎕의 전체 RNA, 8 ㎕의 1.25mM dNTP, 및 1 ㎕의 올리고 dT 프라이머를 5분 동안 70℃에서 인큐베이션하고, 인큐베이션 후, 1 ㎕의 가압증기멸균된 물, 8 ㎕의 5xAMV RT 완충액, 1 ㎕의 RNasin, 및 1 ㎕의 AMV 역전사효소를 첨가하고, 1시간 동안 42℃에서 인큐베이션하여 cDNA를 합성하였다. 이후, 합성된 cDNA를 PCR에서 DNA 주형으로 사용하였다. 1 ㎕의 cDNA, 5 ㎕의 10x PCR 완충액, 8 ㎕의 1.25 mM dNTP, 1 ㎕의 정방향 프라이머, 1 ㎕의 역방향 프라이머, 33 ㎕의 가압증기멸균된 물, 및 1 ㎕의 Taq 중합효소를 함유하는 PCR 혼합물을 GeneAmp® PCR System 2400 반응기(Applied Biosystems)에 두었다. PCR 반응 프로그램은 5분 동안 95℃의 1주기, 95℃/1분, 55℃/30초, 72℃/30초의 30주기 후, 72℃/5분의 인큐베이션이었다. 돼지 면역글로불린 Fc 4a 단편(P IgG Fc 4a)을 클로닝하기 위한 프라이머는 다음과 같다:
PCR 생성물의 크기를 아가로스 전기영동에 의해 검출하였다. 이후, PCR 생성물을 DNA 정제 키트(Geneaid Biotech Ltd., Taiwan)로 정제하였다. 정제 후, PCR 생성물을 pET20b 발현 벡터에 작제하였다. 정제된 PCR 생성물 및 pET20b 발현 벡터를 2개의 제한 효소 BamHI 및 HindIII로 각각 절단하였다. 제한 효소 절단 반응 후, 절단된 PCR 생성물 및 pET20b 발현 벡터를 DNA 정제 키트(Geneaid Biotech Ltd., Taiwan)로 각각 정제하였다. 정제된 PCR 생성물을 정제된 pET20b 발현 벡터와 라이게이션시켜 플라스미드 pET20b-IgG-Fc 4a를 형성시키고, 플라스미드를 숙주 세포(E. coli)에 형질전환시켰다. 형질전환주를 선택하고, 돼지 면역글로불린 Fc 4a 단편(P IgG Fc 4a)의 DNA 서열을 DNA 시퀀싱에 의해 확인하였다. 돼지 면역글로불린 Fc 4a 단편(P IgG Fc 4a)은 SEQ ID NO:3의 DNA 서열 및 SEQ ID NO:4의 아미노산 서열을 갖는다.
실시예
3 - 돼지 재조합 융합 인터페론(P
IFN
-
Fc
)을 인코딩하는 폴리뉴클레오티드 서열을 함유하는 벡터의
작제
본 실시예에서, 실시예 1에서 클로닝된 돼지 인터페론 α1(P IFNα1)의 DNA 서열(SEQ ID NO:1) 및 실시예 2에서 클로닝된 돼지 면역글로불린 Fc 4a 단편(P IgG Fc 4a)의 DNA 서열(SEQ ID NO:3)을 글리신 및 세린 잔기를 포함하는 링커의 DNA 서열(SEQ ID NO:5)과 연결시켜 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a)의 DNA 서열(SEQ ID NO:7)을 작제하였다.
먼저, 돼지 인터페론 α1(P IFNα1)의 DNA 서열(SEQ ID NO:1) 및 돼지 면역글로불린 Fc 4a 단편(P IgG Fc 4a)의 DNA 서열(SEQ ID NO:3)을 PCR에 의해 각각 증폭시켰다. 또한, 글리신 및 세린 잔기를 포함하는 링커의 DNA 서열(SEQ ID NO:5)의 5'-말단 및 3'-말단을 각각 PCR에 의한 PCR 프라이머 설계를 통해 돼지 인터페론 α1(P IFNα1)의 DNA 서열 및 돼지 면역글로불린 Fc 4a 단편(P IgG Fc 4a)의 DNA 서열과 함께 증폭시켰다. 돼지 인터페론 α1(P IFNα1)을 증폭시키기 위한 프라이머는 다음과 같다:
이중으로 밑줄친 뉴클레오티드는 링커의 DNA 서열의 5'-말단이다.
돼지 면역글로불린 Fc 단편(P IgG Fc)을 증폭시키기 위한 프라이머는 다음과 같다:
이중으로 밑줄친 뉴클레오티드는 링커의 DNA 서열의 3'-말단이다.
1 ㎕의 100배 희석된 pET20b-IFNα 또는 pET20b-IgG-Fc, 5 ㎕의 10x PCR 완충액, 8 ㎕의 1.25 mM dNTP, 1 ㎕의 정방향 프라이머, 1 ㎕의 역방향 프라이머, 33 ㎕의 가압증기멸균된 물, 및 1 ㎕의 Taq 중합효소를 함유하는 PCR 혼합물을 GeneAmp® PCR System 2400 반응기(Applied Biosystems)에 두었다. PCR 반응 프로그램은 5분 동안 95℃의 1주기, 95℃/1분, 55℃/30초, 72℃/30초의 30주기 후, 72℃/5분의 인큐베이션이었다.
PCR 생성물의 크기를 아가로스 전기영동에 의해 검출하였다. 이후, PCR 생성물을 DNA 정제 키트(Geneaid Biotech Ltd., Taiwan)로 정제하였다. 돼지 인터페론 α1(P IFNα1)의 정제된 PCR 생성물을 2개의 제한 효소 EcoRV 및 BamHI으로 절단하고, 돼지 면역글로불린 Fc 4a 단편(P IgG Fc 4a)의 정제된 PCR 생성물을 2개의 제한 효소 BamHI 및 HindIII로 절단하고, pET20b 발현 벡터를 2개의 제한 효소 EcoRV 및 HindIII로 절단하였다. 제한 효소 절단 반응 후, 절단된 PCR 생성물 및 pET20b 발현 벡터를 DNA 정제 키트(Geneaid Biotech Ltd., Taiwan)로 각각 정제하였다. 정제된 PCR 생성물을 정제된 pET20b 발현 벡터와 라이게이션시켜 플라스미드 pET20b-IFNα1-Fc 4a를 형성시키고, 플라스미드를 숙주 세포(E. coli)에 형질전환시켰다. 형질전환주를 선택하고, 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a)의 DNA 서열(SEQ ID NO:7)을 DNA 시퀀싱에 의해 확인하였다. 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a)는 SEQ ID NO:8의 아미노산 서열을 갖는다.
실시예
4 - 다른 돼지 재조합 융합 인터페론(P
IFN
-
Fc
)을 인코딩하는 폴리뉴클레오티드 서열을 함유하는 벡터의
작제
실시예 1에서 클로닝된 돼지 인터페론 α1(P IFNα1)의 DNA 서열(SEQ ID NO:1)에 더하여, 다른 돼지 인터페론 α 서브타입, 예를 들어, α2 내지 α17이 존재한다. 돼지 인터페론 α2 내지 α17을 인코딩하는 DNA 서열은 각각 SEQ ID NO:16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 및 46이며, 돼지 인터페론 α2 내지 α17의 아미노산 서열은 각각 SEQ ID NO:17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 및 47이다.
실시예 2에서 클로닝된 돼지 면역글로불린 Fc 4a 단편(P IgG-Fc 4a)의 DNA 서열(SEQ ID NO:3)에 더하여, 돼지 면역글로불린 Fc 1a, 1b, 2a, 2b, 및 4a 단편(P IgG-Fc 1a, 1b, 2a, 2b, 4a)을 또한 본 실시예에서 돼지 인터페론 α1 내지 α17과 각각 융합시키는데 사용하여 돼지 재조합 융합 인터페론을 작제하였다. 돼지 면역글로불린 Fc 1a, 1b, 2a, 2b, 및 4a 단편(P IgG-Fc 1a, 1b, 2a, 2b, 4a)을 인코딩하는 DNA 서열은 각각 SEQ ID NO:48, 50, 52, 54, 및 3이며, 돼지 면역글로불린 Fc 1a, 1b, 2a, 2b, 및 4a 단편의 아미노산 서열은 각각 SEQ ID NO:49, 51, 53, 55, 및 4이다.
실시예 3에 기재된 것과 같이, 돼지 인터페론 α1 내지 α17(P IFNα1-α17)을 인코딩하는 DNA 서열(SEQ ID NO:1, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 및 46) 및 돼지 면역글로불린 Fc 1a, 1b, 2a, 2b, 및 4a 단편(P IgG-Fc 1a, 1b, 2a, 2b, 4a)을 인코딩하는 DNA 서열(SEQ ID NO:48, 50, 52, 54, 및 3)을 글리신 및 세린 잔기를 포함하는 링커를 인코딩하는 DNA 서열(SEQ ID NO:5)에 의해 각각 연결시켜 다양한 돼지 재조합 융합 인터페론(P IFNα-Fc)을 인코딩하는 DNA 서열(SEQ ID NO:7, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 및 222)을 작제하였다. 상기 언급된 돼지 재조합 융합 인터페론(P IFNα-Fc)을 인코딩하는 DNA 서열을 DNA 합성기(Applied Biosystems, Inc., USA)에 의해 돼지 재조합 융합 인터페론을 인코딩하는 각각의 DNA 서열의 5'-말단에 EcoRV 절단 부위(GATATC) 및 돼지 재조합 융합 인터페론을 인코딩하는 각각의 DNA 서열의 3'-말단에 HindIII 절단 부위(AAGCTT)를 각각 갖도록 합성하였다.
5'-말단 및 3'-말단에 각각 EcoRV 절단 부위 및 HindIII 절단 부위를 갖는 돼지 재조합 융합 인터페론의 합성된 DNA 서열 각각, 및 pSecTag2(B) 발현 벡터 모두를 2개의 제한 효소 EcoRV 및 HindIII로 절단하였다. 제한 효소 절단 반응 후, 절단된 DNA 서열 및 pSecTag2(B) 발현 벡터를 DNA 정제 키트(Geneaid Biotech Ltd., Taiwan)로 각각 정제하였다. 정제된 DNA 서열을 정제된 pSecTag2(B) 발현 벡터와 라이게이션시켜 플라스미드 pSecTag2(B)-IFNα-Fc를 형성시키고, 플라스미드를 숙주 세포(E. coli)에 형질전환시켰다. 플라스미드 pSecTag2(B)-IFNα-Fc를 갖는 형질전환주를 선택하였다. 돼지 재조합 융합 인터페론(P IFNα-Fc)은 SEQ ID NO:8, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 및 223의 아미노산 서열 중 하나를 갖는다.
실시예 5 - 돼지 재조합 융합 인터페론(P IFNα-Fc)의 발현
실시예 4에서 작제된 플라스미드 pSecTag2(B)-IFNα1-Fc 4a를 CHO 세포에 트랜스펙션시켰다. 먼저, 4 ㎍의 pSecTag2(B)-IFNα1-Fc 4a DNA를 15초 동안 볼텍싱(vortexing)에 의해 항생제가 없는 VP 혈청-비함유 배지(Invitrogen)에 희석시켰다(용액 A). 4 ㎍의 리포펙타민(Invitrogen)을 항생제가 없는 VP 혈청-비함유 배지(Invitrogen)에 희석시키고(용액 B), 이후 5분 동안 실온에서 인큐베이션하였다. 다음으로, 희석된 플라스미드 DNA(용액 A)를 희석된 리포펙타민(용액 B)과 혼합하고, 혼합물을 20분 동안 37℃에서 인큐베이션하였다. 이후, 혼합물(A+B)을 밤새 배양된 CHO 세포에 균일하게 첨가하고, 혼합물을 갖는 CHO 세포를 6시간 동안 5% CO2 인큐베이터에서 37℃에서 인큐베이션하였다. 인큐베이션 후, 혼합물을 제거하고, 10% 소 태아 혈청(FBS)을 함유하는 F12 배지를 CHO 세포에 첨가하였다. CHO 세포를 48시간 동안 5% CO2 인큐베이터에서 37℃에서 배양하였다.
다음으로, 돼지 재조합 융합 인터페론의 DNA 서열을 갖는 CHO 세포를 제오신을 이용하여 선택하였다. 트랜스펙션된 CHO 세포를 10% FBS, 100 Units/ml 페니실린, 100 Units/ml 스트렙토마이신, 및 700 ㎍/ml 제오신을 갖는 F12 배지 중에서 24-웰 배양 접시에서 배양하여 세포를 선택하였다. 이후, 트랜스펙션된 CHO 세포를 PBS로 2회 세척하고, 0.125% 트립신으로 해리시키고, 세포가 둥근 형태가 된 후에 접시를 진탕시켜 분리시켰다. 분리된 세포를 선택 배지에 현탁시키고, 37℃, 5% CO2에서 배양하였다. 선택 배지를 10 내지 20%의 세포가 생존할 때까지 3 내지 4일 마다 보충하였다. 생존 세포를 세포가 거의 컨플루언스(confluence)까지 성장할 때까지 10% FBS 및 50 ㎍/ml 제오신을 갖는 F12 배지에서 배양하였다. 이후, 선택 세포로부터의 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a)의 발현을 면역형광 검정(IFA), 효소결합면역흡착측정법(ELISA), 및 적절한 항체를 이용한 웨스턴 블롯에 의해 검출하였다.
1. IFA에 의한 돼지 재조합 융합 인터페론의 생물학적 검정
샘플 세포를 24-웰 배양 플레이트에 시딩(1×105 세포/웰)하고, 80 내지 90% 컨플루언스까지 성장시켰다. 이후, 샘플 세포를 PBS로 2회 세척하고, 4℃에서 30분 동안 80% 아세톤(-20℃)으로 고정시켰다. 이후, 아세톤을 폐기하고, 세포를 PBS로 3회 세척하였다. 그 후, 세포를 어두운 곳에서 37℃에서 30분 동안 토끼 항 돼지 IgG-FITC 항체(300 ㎕/웰)(PBS 중 1:1000 희석)와 함께 인큐베이션하였다. 이후, 항혈청을 폐기하고, 세포를 PBS로 3회 세척하고, 최종적으로 형광 현미경 시험을 위해 250 ㎕ PBS에 마운팅하였다.
도 1은 형광 현미경 시험의 결과를 도시한다. 형광 신호를 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 함유하는 플라스미드로 트랜스펙션된 후, 제오신에 의해 스크리닝된 CHO 세포에서 검출하였다(도 1A). 형광 신호가 pSecTag2(B)로 트랜스펙션된 후, 제오신에 의해 스크리닝된 CHO 세포에서 검출되지 않았다(도 1B).
2. ELISA에 의한 돼지 재조합 융합 인터페론의 생물학적 검정
샘플 세포를 72시간 동안 10% FBS를 갖는 F-12 배지를 함유하는 25T-플라스크에서 배양(1×105 세포/플라스크)한 후, 상층액을 수거하고, ELISA 코팅 완충액(0.1 M NaHCO3 및 0.1 M Na2CO3 pH9.6)으로 연속적으로 2배(2, 4, 8, 16, 32, 64, 및 128배) 희석시켰다. 100 ㎕의 각각의 희석된 샘플을 ELISA 플레이트(NUNC)에 첨가하고, 24시간 동안 4℃에 두었다. 그 후, 희석된 상층액을 제거하고, ELISA 플레이트를 ELISA 세척 완충액(0.9% NaCl, 0.1% Tween20)으로 3회 세척하였다. 블로킹 완충액(ELISA 세척 완충액 중 1% BSA)을 ELISA 플레이트에 첨가(100 ㎕/웰)하고, 플레이트를 1시간 동안 실온에서 인큐베이션하여, 단백질의 비-특이적 결합을 방지하였다. 이후, 블로킹 완충액을 제거하고, ELISA 플레이트를 ELISA 세척 완충액으로 3회 세척하였다. 마우스 항 IFNα 모노클로날 항체(SANTA CRUZ)를 1% BSA를 함유하는 ELISA 세척 완충액으로 500배 희석(1:500)시킨 후, ELISA 플레이트에 첨가(100 ㎕/웰)하였다. 1시간 동안 실온에서 인큐베이션시킨 후, ELISA 플레이트를 ELISA 세척 완충액으로 6회 세척하였다. 호스라디쉬 퍼옥시다제(HRP)에 컨쥬게이션된 염소 항 마우스 이차 항체(KPL)를 1% BSA를 함유하는 ELISA 세척 완충액으로 1000배 희석(1:1000)시킨 후, ELISA 플레이트에 첨가(100 ㎕/웰)하였다. 37℃에서 1시간 동안 인큐베이션시킨 후, 플레이트를 PBS로 6회 세척하였다. 결과의 시각화를 위해, 3,3',5,5'-테트라메틸벤지딘(TMB)(KPL)을 웰에 첨가하였다. 10분 동안 인큐베이션시킨 후, 신호의 흡광도를 650 nm에서 설정된 ELISA 판독기를 이용하여 판독하였다.
도 2는 ELISA 시험에 의한 돼지 재조합 융합 인터페론의 생물학적 검정의 결과를 도시한다. 돼지 재조합 융합 인터페론이 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 함유하는 플라스미드로 트랜스펙션된 CHO 세포로부터의 분비물에서 검출되었다. 128배로 희석된 후에도, 재조합 융합 인터페론이 여전히 검출가능하였다. 돼지 재조합 융합 인터페론은 pSecTag2(B)로 트랜스펙션된 CHO 세포로부터의 분비물에서는 검출되지 않았다.
3. 웨스턴 블롯에 의한 돼지 재조합 융합 인터페론의 생물학적 검정
샘플 세포를 72시간 동안 10% FBS를 갖는 F-12 배지에서 배양한 후, 상층액을 수거하고, 소듐 도데실 설페이트-폴리아크릴아미드 겔 전기영동(SDS-PAGE)에 의해 분석하였다. 단백질 면역블로팅을 위해, 전기영동 후, 단백질을 PVDF 막으로 옮겼다. 생성된 막을 16 내지 24시간 동안 4℃에서 TBST(10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.3% Tween 20) 중 5% 스킴 밀크(skim milk)를 이용하여 블로킹시켜, 단백질의 비-특이적 결합을 방지한 후, 각각 5분 동안 TBST로 3회 세척하였다. 이후, 막을 1시간 동안 실온에서 마우스 항 IFNα 모노클로날 항체(SANTA CRUZ)(0.5% 스킨 밀크(skin milk)를 함유하는 TBST에 1:500 희석)와 함께 인큐베이션하였다. 이후, 블롯을 TBST로 6회 세척하고, 1시간 동안 실온에서 알칼리성 포스파타제(AP) 컨쥬게이션된 염소 항-마우스 IgG 모노클로날 항체(0.5% 스킨 밀크를 함유하는 TBST에 1:2000 희석)와 함께 인큐베이션시켰다. 이후, 블롯을 TBST로 6회 세척하였다. 밴드를 5분 동안 니트로 블루 테트라졸륨(NBT)/5-브로모-4-클로로-3-인돌릴-포스페이트(BCIP) 기질을 이용하여 검출한 후, 물로 세척하여 반응을 정지시켰다. 또한, 돼지 재조합 융합 인터페론을 알칼리성 포스파타제(AP) 컨쥬게이션된 염소 항-돼지 IgG 항체(KPL) 및 알칼리성 포스파타제(AP) 컨쥬게이션된 마우스 항 6×His 모노클로날 항체(invitrogen)를 이용하여 또한 검출하였다.
도 3은 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 함유하는 플라스미드로 트랜스펙션된 CHO 세포에서 발현된 단백질의 웨스턴 블롯의 결과를 도시한다. 돼지 재조합 융합 인터페론을 마우스 항 IFNα 모노클로날 항체(레인 2), 마우스 항 6×His 모노클로날 항체(레인 3), 및 염소 항-돼지 IgG 항체(레인 4)에 의해 검출하였다. 결과는 돼지 재조합 융합 인터페론을 인코딩하는 DNA 서열을 함유하는 플라스미드로 트랜스펙션된 CHO 세포가 돼지 재조합 융합 인터페론을 분비하는 것을 나타낸다.
실시예
6 - 돼지 재조합 융합 인터페론(P
IFN
α-
Fc
)의 소규모 및 대규모 생성 및 돼지 재조합 융합 인터페론의
PRRSV
에 대한 항바이러스 활성의 평가
1. 돼지 재조합 융합 인터페론(P
IFN
α-
Fc
)의 소규모 생성
돼지 재조합 융합 인터페론(P INFα1-Fc 4a)의 DNA 서열(SEQ ID NO:7)을 포함하는 CHO 세포를 25 cm2 세포 배양 플라스크에 2×106 세포의 밀도로 시딩하고, 24시간 동안 10% FBS, 100 Units/ml 페니실린, 및 100 Units/ml 스트렙토마이신을 갖는 F12 배지에서 배양하였다. 이후, 배지를 제거하였다. 세포를 PBS로 세척한 후, 100 Units/ml 페니실린 및 100 Units/ml 스트렙토마이신을 갖는 CHO-S-SFM II 혈청-비함유 배지(GIBCO)에서 배양하였다. 상층액을 수거하고, 100 Units/ml 페니실린 및 100 Units/ml 스트렙토마이신을 함유하는 새로운 혈청-비함유 배지를 24, 48, 및 72시간 마다 각각 첨가하였다. 돼지 재조합 융합 인터페론을 함유하는 상층액을 10분 동안 원심분리(1,000 rpm)시켜, 세포 및 세포 부스러기를 제거하였다. 이후, 수거된 돼지 재조합 융합 인터페론의 항바이러스 활성을 돼지 생식기 호흡기 증후군 바이러스(PRRS)로 평가하였다.
2. 돼지 재조합 융합 인터페론의
PRRSV
에 대한 항바이러스 활성의 평가
수거된 돼지 재조합 융합 인터페론을 1% FBS, 100 Units/ml 페니실린, 및 100 Units/ml 스트렙토마이신을 함유하는 MEM 배지로 연속 희석(10, 20, 40, 80, 160, 320, 640, 1280, 및 2560배)시켰다. MARC-145 세포를 96-웰 세포 배양 플레이트에서 1.5×104 세포/웰의 밀도로 시딩하고, 16 내지 24시간 동안 37℃, 5% CO2에서 배양하였다. 배양 배지를 제거한 후, 세포를 희석된 돼지 재조합 융합 인터페론(100 ㎕/웰, n = 4)으로 처리한 후, 24시간 동안 37℃, 5% CO2에서 배양하였다. 희석된 샘플을 제거한 후, 세포를 PRRS 바이러스(100 TCID50/100㎕)로 감염시킨 후, 세포의 90%가 세포병변 효과(CPE)를 나타낼 때까지 약 120시간 동안 37℃, 5% CO2에서 배양하였다. 돼지 재조합 융합 인터페론으로 처리된 후, PRRS 바이러스로 감염된 세포에 더하여, 인터페론으로 처리되지 않고 PRRS 바이러스로 감염되지 않은 세포, PRRS 바이러스로 감염되었으나 인터페론으로 처리되지 않은 세포, 및 인터페론으로 처리되었으나 PRRS 바이러스로 감염되지 않은 세포의 3개의 다른 그룹이 존재하였다. 이후, 세포를 사용하여 돼지 재조합 융합 인터페론(P IFN-Fc)의 항바이러스 활성을 평가하였다. 세포 현탁액을 분리시키고, 세포를 PBS로 2회 세척한 후, 30분 동안 4℃에서 80% 아세톤(-20℃, 100 ㎕/웰)을 갖는 플레이트에 고정시켰다. 아세톤을 제거한 후, 세포를 PBS로 3회 세척하고, 20분 동안 1% 메틸로사닐린 클로라이드로 염색하였다. 그 후, 세포를 증류수로 5회 세척한 후, 100% 에탄올을 첨가하여 메틸로사닐린 클로라이드를 용해시켰다. 10분 후, 신호의 흡광도를 550 nm에서 설정된 ELISA 판독기를 이용하여 판독하였다. 돼지 재조합 융합 인터페론(P IFN-Fc)의 농도를 하기 식에 의해 계산하였다.
상기 식에서, OD maximum은 IFN으로 처리되거나 처리되지 않은 감염되지 않은 세포 단층의 흡광도(보호 100%)이고, OD minimum은 감염된 보호되지 않은 세포 단층의 흡광도(보호 0)이다.
상기 식에서, Tn은 OD50 % 바로 위의 OD에 해당하는 IFN 희석의 역수이고, Tn +1은 OD50 % 바로 아래의 OD에 해당하는 IFN 희석의 역수이고, ODn은 OD50 % 바로 위의 흡광도 값이고, ODn +1은 OD50 % 바로 아래의 흡광도 값이다.
표 1은 상기 기재된 소규모 생성 방법에 의해 생성된 돼지 재조합 융합 인터페론의 PRRSV에 대한 항바이러스 활성을 나타낸다. 결과는 돼지 재조합 융합 인터페론이 PRRSV에 대한 항바이러스 활성을 갖는 것을 나타낸다.
표 1 - 25 cm2 세포 배양 플라스크에서 생성된 돼지 재조합 융합 인터페론의 PRRSV에 대한 항바이러스 활성(IU/ml).
표 2는 돼지 재조합 융합 인터페론의 농도에 25 cm2 세포 배양 플라스크의 부피(5 ml)를 곱하여 계산된 소규모 생성 방법에 의해 생성된 돼지 재조합 융합 인터페론의 양을 나타낸다.
표 2 - 25 cm2 세포 배양 플라스크(25T-플라스크)에서 생성된 돼지 재조합 융합 인터페론의 양(단위: IU/5 ml).
3. 돼지 재조합 융합 인터페론(P
IFN
α-
Fc
)의 대규모 생성
돼지 재조합 융합 인터페론(P INFα1-Fc 4a)의 DNA 서열(SEQ ID NO:7)을 포함하는 CHO 세포를 먼저 175 cm2 세포 배양 플라스크에서 배양하였다. 세포의 단층이 형성된 후, 세포를 0.125% 트립신으로 해리시키고, 10% FBS, 100 Units/ml 페니실린, 및 세포 계수를 위한 100 Units/ml 스트렙토마이신을 함유하는 F12 배지에 현탁시켰다. 이후, 세포를 각각 6.8×107 세포/병 및 8×107 세포/병의 농도로 회전 병에 시딩하고, 37℃, 0.167 rpm에서 10% FBS를 함유하는 200 ml의 F12 배지에서 배양하였다. 24시간 후, 세포를 PBS로 세척하고, 100 Units/ml 페니실린 및 100 Units/ml 스트렙토마이신을 함유하는 CHO-S-SFM II 혈청-비함유 배지(Invitrogen)에서 배양하였다. 상층액을 수거하고, 100 units/ml 페니실린 및 100 units/ml 스트렙토마이신을 함유하는 새로운 혈청-비함유 배지를 72시간 마다 6회 첨가하였다. 돼지 재조합 융합 인터페론을 포함하는 상층액을 10분 동안 원심분리(1,000 rpm)하여 세포 및 세포 부스러기를 제거하였다. 돼지 재조합 융합 인터페론의 농도를 상기 기재된 MTT 방법을 이용하여 PRRSV에 대한 이의 항바이러스 활성을 평가함으로써 계산하였다.
표 3은 회전 병에 의해 생성된 돼지 재조합 융합 인터페론의 농도를 나타낸다. 결과는 회전 병에 의해 생성된 돼지 재조합 융합 인터페론이 25 cm2 세포 배양 플라스크에 의해 생성된 재조합 융합 인터페론보다 PRRSV에 대해 더 높은 항바이러스 활성을 갖는 것을 나타낸다.
표 3 - 회전 병에서 생성된 돼지 재조합 융합 인터페론(P IFN-Fc)의 농도(IU/ml).
또한, 표 4는 대규모 생성 방법에 의해 생성된 돼지 재조합 융합 인터페론의 항바이러스 활성(PRRS 바이러스에 대한 활성)의 전체량을 나타낸다.
표 4 - 회전 병에서 생성된 돼지 재조합 융합 인터페론의 항바이러스 활성의 전체량(단위: IU/200 ml).
실시예
7 - 돼지 재조합 융합 인터페론(P
IFN
α-
Fc
)의
PRRSV
에 대한 항바이러스 활성 및 돼지 면역글로불린
Fc
단편(
IgG
-
Fc
)이 없는 돼지 인터페론(P
IFN
α)의
PRRSV
에 대한 항바이러스 활성의 비교
MARC-145 세포를 16 내지 24시간 동안 37℃, 5% CO2에서 96-웰 세포 배양 플레이트에서 1.5×104 세포/웰의 밀도로 배양하였다. 배양 배지를 제거한 후, 세포를 16 내지 24시간 동안 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a 그룹) 또는 돼지 면역글로불린 Fc 단편이 없는 돼지 인터페론(P IFNα1 그룹)(SEQ ID NO:2)으로 처리하였다. 2개 유형의 인터페론을 제거한 후, 세포를 PRRS 바이러스(100 TCID50/ 100㎕)로 감염시킨 후, 4 내지 5일 동안 37℃, 5% CO2에서 배양하였다. 이후, 세포 생활력을 MTT 방법에 의해 분석하였다.
표 5 및 도 4는 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a 그룹) 및 돼지 인터페론(P IFNα1 그룹)의 PRRSV에 대한 항바이러스 활성의 검정 결과를 나타낸다. 결과는 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a 그룹)이 돼지 인터페론(P IFNα1 그룹)보다 PRRSV에 대해 더 높은 항바이러스 활성을 갖는 것을 나타낸다.
표 5 - 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a 그룹) 및 돼지 인터페론(P IFNα1 그룹)의 PRRSV에 대한 항바이러스 활성의 비교.
실시예
8 - 돼지 재조합 융합 인터페론(P
IFN
-α
Fc
) 및 돼지 면역글로불린 Fc 단편(
IgG
-
Fc
)이 없는 돼지 인터페론(P
IFN
α)의
PRV
에 대한 항바이러스 활성의 비교
ST 세포를 16 내지 24시간 동안 37℃, 5% CO2에서 96-웰 세포 배양 플레이트에서 1.5×104 세포/웰의 밀도로 배양하였다. 배양 배지를 제거한 후, 세포를 16 내지 24시간 동안 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a 그룹) 또는 돼지 면역글로불린 Fc 단편을 갖지 않는 돼지 인터페론(P IFNα1 그룹)(SEQ ID NO:2)으로 처리하였다. 2개 유형의 인터페론을 제거한 후, 세포를 PR 바이러스(1 TCID50/ 100㎕)로 감염시킨 후, 4 내지 5일 동안 37℃, 5% CO2에서 배양하였다. 이후, 세포 생활력을 MTT 방법에 의해 분석하였다.
표 6 및 도 4는 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a 그룹) 및 돼지 인터페론(P IFNα1 그룹)의 PRV에 대한 항바이러스 활성의 검정 결과를 나타낸다. 결과는 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a 그룹)이 돼지 인터페론(P IFNα1 그룹)보다 PRV에 대해 더 높은 항바이러스 활성을 갖는 것을 나타낸다.
표 6 - 돼지 재조합 융합 인터페론(P IFNα1-Fc 4a 그룹) 및 돼지 인터페론(P IFNα1 그룹)의 PRV에 대한 항바이러스 활성의 비교.
유사하게, 실시예 4에서 작제된 다른 돼지 재조합 융합 인터페론의 DNA 서열(SEQ ID NO:7, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 및 222)을 함유하는 플라스미드 pSecTag2(B)-IFNα-Fc를 실시예 5에 기재된 방법에 의해 CHO 세포에 트랜스펙션시켜, 돼지 재조합 융합 인터페론(P IFNα-Fc)(SEQ ID NO:8, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 및 223)을 발현시켰다. 발현된 돼지 재조합 융합 인터페론(P IFNα-Fc)의 PRRS 바이러스 및 PR 바이러스에 대한 항바이러스 활성을 실시예 7 및 8에 기재된 방법에 의해 평가하였다. 결과는 돼지 재조합 융합 인터페론(P IFNα-Fc)이 돼지 면역글로불린 Fc 단편이 없는 돼지 인터페론보다 높은 항바이러스 활성을 갖는 것을 나타낸다.
상기 실시예의 결과를 기초로 하여, 본 발명의 동물용 재조합 융합 인터페론은 돼지 면역글로불린 Fc 단편이 없는 동물 인터페론보다 RNA 바이러스 및 DNA 바이러스 둘 모두에 대해 더 높은 항바이러스 활성을 갖는다.
본 발명의 상기 기재된 구현예에서 많은 변화 및 변형이 물론 본 발명의 범위로부터 벗어남이 없이 수행될 수 있다. 따라서, 과학 및 유용한 분야에서 발달을 촉진시키기 위해, 본 발명이 개시되며, 이는 첨부된 청구항의 범위에 의해서만 제한된다.
SEQUENCE LISTING
<110> SBC Virbac Biotech Co., Ltd.
<120> Interferon And Immune Globulin Fc Section Fusion Protein
<130> P14-0127
<150> CN201210016618.8
<151> 2012-01-19
<150> PCT/CN2013/070693
<151> 2013-01-18
<160> 223
<170> PatentIn version 3.5
<210> 1
<211> 543
<212> DNA
<213> Sus scrofa
<400> 1
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacaaa tgaggagaat ctcccccttc tcctgcctgg accacagaag ggactttgga 180
ttcccccaag aggccttggg gggcaaccag gtccagaagg ctcaagccat ggctctggtg 240
catgagatgc tccagcagac cttccagctc ttcagcacag agggctcggc tgctgcctgg 300
gatgagagcc tcctgcacca gttctgcact ggactggatc agcagctcag ggacctggaa 360
gcctgtgtca tgcaggaggc ggggctggaa gggacccccc tgctggagga ggactccatc 420
ctggctgtga ggaaatactt ccacagactc accctctatc tgcaagagaa gagctacagc 480
ccctgtgcct gggagatcgt cagagcagaa gtcatgagag ccttctcttc ctccagaaac 540
ctg 543
<210> 2
<211> 181
<212> PRT
<213> Sus scrofa
<400> 2
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Gly
115 120 125
Leu Glu Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg
130 135 140
Lys Tyr Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser
145 150 155 160
Pro Cys Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser
165 170 175
Ser Ser Arg Asn Leu
180
<210> 3
<211> 690
<212> DNA
<213> Sus scrofa
<400> 3
ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaagggcc cgggccctcg 60
gccttcatct tccctccaaa acccaaggac accctcatga tctcccggac ccccaaggtc 120
acgtgcgtgg tggtagatgt gagccaggag aacccggagg tccagttctc ctggtacgtg 180
gacggcgtag aggtgcacac ggcccagacg aggccaaagg aggagcagtt caacagcacc 240
taccgcgtgg tcagcgtcct gcccatccag caccaggact ggctgaacgg gaaggagttc 300
aagtgcaagg tcaacaacaa agacctccca gcccccatca caaggatcat ctccaaggcc 360
aaagggcaga cccgggagcc gcaggtgtac accctgcccc cacccaccga ggagctgtcc 420
aggagcaaag tcacgctaac ctgcctggtc actggcttct acccacctga catcgatgtc 480
gagtggcaaa gaaacggaca gccggagcca gagggcaatt accgcaccac cccgccccag 540
caggacgtgg acgggaccta cttcctgtac agcaagctcg cggtggacaa ggccagctgg 600
cagcgtggag acacattcca gtgtgcggtg atgcacgagg ctctgcacaa ccactacacc 660
cagaagtcca tcttcaagac tccgggtaaa 690
<210> 4
<211> 230
<212> PRT
<213> Sus scrofa
<400> 4
Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly
1 5 10 15
Pro Gly Pro Ser Ala Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu
20 25 30
Met Ile Ser Arg Thr Pro Lys Val Thr Cys Val Val Val Asp Val Ser
35 40 45
Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu
50 55 60
Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr
65 70 75 80
Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn
85 90 95
Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro
100 105 110
Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Gln
115 120 125
Val Tyr Thr Leu Pro Pro Pro Thr Glu Glu Leu Ser Arg Ser Lys Val
130 135 140
Thr Leu Thr Cys Leu Val Thr Gly Phe Tyr Pro Pro Asp Ile Asp Val
145 150 155 160
Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg Thr
165 170 175
Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser Lys
180 185 190
Leu Ala Val Asp Lys Ala Ser Trp Gln Arg Gly Asp Thr Phe Gln Cys
195 200 205
Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Ile
210 215 220
Phe Lys Thr Pro Gly Lys
225 230
<210> 5
<211> 48
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of a linker of interferon and IgG Fc fragment
<400> 5
ggtggctcag gtggatccgg tggaggcgga agcggcggtg gaggatca 48
<210> 6
<211> 16
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of a linker of interferon and IgG Fc fragment
<400> 6
Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
1 5 10 15
<210> 7
<211> 1281
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa1+IgG-Fc 4a
<400> 7
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacaaa tgaggagaat ctcccccttc tcctgcctgg accacagaag ggactttgga 180
ttcccccaag aggccttggg gggcaaccag gtccagaagg ctcaagccat ggctctggtg 240
catgagatgc tccagcagac cttccagctc ttcagcacag agggctcggc tgctgcctgg 300
gatgagagcc tcctgcacca gttctgcact ggactggatc agcagctcag ggacctggaa 360
gcctgtgtca tgcaggaggc ggggctggaa gggacccccc tgctggagga ggactccatc 420
ctggctgtga ggaaatactt ccacagactc accctctatc tgcaagagaa gagctacagc 480
ccctgtgcct gggagatcgt cagagcagaa gtcatgagag ccttctcttc ctccagaaac 540
ctgggtggct caggtggatc cggtggaggc ggaagcggcg gtggaggatc aggaacaaag 600
accaaaccac catgtcccat atgcccagcc tgtgaagggc ccgggccctc ggccttcatc 660
ttccctccaa aacccaagga caccctcatg atctcccgga cccccaaggt cacgtgcgtg 720
gtggtagatg tgagccagga gaacccggag gtccagttct cctggtacgt ggacggcgta 780
gaggtgcaca cggcccagac gaggccaaag gaggagcagt tcaacagcac ctaccgcgtg 840
gtcagcgtcc tgcccatcca gcaccaggac tggctgaacg ggaaggagtt caagtgcaag 900
gtcaacaaca aagacctccc agcccccatc acaaggatca tctccaaggc caaagggcag 960
acccgggagc cgcaggtgta caccctgccc ccacccaccg aggagctgtc caggagcaaa 1020
gtcacgctaa cctgcctggt cactggcttc tacccacctg acatcgatgt cgagtggcaa 1080
agaaacggac agccggagcc agagggcaat taccgcacca ccccgcccca gcaggacgtg 1140
gacgggacct acttcctgta cagcaagctc gcggtggaca aggccagctg gcagcgtgga 1200
gacacattcc agtgtgcggt gatgcacgag gctctgcaca accactacac ccagaagtcc 1260
atcttcaaga ctccgggtaa a 1281
<210> 8
<211> 427
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa1+IgG-Fc 4a
<400> 8
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Gly
115 120 125
Leu Glu Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg
130 135 140
Lys Tyr Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser
145 150 155 160
Pro Cys Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser
165 170 175
Ser Ser Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser
180 185 190
Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys
195 200 205
Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala Phe Ile Phe Pro Pro Lys
210 215 220
Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Lys Val Thr Cys Val
225 230 235 240
Val Val Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr
245 250 255
Val Asp Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu
260 265 270
Gln Phe Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His
275 280 285
Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys
290 295 300
Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln
305 310 315 320
Thr Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Pro Thr Glu Glu Leu
325 330 335
Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr Gly Phe Tyr Pro
340 345 350
Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu
355 360 365
Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr
370 375 380
Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser Trp Gln Arg Gly
385 390 395 400
Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu His Asn His Tyr
405 410 415
Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425
<210> 9
<211> 27
<212> DNA
<213> Artificial Sequence
<220>
<223> Forward primer for interferon
<400> 9
cccaagctta tggccccaac ctcagcc 27
<210> 10
<211> 27
<212> DNA
<213> Artificial Sequence
<220>
<223> Reverse primer for interferon
<400> 10
ccgctcgagc aggtttctgg aggaaga 27
<210> 11
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> Forward primer for IgG Fc fragment
<400> 11
cgggatccgg gaacaaagac c 21
<210> 12
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> Reverse primer for IgG Fc fragment
<400> 12
cccaagcttt ttacccggag tc 22
<210> 13
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> Forward primer for interferon
<400> 13
gcgatatcat ggccccaacc tc 22
<210> 14
<211> 34
<212> DNA
<213> Artificial Sequence
<220>
<223> Reverse primer for interferon
<400> 14
cgggatccac ctgagccacc caggtttctg gagg 34
<210> 15
<211> 48
<212> DNA
<213> Artificial Sequence
<220>
<223> Forward primer for IgG Fc fragment
<400> 15
cgggatccgg tggaggcgga agcggcggtg gaggatcagg aacaaaga 48
<210> 16
<211> 538
<212> DNA
<213> Sus scrofa
<400> 16
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtga 538
<210> 17
<211> 179
<212> PRT
<213> Sus scrofa
<400> 17
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu
<210> 18
<211> 538
<212> DNA
<213> Sus scrofa
<400> 18
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccacaa acctgtga 538
<210> 19
<211> 179
<212> PRT
<213> Sus scrofa
<400> 19
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Thr Asn Leu
<210> 20
<211> 562
<212> DNA
<213> Sus scrofa
<400> 20
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagattcagg aagaaggagt ga 562
<210> 21
<211> 187
<212> PRT
<213> Sus scrofa
<400> 21
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Phe Arg Lys Lys Glu
180 185
<210> 22
<211> 562
<212> DNA
<213> Sus scrofa
<400> 22
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacctac agcctggctc acaccagggc cctgaggccc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac tacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaacctcc cagctcttca gcacagaggg ctcagctgct gcctgggatg 300
acagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt ga 562
<210> 23
<211> 187
<212> PRT
<213> Sus scrofa
<400> 23
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr Tyr Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Pro Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp Tyr Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Ser Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Asp Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu
180 185
<210> 24
<211> 562
<212> DNA
<213> Sus scrofa
<400> 24
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctacc tcagacacac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatat ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgcaaga 540
cagactcagg aagaaggagt ga 562
<210> 25
<211> 187
<212> PRT
<213> Sus scrofa
<400> 25
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu
180 185
<210> 26
<211> 538
<212> DNA
<213> Sus scrofa
<400> 26
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaa 538
<210> 27
<211> 179
<212> PRT
<213> Sus scrofa
<400> 27
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu
<210> 28
<211> 564
<212> DNA
<213> Sus scrofa
<400> 28
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggccggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagccttct cttcctccac aaacctgcaa 540
gacagactca ggaggaagga gtga 564
<210> 29
<211> 187
<212> PRT
<213> Sus scrofa
<400> 29
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu
180 185
<210> 30
<211> 562
<212> DNA
<213> Sus scrofa
<400> 30
atggccccaa cctcagcctt cctcatggcc ctggtgctgc tcagctgcaa ggccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttgggtt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt ga 562
<210> 31
<211> 187
<212> PRT
<213> Sus scrofa
<400> 31
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Lys Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu
180 185
<210> 32
<211> 538
<212> DNA
<213> Sus scrofa
<400> 32
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaagg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgtga 538
<210> 33
<211> 179
<212> PRT
<213> Sus scrofa
<400> 33
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Lys Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu
<210> 34
<211> 538
<212> DNA
<213> Sus scrofa
<400> 34
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcatcctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaa 538
<210> 35
<211> 179
<212> PRT
<213> Sus scrofa
<400> 35
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Ile Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu
<210> 36
<211> 564
<212> DNA
<213> Sus scrofa
<400> 36
atggccccaa cctcagcctt cctcacggtc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggg ctggaaggga cgcccctgct ggaggaggac tccatcctgg 420
ctgtgaggaa atacttccac agactcaccc tctatctgca agagaagata cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagtcttct cttcctccac aaacctgcaa 540
gacagactca ggaagaagga gtga 564
<210> 37
<211> 187
<212> PRT
<213> Sus scrofa
<400> 37
Met Ala Pro Thr Ser Ala Phe Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu
180 185
<210> 38
<211> 562
<212> DNA
<213> Sus scrofa
<400> 38
atggccccat cctcagccct cctcacagcc ctggtgctgc tcagttgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcctttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaaggcacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt ga 562
<210> 39
<211> 187
<212> PRT
<213> Sus scrofa
<400> 39
Met Ala Pro Ser Ser Ala Leu Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu
180 185
<210> 40
<211> 562
<212> DNA
<213> Sus scrofa
<400> 40
atggccccat cctcaactct cctcacggtc ctggtgctgc tcagctgcaa tgccatctgc 60
tgtctgggct gcaacctgcc tcagacccac agcctggctc ataccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcataca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcagg agaagaacta cagcctctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt ga 562
<210> 41
<211> 187
<212> PRT
<213> Sus scrofa
<400> 41
Met Ala Pro Ser Ser Thr Leu Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Ile Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Asn Tyr Ser Leu Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu
180 185
<210> 42
<211> 559
<212> DNA
<213> Sus scrofa
<400> 42
atggccccaa cctcagcctt cctcatggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg agaatctccc ctttctcctg cctggaccac agaagggact ttggattccc 180
ccaagaggcc ttggggggca accaggtcca gaaggctcaa gccatggctc tggtgcatga 240
gatgctccag cagcttccag ctcttcagca cagagggctc ggctgctgcc tgggatgaga 300
gcctcctgca ccagttctgc actggactgg atcagcagct cagggacctg gaagcctgtg 360
tcatgcagga ggcggggctg agggaccccc ctgctggagg aggactccat cctggctgtg 420
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 480
tgggagatcg tcagggcaga agtcagaggc cttctcttcc tccacaaacc tgcaagacag 540
actcaggagg aaggagtga 559
<210> 43
<211> 186
<212> PRT
<213> Sus scrofa
<400> 43
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Ile Ser Pro
35 40 45
Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu Ala
50 55 60
Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val His
65 70 75 80
Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser Ala
85 90 95
Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu Asp
100 105 110
Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Gly Gly
115 120 125
Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe
130 135 140
His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys Ala
145 150 155 160
Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser Thr
165 170 175
Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu
180 185
<210> 44
<211> 562
<212> DNA
<213> Sus scrofa
<400> 44
atggccccaa cctcagcctt cttcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacccggt tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggagggctc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt ga 562
<210> 45
<211> 187
<212> PRT
<213> Sus scrofa
<400> 45
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Pro Val Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Gly Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu
180 185
<210> 46
<211> 538
<212> DNA
<213> Sus scrofa
<400> 46
atggccccaa cctcagcctt cttcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccat agcctggcgc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtga 538
<210> 47
<211> 179
<212> PRT
<213> Sus scrofa
<400> 47
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu
<210> 48
<211> 680
<212> DNA
<213> Sus scrofa
<400> 48
ggaacaaaga ccaaaccacc atgtcccata tgcccaggct gtgaagtggc cgggccctcg 60
gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac ccccgaggtc 120
acgtgcggtg gtggacgtca gcaaggagca cgccgaggtc cagttctcct ggtacgtgga 180
cggcgtagag gtgcacacgg ccgagacgag accaaaggag gagcagttca acagcaccta 240
ccgtgtggtc agctctgccc atccagcacc aggactggct gaaggggaag gagttcaagt 300
gcaaggtcaa caacgtagac ctcccagccc ccatcacgag gaccatctcc aaggctatag 360
ggcagagccg ggagccgcag ttacaccctg cccccacccg ccgaggagct gtccaggagc 420
aaagtcaccg taacctgcct ggtcattggc ttctacccac ctgacatcca tgttgagtgg 480
aagagcaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc agcaggacgt 540
ggacgggacc ttcttcctgt acagcaagct cgcggtggac aaggcaagat gggaccatgg 600
agaaacattt gagtgtgcgg tgatgcacga gctctcacaa ccactacacc cagaagtcca 660
tctccaagac tcagggtaaa 680
<210> 49
<211> 228
<212> PRT
<213> Sus scrofa
<400> 49
Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val
1 5 10 15
Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu
20 25 30
Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser
35 40 45
Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu
50 55 60
Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr
65 70 75 80
Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys
85 90 95
Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro
100 105 110
Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr
115 120 125
Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val
130 135 140
Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp
145 150 155 160
Lys Ser Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro
165 170 175
Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala
180 185 190
Val Asp Lys Ala Arg Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val
195 200 205
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys
210 215 220
Thr Gln Gly Lys
225
<210> 50
<211> 685
<212> DNA
<213> Sus scrofa
<400> 50
ggaatacacc agccgcaaac atgtcccata tgcccaggct gtgaagtggc cgggccctcg 60
gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac ccccgaggtc 120
acgtgcgggt ggtggacgtc agcaaggagc acgccgaggt ccagttctcc tggtacgtgg 180
acggcgtaga ggtgcacacg gccgagacga gaccaaagga ggagcagttc aacagcacct 240
accgtgtggt cagctcctgc ccatccagca ccaggactgg ctgaagggga aggagttcaa 300
gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct ccaaggctat 360
agggcagagc cgggagccgc agtgtacacc ctgcccccac ccgccgagga gctgtccagg 420
agcaaagtca cgctaacctg cctggtcatt ggcttctacc cacctgacat ccatgttgag 480
tggaagagca acggacagcc ggagccagga acacataccg caccaccccg ccccagcagg 540
acgtggacgg gaccttcttc ctgtacagca aactcgcggt ggacaaggca agatgggacc 600
atggagacaa atttgagtgt gcggtgatgc acgagctctg cacaaccact acacccagaa 660
gtccatctcc aagactcagg gtaaa 685
<210> 51
<211> 228
<212> PRT
<213> Sus scrofa
<400> 51
Gly Ile His Gln Pro Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val
1 5 10 15
Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu
20 25 30
Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser
35 40 45
Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu
50 55 60
Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr
65 70 75 80
Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys
85 90 95
Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro
100 105 110
Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr
115 120 125
Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu
130 135 140
Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp
145 150 155 160
Lys Ser Asn Gly Gln Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro
165 170 175
Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala
180 185 190
Val Asp Lys Ala Arg Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val
195 200 205
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys
210 215 220
Thr Gln Gly Lys
225
<210> 52
<211> 680
<212> DNA
<213> Sus scrofa
<400> 52
ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcacc agggccctcg 60
gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac accccaggtc 120
acgtgcggtg gttgatgtga gccaggagaa cccggaggtc cagttctcct ggtacgtgga 180
cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca acagcaccta 240
ccgcgtggtc agctctaccc atccagcacc aggactggct gaacgggaag gagttcaagt 300
gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc aaggccaaag 360
ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct gtccaggagc 420
aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga tgtcgagtgg 480
caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc agcaggacgt 540
ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct ggcagggtgg 600
aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc cagaagtcta 660
tctccaagac tccgggtaaa 680
<210> 53
<211> 228
<212> PRT
<213> Sus scrofa
<400> 53
Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser
1 5 10 15
Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu
20 25 30
Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val Asp Val Ser
35 40 45
Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu
50 55 60
Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr
65 70 75 80
Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn
85 90 95
Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro
100 105 110
Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr
115 120 125
Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile
130 135 140
Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp
145 150 155 160
Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro
165 170 175
Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser
180 185 190
Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val
195 200 205
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys
210 215 220
Thr Pro Gly Lys
225
<210> 54
<211> 680
<212> DNA
<213> Sus scrofa
<400> 54
ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcgcc agggccctcg 60
gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac accccaggtc 120
acgtgcggta gttgatgtga gccaggagaa cccggaggtc cagttctcct ggtacgtgga 180
cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca acagcaccta 240
ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag gagttcaagt 300
gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc aaggccaaag 360
ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct gtccaggagc 420
aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga tgtcgagtgg 480
caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc agcaggacgt 540
ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct ggcagggtgg 600
aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc cagaagtcta 660
tctccaagac tccgggtaaa 680
<210> 55
<211> 228
<212> PRT
<213> Sus scrofa
<400> 55
Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser
1 5 10 15
Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu
20 25 30
Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val Asp Val Ser
35 40 45
Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu
50 55 60
Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr
65 70 75 80
Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn
85 90 95
Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro
100 105 110
Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr
115 120 125
Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile
130 135 140
Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp
145 150 155 160
Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro
165 170 175
Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser
180 185 190
Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val
195 200 205
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys
210 215 220
Thr Pro Gly Lys
225
<210> 56
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa1+IgG-Fc 1a
<400> 56
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcggtggtgg 720
acgtcagcaa ggagcacgcc gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccga gacgagacca aaggaggagc agttcaacag cacctaccgt gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaag gggaaggagt tcaagtgcaa ggtcaacaac 900
gtagacctcc cagcccccat cacgaggacc atctccaagg ctatagggca gagccgggag 960
ccgcagttac accctgcccc cacccgccga ggagctgtcc aggagcaaag tcaccgtaac 1020
ctgcctggtc attggcttct acccacctga catccatgtt gagtggaaga gcaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggaccttct 1140
tcctgtacag caagctcgcg gtggacaagg caagatggga ccatggagaa acatttgagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctc caagactcag 1260
ggtaaa 1266
<210> 57
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa1+IgG-Fc 1a
<400> 57
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Val Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Glu Thr Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 58
<211> 1271
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa1+IgG-Fc 1b
<400> 58
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa tacaccagcc 600
gcaaacatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcgggtggtg 720
gacgtcagca aggagcacgc cgaggtccag ttctcctggt acgtggacgg cgtagaggtg 780
cacacggccg agacgagacc aaaggaggag cagttcaaca gcacctaccg tgtggtcagc 840
tcctgcccat ccagcaccag gactggctga aggggaagga gttcaagtgc aaggtcaaca 900
acgtagacct cccagccccc atcacgagga ccatctccaa ggctataggg cagagccggg 960
agccgcagtg tacaccctgc ccccacccgc cgaggagctg tccaggagca aagtcacgct 1020
aacctgcctg gtcattggct tctacccacc tgacatccat gttgagtgga agagcaacgg 1080
acagccggag ccaggaacac ataccgcacc accccgcccc agcaggacgt ggacgggacc 1140
ttcttcctgt acagcaaact cgcggtggac aaggcaagat gggaccatgg agacaaattt 1200
gagtgtgcgg tgatgcacga gctctgcaca accactacac ccagaagtcc atctccaaga 1260
ctcagggtaa a 1271
<210> 59
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa1+IgG-Fc 1b
<400> 59
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Ile His Gln Pro Gln Thr Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Asn Thr Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Asp Lys Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 60
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa1+IgG-Fc2a
<400> 60
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcaccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtggttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctacccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 61
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa1+IgG-Fc 2a
<400> 61
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 62
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa1+IgG-Fc 2b
<400> 62
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcgccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtagttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 63
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa1+IgG-Fc 2b
<400> 63
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 64
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa2+IgG-Fc1a
<400> 64
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcggtggtgg 720
acgtcagcaa ggagcacgcc gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccga gacgagacca aaggaggagc agttcaacag cacctaccgt gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaag gggaaggagt tcaagtgcaa ggtcaacaac 900
gtagacctcc cagcccccat cacgaggacc atctccaagg ctatagggca gagccgggag 960
ccgcagttac accctgcccc cacccgccga ggagctgtcc aggagcaaag tcaccgtaac 1020
ctgcctggtc attggcttct acccacctga catccatgtt gagtggaaga gcaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggaccttct 1140
tcctgtacag caagctcgcg gtggacaagg caagatggga ccatggagaa acatttgagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctc caagactcag 1260
ggtaaa 1266
<210> 65
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa2+IgG-Fc 1a
<400> 65
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Val Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Glu Thr Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 66
<211> 1271
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa2+IgG-Fc 1b
<400> 66
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa tacaccagcc 600
gcaaacatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcgggtggtg 720
gacgtcagca aggagcacgc cgaggtccag ttctcctggt acgtggacgg cgtagaggtg 780
cacacggccg agacgagacc aaaggaggag cagttcaaca gcacctaccg tgtggtcagc 840
tcctgcccat ccagcaccag gactggctga aggggaagga gttcaagtgc aaggtcaaca 900
acgtagacct cccagccccc atcacgagga ccatctccaa ggctataggg cagagccggg 960
agccgcagtg tacaccctgc ccccacccgc cgaggagctg tccaggagca aagtcacgct 1020
aacctgcctg gtcattggct tctacccacc tgacatccat gttgagtgga agagcaacgg 1080
acagccggag ccaggaacac ataccgcacc accccgcccc agcaggacgt ggacgggacc 1140
ttcttcctgt acagcaaact cgcggtggac aaggcaagat gggaccatgg agacaaattt 1200
gagtgtgcgg tgatgcacga gctctgcaca accactacac ccagaagtcc atctccaaga 1260
ctcagggtaa a 1271
<210> 67
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa2+IgG-Fc 1b
<400> 67
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Ile His Gln Pro Gln Thr Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Asn Thr Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Asp Lys Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 68
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa2+IgG-Fc 2a
<400> 68
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcaccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtggttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctacccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 69
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa2-IgG-Fc2a
<400> 69
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 70
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa2+IgG-Fc2b
<400> 70
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcgccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtagttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 71
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa2+IgG-Fc 2b
<400> 71
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 72
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa2+IgG-Fc 4a
<400> 72
atggccccaa cctcagcctt cctcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga agggcccggg ccctcggcct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggaccccc aaggtcacgt gcggtggtag 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacccaccga ggagctgtcc aggagcaaag tcacgctaac 1020
ctgcctggtc actggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagctcgcg gtggacaagg ccagctggca gcgtggagac acattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctt caagactccg 1260
ggtaaa 1266
<210> 73
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa2+IgG-Fc 4a
<400> 73
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Gly Pro Gly Pro Ser Ala Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Lys Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Thr Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Thr Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Ser Trp Gln Arg Gly Asp Thr Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Phe Lys Thr Pro Gly Lys
420
<210> 74
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa3+IgG-Fc1a
<400> 74
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccacaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcggtggtgg 720
acgtcagcaa ggagcacgcc gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccga gacgagacca aaggaggagc agttcaacag cacctaccgt gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaag gggaaggagt tcaagtgcaa ggtcaacaac 900
gtagacctcc cagcccccat cacgaggacc atctccaagg ctatagggca gagccgggag 960
ccgcagttac accctgcccc cacccgccga ggagctgtcc aggagcaaag tcaccgtaac 1020
ctgcctggtc attggcttct acccacctga catccatgtt gagtggaaga gcaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggaccttct 1140
tcctgtacag caagctcgcg gtggacaagg caagatggga ccatggagaa acatttgagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctc caagactcag 1260
ggtaaa 1266
<210> 75
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa3+IgG-Fc 1a
<400> 75
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Val Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Glu Thr Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 76
<211> 1271
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa3+IgG-Fc 1b
<400> 76
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccacaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa tacaccagcc 600
gcaaacatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcgggtggtg 720
gacgtcagca aggagcacgc cgaggtccag ttctcctggt acgtggacgg cgtagaggtg 780
cacacggccg agacgagacc aaaggaggag cagttcaaca gcacctaccg tgtggtcagc 840
tcctgcccat ccagcaccag gactggctga aggggaagga gttcaagtgc aaggtcaaca 900
acgtagacct cccagccccc atcacgagga ccatctccaa ggctataggg cagagccggg 960
agccgcagtg tacaccctgc ccccacccgc cgaggagctg tccaggagca aagtcacgct 1020
aacctgcctg gtcattggct tctacccacc tgacatccat gttgagtgga agagcaacgg 1080
acagccggag ccaggaacac ataccgcacc accccgcccc agcaggacgt ggacgggacc 1140
ttcttcctgt acagcaaact cgcggtggac aaggcaagat gggaccatgg agacaaattt 1200
gagtgtgcgg tgatgcacga gctctgcaca accactacac ccagaagtcc atctccaaga 1260
ctcagggtaa a 1271
<210> 77
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa3+IgG-Fc 1b
<400> 77
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Ile His Gln Pro Gln Thr Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Asn Thr Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Asp Lys Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 78
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa3+IgG-Fc 2a
<400> 78
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccacaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcaccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtggttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctacccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 79
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa3+IgG-Fc 2a
<400> 79
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 80
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa3+IgG-Fc 2b
<400> 80
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccacaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcgccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtagttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 81
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa3+IgG-Fc 2b
<400> 81
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 82
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa3+IgG-Fc 4a
<400> 82
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccacaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga agggcccggg ccctcggcct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggaccccc aaggtcacgt gcggtggtag 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacccaccga ggagctgtcc aggagcaaag tcacgctaac 1020
ctgcctggtc actggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagctcgcg gtggacaagg ccagctggca gcgtggagac acattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctt caagactccg 1260
ggtaaa 1266
<210> 83
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa3+IgG-Fc 4a
<400> 83
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Gly Pro Gly Pro Ser Ala Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Lys Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Thr Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Thr Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Ser Trp Gln Arg Gly Asp Thr Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Phe Lys Thr Pro Gly Lys
420
<210> 84
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa4+IgG-Fc 1a
<400> 84
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagattcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcggtg gtggacgtca gcaaggagca cgccgaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg ccgagacgag accaaaggag gagcagttca 840
acagcaccta ccgtgtggtc agctctgccc atccagcacc aggactggct gaaggggaag 900
gagttcaagt gcaaggtcaa caacgtagac ctcccagccc ccatcacgag gaccatctcc 960
aaggctatag ggcagagccg ggagccgcag ttacaccctg cccccacccg ccgaggagct 1020
gtccaggagc aaagtcaccg taacctgcct ggtcattggc ttctacccac ctgacatcca 1080
tgttgagtgg aagagcaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc ttcttcctgt acagcaagct cgcggtggac aaggcaagat 1200
gggaccatgg agaaacattt gagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tctccaagac tcagggtaaa 1290
<210> 85
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa4+IgG-Fc 1a
<400> 85
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Phe Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 86
<211> 1295
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa4+IgG-Fc 1b
<400> 86
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagattcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaatacacc agccgcaaac atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcgggt ggtggacgtc agcaaggagc acgccgaggt ccagttctcc 780
tggtacgtgg acggcgtaga ggtgcacacg gccgagacga gaccaaagga ggagcagttc 840
aacagcacct accgtgtggt cagctcctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agtgtacacc ctgcccccac ccgccgagga 1020
gctgtccagg agcaaagtca cgctaacctg cctggtcatt ggcttctacc cacctgacat 1080
ccatgttgag tggaagagca acggacagcc ggagccagga acacataccg caccaccccg 1140
ccccagcagg acgtggacgg gaccttcttc ctgtacagca aactcgcggt ggacaaggca 1200
agatgggacc atggagacaa atttgagtgt gcggtgatgc acgagctctg cacaaccact 1260
acacccagaa gtccatctcc aagactcagg gtaaa 1295
<210> 87
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa4+IgG-Fc 1b
<400> 87
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Phe Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 88
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa4+IgG-Fc 2a
<400> 88
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagattcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcacc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggtg gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctaccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 89
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa4+IgG-Fc 2a
<400> 89
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Phe Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 90
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa4+IgG-Fc 2b
<400> 90
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagattcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcgcc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggta gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 91
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa4+IgG-Fc 2b
<400> 91
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Phe Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 92
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa4+IgG-Fc 4a
<400> 92
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagattcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaagggcc 660
cgggccctcg gccttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
ccccaaggtc acgtgcggtg gtagatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccaccca ccgaggagct 1020
gtccaggagc aaagtcacgc taacctgcct ggtcactggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagct cgcggtggac aaggccagct 1200
ggcagcgtgg agacacattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tcttcaagac tccgggtaaa 1290
<210> 93
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa4+IgG-Fc 4a
<400> 93
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Phe Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 94
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa5+IgG-Fc 1a
<400> 94
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacctac agcctggctc acaccagggc cctgaggccc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac tacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaacctcc cagctcttca gcacagaggg ctcagctgct gcctgggatg 300
acagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcggtg gtggacgtca gcaaggagca cgccgaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg ccgagacgag accaaaggag gagcagttca 840
acagcaccta ccgtgtggtc agctctgccc atccagcacc aggactggct gaaggggaag 900
gagttcaagt gcaaggtcaa caacgtagac ctcccagccc ccatcacgag gaccatctcc 960
aaggctatag ggcagagccg ggagccgcag ttacaccctg cccccacccg ccgaggagct 1020
gtccaggagc aaagtcaccg taacctgcct ggtcattggc ttctacccac ctgacatcca 1080
tgttgagtgg aagagcaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc ttcttcctgt acagcaagct cgcggtggac aaggcaagat 1200
gggaccatgg agaaacattt gagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tctccaagac tcagggtaaa 1290
<210> 95
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa5+IgG-Fc 1a
<400> 95
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr Tyr Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Pro Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp Tyr Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Ser Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Asp Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 96
<211> 1295
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa5+IgG-Fc 1b
<400> 96
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacctac agcctggctc acaccagggc cctgaggccc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac tacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaacctcc cagctcttca gcacagaggg ctcagctgct gcctgggatg 300
acagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaatacacc agccgcaaac atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcgggt ggtggacgtc agcaaggagc acgccgaggt ccagttctcc 780
tggtacgtgg acggcgtaga ggtgcacacg gccgagacga gaccaaagga ggagcagttc 840
aacagcacct accgtgtggt cagctcctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agtgtacacc ctgcccccac ccgccgagga 1020
gctgtccagg agcaaagtca cgctaacctg cctggtcatt ggcttctacc cacctgacat 1080
ccatgttgag tggaagagca acggacagcc ggagccagga acacataccg caccaccccg 1140
ccccagcagg acgtggacgg gaccttcttc ctgtacagca aactcgcggt ggacaaggca 1200
agatgggacc atggagacaa atttgagtgt gcggtgatgc acgagctctg cacaaccact 1260
acacccagaa gtccatctcc aagactcagg gtaaa 1295
<210> 97
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa5+IgG-Fc 1b
<400> 97
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr Tyr Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Pro Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp Tyr Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Ser Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Asp Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 98
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa5+IgG-Fc 2a
<400> 98
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacctac agcctggctc acaccagggc cctgaggccc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac tacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaacctcc cagctcttca gcacagaggg ctcagctgct gcctgggatg 300
acagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcacc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggtg gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctaccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 99
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa5+IgG-Fc 2a
<400> 99
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr Tyr Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Pro Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp Tyr Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Ser Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Asp Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 100
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INF a5+IgG-Fc 2b
<400> 100
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacctac agcctggctc acaccagggc cctgaggccc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac tacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaacctcc cagctcttca gcacagaggg ctcagctgct gcctgggatg 300
acagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcgcc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggta gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 101
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa5+IgG-Fc 2b
<400> 101
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr Tyr Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Pro Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp Tyr Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Ser Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Asp Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 102
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa5+IgG-Fc 4a
<400> 102
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctac 60
tctctgggct gtgacctgcc tcagacctac agcctggctc acaccagggc cctgaggccc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac tacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaacctcc cagctcttca gcacagaggg ctcagctgct gcctgggatg 300
acagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaagggcc 660
cgggccctcg gccttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
ccccaaggtc acgtgcggtg gtagatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccaccca ccgaggagct 1020
gtccaggagc aaagtcacgc taacctgcct ggtcactggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagct cgcggtggac aaggccagct 1200
ggcagcgtgg agacacattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tcttcaagac tccgggtaaa 1290
<210> 103
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa5+IgG-Fc 4a
<400> 103
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Tyr Ser Leu Gly Cys Asp Leu Pro Gln Thr Tyr Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Pro Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp Tyr Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Ser Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Asp Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 104
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa6+IgG-Fc 1a
<400> 104
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctacc tcagacacac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatat ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcggtg gtggacgtca gcaaggagca cgccgaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg ccgagacgag accaaaggag gagcagttca 840
acagcaccta ccgtgtggtc agctctgccc atccagcacc aggactggct gaaggggaag 900
gagttcaagt gcaaggtcaa caacgtagac ctcccagccc ccatcacgag gaccatctcc 960
aaggctatag ggcagagccg ggagccgcag ttacaccctg cccccacccg ccgaggagct 1020
gtccaggagc aaagtcaccg taacctgcct ggtcattggc ttctacccac ctgacatcca 1080
tgttgagtgg aagagcaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc ttcttcctgt acagcaagct cgcggtggac aaggcaagat 1200
gggaccatgg agaaacattt gagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tctccaagac tcagggtaaa 1290
<210> 105
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa6+IgG-Fc 1a
<400> 105
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 106
<211> 1295
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa6+IgG-Fc 1b
<400> 106
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctacc tcagacacac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatat ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaatacacc agccgcaaac atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcgggt ggtggacgtc agcaaggagc acgccgaggt ccagttctcc 780
tggtacgtgg acggcgtaga ggtgcacacg gccgagacga gaccaaagga ggagcagttc 840
aacagcacct accgtgtggt cagctcctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agtgtacacc ctgcccccac ccgccgagga 1020
gctgtccagg agcaaagtca cgctaacctg cctggtcatt ggcttctacc cacctgacat 1080
ccatgttgag tggaagagca acggacagcc ggagccagga acacataccg caccaccccg 1140
ccccagcagg acgtggacgg gaccttcttc ctgtacagca aactcgcggt ggacaaggca 1200
agatgggacc atggagacaa atttgagtgt gcggtgatgc acgagctctg cacaaccact 1260
acacccagaa gtccatctcc aagactcagg gtaaa 1295
<210> 107
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa6+IgG-Fc 1b
<400> 107
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 108
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa6+IgG-Fc 2a
<400> 108
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctacc tcagacacac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatat ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcacc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggtg gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctaccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 109
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa6+IgG-Fc 2a
<400> 109
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 110
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa6+IgG-Fc 2b
<400> 110
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctacc tcagacacac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatat ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcgcc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggta gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 111
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa6+IgG-Fc 2b
<400> 111
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 112
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa6+IgG-Fc 4a
<400> 112
atggccccaa cctcagcctt cctcacggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctacc tcagacacac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatat ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaagggcc 660
cgggccctcg gccttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
ccccaaggtc acgtgcggtg gtagatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccaccca ccgaggagct 1020
gtccaggagc aaagtcacgc taacctgcct ggtcactggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagct cgcggtggac aaggccagct 1200
ggcagcgtgg agacacattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tcttcaagac tccgggtaaa 1290
<210> 113
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa6+IgG-Fc 4a
<400> 113
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 114
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa7+IgG-Fc 1a
<400> 114
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcggtggtgg 720
acgtcagcaa ggagcacgcc gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccga gacgagacca aaggaggagc agttcaacag cacctaccgt gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaag gggaaggagt tcaagtgcaa ggtcaacaac 900
gtagacctcc cagcccccat cacgaggacc atctccaagg ctatagggca gagccgggag 960
ccgcagttac accctgcccc cacccgccga ggagctgtcc aggagcaaag tcaccgtaac 1020
ctgcctggtc attggcttct acccacctga catccatgtt gagtggaaga gcaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggaccttct 1140
tcctgtacag caagctcgcg gtggacaagg caagatggga ccatggagaa acatttgagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctc caagactcag 1260
ggtaaa 1266
<210> 115
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa7+IgG-Fc 1a
<400> 115
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Val Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Glu Thr Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 116
<211> 1271
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa7+IgG-Fc 1b
<400> 116
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa tacaccagcc 600
gcaaacatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcgggtggtg 720
gacgtcagca aggagcacgc cgaggtccag ttctcctggt acgtggacgg cgtagaggtg 780
cacacggccg agacgagacc aaaggaggag cagttcaaca gcacctaccg tgtggtcagc 840
tcctgcccat ccagcaccag gactggctga aggggaagga gttcaagtgc aaggtcaaca 900
acgtagacct cccagccccc atcacgagga ccatctccaa ggctataggg cagagccggg 960
agccgcagtg tacaccctgc ccccacccgc cgaggagctg tccaggagca aagtcacgct 1020
aacctgcctg gtcattggct tctacccacc tgacatccat gttgagtgga agagcaacgg 1080
acagccggag ccaggaacac ataccgcacc accccgcccc agcaggacgt ggacgggacc 1140
ttcttcctgt acagcaaact cgcggtggac aaggcaagat gggaccatgg agacaaattt 1200
gagtgtgcgg tgatgcacga gctctgcaca accactacac ccagaagtcc atctccaaga 1260
ctcagggtaa a 1271
<210> 117
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa7+IgG-Fc 1b
<400> 117
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Ile His Gln Pro Gln Thr Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Asn Thr Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Asp Lys Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 118
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa7+IgG-Fc 2a
<400> 118
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcaccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtggttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctacccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 119
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa7+IgG-Fc 2a
<400> 119
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 120
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa7+IgG-Fc 2b
<400> 120
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcgccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtagttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 121
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa7+IgG-Fc2b
<400> 121
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 122
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa7+IgG-Fc 4a
<400> 122
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga agggcccggg ccctcggcct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggaccccc aaggtcacgt gcggtggtag 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacccaccga ggagctgtcc aggagcaaag tcacgctaac 1020
ctgcctggtc actggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagctcgcg gtggacaagg ccagctggca gcgtggagac acattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctt caagactccg 1260
ggtaaa 1266
<210> 123
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa7+IgG-Fc4a
<400> 123
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Gly Pro Gly Pro Ser Ala Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Lys Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Thr Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Thr Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Ser Trp Gln Arg Gly Asp Thr Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Phe Lys Thr Pro Gly Lys
420
<210> 124
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa8+IgG-Fc1a
<400> 124
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggccggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagccttct cttcctccac aaacctgcaa 540
gacagactca ggaggaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaacaaa gaccaaacca ccatgtccca tatgcccagg ctgtgaagtg 660
gccgggccct cggtcttcat cttccctcca aaacccaagg acaccctcat gatctcccag 720
acccccgagg tcacgtgcgg tggtggacgt cagcaaggag cacgccgagg tccagttctc 780
ctggtacgtg gacggcgtag aggtgcacac ggccgagacg agaccaaagg aggagcagtt 840
caacagcacc taccgtgtgg tcagctctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agttacaccc tgcccccacc cgccgaggag 1020
ctgtccagga gcaaagtcac cgtaacctgc ctggtcattg gcttctaccc acctgacatc 1080
catgttgagt ggaagagcaa cggacagccg gagccagggg aattaccgca ccaccccgcc 1140
ccagcaggac gtggacggga ccttcttcct gtacagcaag ctcgcggtgg acaaggcaag 1200
atgggaccat ggagaaacat ttgagtgtgc ggtgatgcac gagctctcac aaccactaca 1260
cccagaagtc catctccaag actcagggta aa 1292
<210> 125
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa8+IgG-Fc1a
<400> 125
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 126
<211> 1297
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa8+IgG-Fc 1b
<400> 126
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggccggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagccttct cttcctccac aaacctgcaa 540
gacagactca ggaggaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaataca ccagccgcaa acatgtccca tatgcccagg ctgtgaagtg 660
gccgggccct cggtcttcat cttccctcca aaacccaagg acaccctcat gatctcccag 720
acccccgagg tcacgtgcgg gtggtggacg tcagcaagga gcacgccgag gtccagttct 780
cctggtacgt ggacggcgta gaggtgcaca cggccgagac gagaccaaag gaggagcagt 840
tcaacagcac ctaccgtgtg gtcagctcct gcccatccag caccaggact ggctgaaggg 900
gaaggagttc aagtgcaagg tcaacaacgt agacctccca gcccccatca cgaggaccat 960
ctccaaggct atagggcaga gccgggagcc gcagtgtaca ccctgccccc acccgccgag 1020
gagctgtcca ggagcaaagt cacgctaacc tgcctggtca ttggcttcta cccacctgac 1080
atccatgttg agtggaagag caacggacag ccggagccag gaacacatac cgcaccaccc 1140
cgccccagca ggacgtggac gggaccttct tcctgtacag caaactcgcg gtggacaagg 1200
caagatggga ccatggagac aaatttgagt gtgcggtgat gcacgagctc tgcacaacca 1260
ctacacccag aagtccatct ccaagactca gggtaaa 1297
<210> 127
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa8+IgG-Fc1b
<400> 127
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 128
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa8+IgG-Fc2a
<400> 128
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggccggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagccttct cttcctccac aaacctgcaa 540
gacagactca ggaggaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaacaaa gaccaaacca ccatgtccca tatgcccagc ctgtgaatca 660
ccagggccct cggtcttcat cttccctcca aaacccaagg acaccctcat gatctcccgg 720
acaccccagg tcacgtgcgg tggttgatgt gagccaggag aacccggagg tccagttctc 780
ctggtacgtg gacggcgtag aggtgcacac ggcccagacg aggccaaagg aggagcagtt 840
caacagcacc taccgcgtgg tcagctctac ccatccagca ccaggactgg ctgaacggga 900
aggagttcaa gtgcaaggtc aacaacaaag acctcccagc ccccatcaca aggatcatct 960
ccaaggccaa agggcagacc cgggagccgc agttacaccc tgcccccaca cgccgaggag 1020
ctgtccagga gcaaagtcag cataacctgc ctggtcattg gcttctaccc acctgacatc 1080
gatgtcgagt ggcaaagaaa cggacagccg gagccagggg aattaccgca ccaccccgcc 1140
ccagcaggac gtggacggga cctacttcct gtacagcaag ttctcggtgg acaaggccag 1200
ctggcagggt ggaggcatat tccagtgtgc ggtgatgcac gagctctcac aaccactaca 1260
cccagaagtc tatctccaag actccgggta aa 1292
<210> 129
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa8+IgG-Fc2a
<400> 129
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 130
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa8+IgG-Fc2b
<400> 130
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggccggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagccttct cttcctccac aaacctgcaa 540
gacagactca ggaggaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaacaaa gaccaaacca ccatgtccca tatgcccagc ctgtgaatcg 660
ccagggccct cggtcttcat cttccctcca aaacccaagg acaccctcat gatctcccgg 720
acaccccagg tcacgtgcgg tagttgatgt gagccaggag aacccggagg tccagttctc 780
ctggtacgtg gacggcgtag aggtgcacac ggcccagacg aggccaaagg aggagcagtt 840
caacagcacc taccgcgtgg tcagctctgc ccatccagca ccaggactgg ctgaacggga 900
aggagttcaa gtgcaaggtc aacaacaaag acctcccagc ccccatcaca aggatcatct 960
ccaaggccaa agggcagacc cgggagccgc agttacaccc tgcccccaca cgccgaggag 1020
ctgtccagga gcaaagtcag cataacctgc ctggtcattg gcttctaccc acctgacatc 1080
gatgtcgagt ggcaaagaaa cggacagccg gagccagggg aattaccgca ccaccccgcc 1140
ccagcaggac gtggacggga cctacttcct gtacagcaag ttctcggtgg acaaggccag 1200
ctggcagggt ggaggcatat tccagtgtgc ggtgatgcac gagctctcac aaccactaca 1260
cccagaagtc tatctccaag actccgggta aa 1292
<210> 131
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa8+IgG-Fc2b
<400> 131
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 132
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa8+IgG-Fc4a
<400> 132
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggccggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagccttct cttcctccac aaacctgcaa 540
gacagactca ggaggaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaacaaa gaccaaacca ccatgtccca tatgcccagc ctgtgaaggg 660
cccgggccct cggccttcat cttccctcca aaacccaagg acaccctcat gatctcccgg 720
acccccaagg tcacgtgcgg tggtagatgt gagccaggag aacccggagg tccagttctc 780
ctggtacgtg gacggcgtag aggtgcacac ggcccagacg aggccaaagg aggagcagtt 840
caacagcacc taccgcgtgg tcagctctgc ccatccagca ccaggactgg ctgaacggga 900
aggagttcaa gtgcaaggtc aacaacaaag acctcccagc ccccatcaca aggatcatct 960
ccaaggccaa agggcagacc cgggagccgc agttacaccc tgcccccacc caccgaggag 1020
ctgtccagga gcaaagtcac gctaacctgc ctggtcactg gcttctaccc acctgacatc 1080
gatgtcgagt ggcaaagaaa cggacagccg gagccagggg aattaccgca ccaccccgcc 1140
ccagcaggac gtggacggga cctacttcct gtacagcaag ctcgcggtgg acaaggccag 1200
ctggcagcgt ggagacacat tccagtgtgc ggtgatgcac gagctctcac aaccactaca 1260
cccagaagtc catcttcaag actccgggta aa 1292
<210> 133
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa8+IgG-Fc4a
<400> 133
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 134
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa9+IgG-Fc 1a
<400> 134
atggccccaa cctcagcctt cctcatggcc ctggtgctgc tcagctgcaa ggccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttgggtt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcggtg gtggacgtca gcaaggagca cgccgaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg ccgagacgag accaaaggag gagcagttca 840
acagcaccta ccgtgtggtc agctctgccc atccagcacc aggactggct gaaggggaag 900
gagttcaagt gcaaggtcaa caacgtagac ctcccagccc ccatcacgag gaccatctcc 960
aaggctatag ggcagagccg ggagccgcag ttacaccctg cccccacccg ccgaggagct 1020
gtccaggagc aaagtcaccg taacctgcct ggtcattggc ttctacccac ctgacatcca 1080
tgttgagtgg aagagcaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc ttcttcctgt acagcaagct cgcggtggac aaggcaagat 1200
gggaccatgg agaaacattt gagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tctccaagac tcagggtaaa 1290
<210> 135
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa9+IgG-Fc1a
<400> 135
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Lys Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 136
<211> 1295
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa9+IgG-Fc1b
<400> 136
atggccccaa cctcagcctt cctcatggcc ctggtgctgc tcagctgcaa ggccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttgggtt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaatacacc agccgcaaac atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcgggt ggtggacgtc agcaaggagc acgccgaggt ccagttctcc 780
tggtacgtgg acggcgtaga ggtgcacacg gccgagacga gaccaaagga ggagcagttc 840
aacagcacct accgtgtggt cagctcctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agtgtacacc ctgcccccac ccgccgagga 1020
gctgtccagg agcaaagtca cgctaacctg cctggtcatt ggcttctacc cacctgacat 1080
ccatgttgag tggaagagca acggacagcc ggagccagga acacataccg caccaccccg 1140
ccccagcagg acgtggacgg gaccttcttc ctgtacagca aactcgcggt ggacaaggca 1200
agatgggacc atggagacaa atttgagtgt gcggtgatgc acgagctctg cacaaccact 1260
acacccagaa gtccatctcc aagactcagg gtaaa 1295
<210> 137
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa9+IgG-Fc1b
<400> 137
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Lys Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 138
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa9+IgG-Fc2a
<400> 138
atggccccaa cctcagcctt cctcatggcc ctggtgctgc tcagctgcaa ggccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttgggtt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcacc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggtg gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctaccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 139
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa9+IgG-Fc2a
<400> 139
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Lys Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 140
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa9+IgG-Fc2b
<400> 140
atggccccaa cctcagcctt cctcatggcc ctggtgctgc tcagctgcaa ggccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttgggtt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcgcc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggta gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 141
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa9+IgG-Fc2b
<400> 141
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Lys Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 142
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa9+IgG-Fc4a
<400> 142
atggccccaa cctcagcctt cctcatggcc ctggtgctgc tcagctgcaa ggccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttgggtt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaagggcc 660
cgggccctcg gccttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
ccccaaggtc acgtgcggtg gtagatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccaccca ccgaggagct 1020
gtccaggagc aaagtcacgc taacctgcct ggtcactggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagct cgcggtggac aaggccagct 1200
ggcagcgtgg agacacattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tcttcaagac tccgggtaaa 1290
<210> 143
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa9+IgG-Fc4a
<400> 143
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Lys Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 144
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa10+IgG-Fc1a
<400> 144
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaagg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcggtggtgg 720
acgtcagcaa ggagcacgcc gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccga gacgagacca aaggaggagc agttcaacag cacctaccgt gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaag gggaaggagt tcaagtgcaa ggtcaacaac 900
gtagacctcc cagcccccat cacgaggacc atctccaagg ctatagggca gagccgggag 960
ccgcagttac accctgcccc cacccgccga ggagctgtcc aggagcaaag tcaccgtaac 1020
ctgcctggtc attggcttct acccacctga catccatgtt gagtggaaga gcaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggaccttct 1140
tcctgtacag caagctcgcg gtggacaagg caagatggga ccatggagaa acatttgagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctc caagactcag 1260
ggtaaa 1266
<210> 145
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa10+IgG-Fc1a
<400> 145
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Lys Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Val Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Glu Thr Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 146
<211> 1271
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa10+IgG-Fc1b
<400> 146
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaagg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa tacaccagcc 600
gcaaacatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcgggtggtg 720
gacgtcagca aggagcacgc cgaggtccag ttctcctggt acgtggacgg cgtagaggtg 780
cacacggccg agacgagacc aaaggaggag cagttcaaca gcacctaccg tgtggtcagc 840
tcctgcccat ccagcaccag gactggctga aggggaagga gttcaagtgc aaggtcaaca 900
acgtagacct cccagccccc atcacgagga ccatctccaa ggctataggg cagagccggg 960
agccgcagtg tacaccctgc ccccacccgc cgaggagctg tccaggagca aagtcacgct 1020
aacctgcctg gtcattggct tctacccacc tgacatccat gttgagtgga agagcaacgg 1080
acagccggag ccaggaacac ataccgcacc accccgcccc agcaggacgt ggacgggacc 1140
ttcttcctgt acagcaaact cgcggtggac aaggcaagat gggaccatgg agacaaattt 1200
gagtgtgcgg tgatgcacga gctctgcaca accactacac ccagaagtcc atctccaaga 1260
ctcagggtaa a 1271
<210> 147
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa10+IgG-Fc1b
<400> 147
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Lys Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Ile His Gln Pro Gln Thr Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Asn Thr Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Asp Lys Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 148
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa10+IgG-Fc2a
<400> 148
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaagg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcaccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtggttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctacccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 149
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa10+IgG-Fc2a
<400> 149
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Lys Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 150
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa10+IgG-Fc2b
<400> 150
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaagg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcgccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtagttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 151
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa10+IgG-Fc2b
<400> 151
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Lys Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 152
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa10+IgG-Fc4a
<400> 152
atggccccaa cctcagcctt cctcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaagg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag atccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga agggcccggg ccctcggcct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggaccccc aaggtcacgt gcggtggtag 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacccaccga ggagctgtcc aggagcaaag tcacgctaac 1020
ctgcctggtc actggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagctcgcg gtggacaagg ccagctggca gcgtggagac acattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctt caagactccg 1260
ggtaaa 1266
<210> 153
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa10+IgG-Fc4a
<400> 153
Met Ala Pro Thr Ser Ala Phe Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Lys Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ser Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Gly Pro Gly Pro Ser Ala Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Lys Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Thr Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Thr Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Ser Trp Gln Arg Gly Asp Thr Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Phe Lys Thr Pro Gly Lys
420
<210> 154
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa11+IgG-Fc1a
<400> 154
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcatcctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcggtggtgg 720
acgtcagcaa ggagcacgcc gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccga gacgagacca aaggaggagc agttcaacag cacctaccgt gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaag gggaaggagt tcaagtgcaa ggtcaacaac 900
gtagacctcc cagcccccat cacgaggacc atctccaagg ctatagggca gagccgggag 960
ccgcagttac accctgcccc cacccgccga ggagctgtcc aggagcaaag tcaccgtaac 1020
ctgcctggtc attggcttct acccacctga catccatgtt gagtggaaga gcaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggaccttct 1140
tcctgtacag caagctcgcg gtggacaagg caagatggga ccatggagaa acatttgagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctc caagactcag 1260
ggtaaa 1266
<210> 155
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa11+IgG-Fc1a
<400> 155
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Ile Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Val Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Glu Thr Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 156
<211> 1271
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa11+IgG-Fc1b
<400> 156
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcatcctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa tacaccagcc 600
gcaaacatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcgggtggtg 720
gacgtcagca aggagcacgc cgaggtccag ttctcctggt acgtggacgg cgtagaggtg 780
cacacggccg agacgagacc aaaggaggag cagttcaaca gcacctaccg tgtggtcagc 840
tcctgcccat ccagcaccag gactggctga aggggaagga gttcaagtgc aaggtcaaca 900
acgtagacct cccagccccc atcacgagga ccatctccaa ggctataggg cagagccggg 960
agccgcagtg tacaccctgc ccccacccgc cgaggagctg tccaggagca aagtcacgct 1020
aacctgcctg gtcattggct tctacccacc tgacatccat gttgagtgga agagcaacgg 1080
acagccggag ccaggaacac ataccgcacc accccgcccc agcaggacgt ggacgggacc 1140
ttcttcctgt acagcaaact cgcggtggac aaggcaagat gggaccatgg agacaaattt 1200
gagtgtgcgg tgatgcacga gctctgcaca accactacac ccagaagtcc atctccaaga 1260
ctcagggtaa a 1271
<210> 157
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa11+IgG-Fc1b
<400> 157
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Ile Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Ile His Gln Pro Gln Thr Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Asn Thr Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Asp Lys Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 158
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa11+IgG-Fc2a
<400> 158
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcatcctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcaccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtggttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctacccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 159
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa11+IgG-Fc2a
<400> 159
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Ile Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 160
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa11+IgG-Fc2b
<400> 160
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcatcctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcgccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtagttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 161
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa11+IgG-Fc2b
<400> 161
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Ile Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 162
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa11+IgG-Fc4a
<400> 162
atggccccaa cctcagcctt cttcacagcc ctggtgctgc tcagctacaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctggaatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcatcctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatac atccttctct tcctccacac acctgtaagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga agggcccggg ccctcggcct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggaccccc aaggtcacgt gcggtggtag 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacccaccga ggagctgtcc aggagcaaag tcacgctaac 1020
ctgcctggtc actggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagctcgcg gtggacaagg ccagctggca gcgtggagac acattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctt caagactccg 1260
ggtaaa 1266
<210> 163
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa11+IgG-Fc4a
<400> 163
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Tyr
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asn Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Ile Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Thr Ser Phe Ser Ser Ser
165 170 175
Thr His Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Gly Pro Gly Pro Ser Ala Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Lys Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Thr Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Thr Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Ser Trp Gln Arg Gly Asp Thr Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Phe Lys Thr Pro Gly Lys
420
<210> 164
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa112+IgG-Fc1a
<400> 164
atggccccaa cctcagcctt cctcacggtc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggg ctggaaggga cgcccctgct ggaggaggac tccatcctgg 420
ctgtgaggaa atacttccac agactcaccc tctatctgca agagaagata cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagtcttct cttcctccac aaacctgcaa 540
gacagactca ggaagaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaacaaa gaccaaacca ccatgtccca tatgcccagg ctgtgaagtg 660
gccgggccct cggtcttcat cttccctcca aaacccaagg acaccctcat gatctcccag 720
acccccgagg tcacgtgcgg tggtggacgt cagcaaggag cacgccgagg tccagttctc 780
ctggtacgtg gacggcgtag aggtgcacac ggccgagacg agaccaaagg aggagcagtt 840
caacagcacc taccgtgtgg tcagctctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agttacaccc tgcccccacc cgccgaggag 1020
ctgtccagga gcaaagtcac cgtaacctgc ctggtcattg gcttctaccc acctgacatc 1080
catgttgagt ggaagagcaa cggacagccg gagccagggg aattaccgca ccaccccgcc 1140
ccagcaggac gtggacggga ccttcttcct gtacagcaag ctcgcggtgg acaaggcaag 1200
atgggaccat ggagaaacat ttgagtgtgc ggtgatgcac gagctctcac aaccactaca 1260
cccagaagtc catctccaag actcagggta aa 1292
<210> 165
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa12+IgG-Fc1a
<400> 165
Met Ala Pro Thr Ser Ala Phe Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 166
<211> 1297
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa12+IgG-Fc1b
<400> 166
atggccccaa cctcagcctt cctcacggtc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggg ctggaaggga cgcccctgct ggaggaggac tccatcctgg 420
ctgtgaggaa atacttccac agactcaccc tctatctgca agagaagata cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagtcttct cttcctccac aaacctgcaa 540
gacagactca ggaagaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaataca ccagccgcaa acatgtccca tatgcccagg ctgtgaagtg 660
gccgggccct cggtcttcat cttccctcca aaacccaagg acaccctcat gatctcccag 720
acccccgagg tcacgtgcgg gtggtggacg tcagcaagga gcacgccgag gtccagttct 780
cctggtacgt ggacggcgta gaggtgcaca cggccgagac gagaccaaag gaggagcagt 840
tcaacagcac ctaccgtgtg gtcagctcct gcccatccag caccaggact ggctgaaggg 900
gaaggagttc aagtgcaagg tcaacaacgt agacctccca gcccccatca cgaggaccat 960
ctccaaggct atagggcaga gccgggagcc gcagtgtaca ccctgccccc acccgccgag 1020
gagctgtcca ggagcaaagt cacgctaacc tgcctggtca ttggcttcta cccacctgac 1080
atccatgttg agtggaagag caacggacag ccggagccag gaacacatac cgcaccaccc 1140
cgccccagca ggacgtggac gggaccttct tcctgtacag caaactcgcg gtggacaagg 1200
caagatggga ccatggagac aaatttgagt gtgcggtgat gcacgagctc tgcacaacca 1260
ctacacccag aagtccatct ccaagactca gggtaaa 1297
<210> 167
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa12+IgG-Fc1b
<400> 167
Met Ala Pro Thr Ser Ala Phe Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 168
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa12+IgG-Fc2a
<400> 168
atggccccaa cctcagcctt cctcacggtc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggg ctggaaggga cgcccctgct ggaggaggac tccatcctgg 420
ctgtgaggaa atacttccac agactcaccc tctatctgca agagaagata cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagtcttct cttcctccac aaacctgcaa 540
gacagactca ggaagaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaacaaa gaccaaacca ccatgtccca tatgcccagc ctgtgaatca 660
ccagggccct cggtcttcat cttccctcca aaacccaagg acaccctcat gatctcccgg 720
acaccccagg tcacgtgcgg tggttgatgt gagccaggag aacccggagg tccagttctc 780
ctggtacgtg gacggcgtag aggtgcacac ggcccagacg aggccaaagg aggagcagtt 840
caacagcacc taccgcgtgg tcagctctac ccatccagca ccaggactgg ctgaacggga 900
aggagttcaa gtgcaaggtc aacaacaaag acctcccagc ccccatcaca aggatcatct 960
ccaaggccaa agggcagacc cgggagccgc agttacaccc tgcccccaca cgccgaggag 1020
ctgtccagga gcaaagtcag cataacctgc ctggtcattg gcttctaccc acctgacatc 1080
gatgtcgagt ggcaaagaaa cggacagccg gagccagggg aattaccgca ccaccccgcc 1140
ccagcaggac gtggacggga cctacttcct gtacagcaag ttctcggtgg acaaggccag 1200
ctggcagggt ggaggcatat tccagtgtgc ggtgatgcac gagctctcac aaccactaca 1260
cccagaagtc tatctccaag actccgggta aa 1292
<210> 169
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa12+IgG-Fc2a
<400> 169
Met Ala Pro Thr Ser Ala Phe Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 170
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa12+IgG-Fc2b
<400> 170
atggccccaa cctcagcctt cctcacggtc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggg ctggaaggga cgcccctgct ggaggaggac tccatcctgg 420
ctgtgaggaa atacttccac agactcaccc tctatctgca agagaagata cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagtcttct cttcctccac aaacctgcaa 540
gacagactca ggaagaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaacaaa gaccaaacca ccatgtccca tatgcccagc ctgtgaatcg 660
ccagggccct cggtcttcat cttccctcca aaacccaagg acaccctcat gatctcccgg 720
acaccccagg tcacgtgcgg tagttgatgt gagccaggag aacccggagg tccagttctc 780
ctggtacgtg gacggcgtag aggtgcacac ggcccagacg aggccaaagg aggagcagtt 840
caacagcacc taccgcgtgg tcagctctgc ccatccagca ccaggactgg ctgaacggga 900
aggagttcaa gtgcaaggtc aacaacaaag acctcccagc ccccatcaca aggatcatct 960
ccaaggccaa agggcagacc cgggagccgc agttacaccc tgcccccaca cgccgaggag 1020
ctgtccagga gcaaagtcag cataacctgc ctggtcattg gcttctaccc acctgacatc 1080
gatgtcgagt ggcaaagaaa cggacagccg gagccagggg aattaccgca ccaccccgcc 1140
ccagcaggac gtggacggga cctacttcct gtacagcaag ttctcggtgg acaaggccag 1200
ctggcagggt ggaggcatat tccagtgtgc ggtgatgcac gagctctcac aaccactaca 1260
cccagaagtc tatctccaag actccgggta aa 1292
<210> 171
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa12+IgG-Fc2b
<400> 171
Met Ala Pro Thr Ser Ala Phe Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 172
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa12+IgG-Fc4a
<400> 172
atggccccaa cctcagcctt cctcacggtc ctggtgctac tcagctgcaa tgccatctgc 60
tgtctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggg ctggaaggga cgcccctgct ggaggaggac tccatcctgg 420
ctgtgaggaa atacttccac agactcaccc tctatctgca agagaagata cagcccctgt 480
gcctgggaga tcgtcagggc agaagtcatg agagtcttct cttcctccac aaacctgcaa 540
gacagactca ggaagaagga gtgaggtggc tcaggtggat ccggtggagg cggaagcggc 600
ggtggaggat caggaacaaa gaccaaacca ccatgtccca tatgcccagc ctgtgaaggg 660
cccgggccct cggccttcat cttccctcca aaacccaagg acaccctcat gatctcccgg 720
acccccaagg tcacgtgcgg tggtagatgt gagccaggag aacccggagg tccagttctc 780
ctggtacgtg gacggcgtag aggtgcacac ggcccagacg aggccaaagg aggagcagtt 840
caacagcacc taccgcgtgg tcagctctgc ccatccagca ccaggactgg ctgaacggga 900
aggagttcaa gtgcaaggtc aacaacaaag acctcccagc ccccatcaca aggatcatct 960
ccaaggccaa agggcagacc cgggagccgc agttacaccc tgcccccacc caccgaggag 1020
ctgtccagga gcaaagtcac gctaacctgc ctggtcactg gcttctaccc acctgacatc 1080
gatgtcgagt ggcaaagaaa cggacagccg gagccagggg aattaccgca ccaccccgcc 1140
ccagcaggac gtggacggga cctacttcct gtacagcaag ctcgcggtgg acaaggccag 1200
ctggcagcgt ggagacacat tccagtgtgc ggtgatgcac gagctctcac aaccactaca 1260
cccagaagtc catcttcaag actccgggta aa 1292
<210> 173
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa12+IgG-Fc4a
<400> 173
Met Ala Pro Thr Ser Ala Phe Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 174
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa13+IgG-Fc1a
<400> 174
atggccccat cctcagccct cctcacagcc ctggtgctgc tcagttgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcctttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaaggcacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcggtg gtggacgtca gcaaggagca cgccgaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg ccgagacgag accaaaggag gagcagttca 840
acagcaccta ccgtgtggtc agctctgccc atccagcacc aggactggct gaaggggaag 900
gagttcaagt gcaaggtcaa caacgtagac ctcccagccc ccatcacgag gaccatctcc 960
aaggctatag ggcagagccg ggagccgcag ttacaccctg cccccacccg ccgaggagct 1020
gtccaggagc aaagtcaccg taacctgcct ggtcattggc ttctacccac ctgacatcca 1080
tgttgagtgg aagagcaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc ttcttcctgt acagcaagct cgcggtggac aaggcaagat 1200
gggaccatgg agaaacattt gagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tctccaagac tcagggtaaa 1290
<210> 175
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa13+IgG-Fc1a
<400> 175
Met Ala Pro Ser Ser Ala Leu Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 176
<211> 1295
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa13+IgG-Fc1b
<400> 176
atggccccat cctcagccct cctcacagcc ctggtgctgc tcagttgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcctttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaaggcacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaatacacc agccgcaaac atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcgggt ggtggacgtc agcaaggagc acgccgaggt ccagttctcc 780
tggtacgtgg acggcgtaga ggtgcacacg gccgagacga gaccaaagga ggagcagttc 840
aacagcacct accgtgtggt cagctcctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agtgtacacc ctgcccccac ccgccgagga 1020
gctgtccagg agcaaagtca cgctaacctg cctggtcatt ggcttctacc cacctgacat 1080
ccatgttgag tggaagagca acggacagcc ggagccagga acacataccg caccaccccg 1140
ccccagcagg acgtggacgg gaccttcttc ctgtacagca aactcgcggt ggacaaggca 1200
agatgggacc atggagacaa atttgagtgt gcggtgatgc acgagctctg cacaaccact 1260
acacccagaa gtccatctcc aagactcagg gtaaa 1295
<210> 177
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa13+IgG-Fc1b
<400> 177
Met Ala Pro Ser Ser Ala Leu Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 178
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa13+IgG-Fc2a
<400> 178
atggccccat cctcagccct cctcacagcc ctggtgctgc tcagttgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcctttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaaggcacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcacc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggtg gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctaccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 179
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa13+IgG-Fc2a
<400> 179
Met Ala Pro Ser Ser Ala Leu Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 180
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa13+IgG-Fc2b
<400> 180
atggccccat cctcagccct cctcacagcc ctggtgctgc tcagttgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcctttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaaggcacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcgcc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggta gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 181
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa13+IgG-Fc2b
<400> 181
Met Ala Pro Ser Ser Ala Leu Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 182
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa13+IgG-Fc4a
<400> 182
atggccccat cctcagccct cctcacagcc ctggtgctgc tcagttgcaa tgccatctgc 60
tctctgggct gcaacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcctttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggcgggc tgaaggcacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaagggcc 660
cgggccctcg gccttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
ccccaaggtc acgtgcggtg gtagatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccaccca ccgaggagct 1020
gtccaggagc aaagtcacgc taacctgcct ggtcactggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagct cgcggtggac aaggccagct 1200
ggcagcgtgg agacacattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tcttcaagac tccgggtaaa 1290
<210> 183
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa13+IgG-Fc4a
<400> 183
Met Ala Pro Ser Ser Ala Leu Leu Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 184
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa14+IgG-Fc1a
<400> 184
atggccccat cctcaactct cctcacggtc ctggtgctgc tcagctgcaa tgccatctgc 60
tgtctgggct gcaacctgcc tcagacccac agcctggctc ataccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcataca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcagg agaagaacta cagcctctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcggtg gtggacgtca gcaaggagca cgccgaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg ccgagacgag accaaaggag gagcagttca 840
acagcaccta ccgtgtggtc agctctgccc atccagcacc aggactggct gaaggggaag 900
gagttcaagt gcaaggtcaa caacgtagac ctcccagccc ccatcacgag gaccatctcc 960
aaggctatag ggcagagccg ggagccgcag ttacaccctg cccccacccg ccgaggagct 1020
gtccaggagc aaagtcaccg taacctgcct ggtcattggc ttctacccac ctgacatcca 1080
tgttgagtgg aagagcaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc ttcttcctgt acagcaagct cgcggtggac aaggcaagat 1200
gggaccatgg agaaacattt gagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tctccaagac tcagggtaaa 1290
<210> 185
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa14+IgG-Fc1a
<400> 185
Met Ala Pro Ser Ser Thr Leu Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Ile Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Asn Tyr Ser Leu Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 186
<211> 1295
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa14+IgG-Fc1b
<400> 186
atggccccat cctcaactct cctcacggtc ctggtgctgc tcagctgcaa tgccatctgc 60
tgtctgggct gcaacctgcc tcagacccac agcctggctc ataccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcataca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcagg agaagaacta cagcctctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaatacacc agccgcaaac atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcgggt ggtggacgtc agcaaggagc acgccgaggt ccagttctcc 780
tggtacgtgg acggcgtaga ggtgcacacg gccgagacga gaccaaagga ggagcagttc 840
aacagcacct accgtgtggt cagctcctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agtgtacacc ctgcccccac ccgccgagga 1020
gctgtccagg agcaaagtca cgctaacctg cctggtcatt ggcttctacc cacctgacat 1080
ccatgttgag tggaagagca acggacagcc ggagccagga acacataccg caccaccccg 1140
ccccagcagg acgtggacgg gaccttcttc ctgtacagca aactcgcggt ggacaaggca 1200
agatgggacc atggagacaa atttgagtgt gcggtgatgc acgagctctg cacaaccact 1260
acacccagaa gtccatctcc aagactcagg gtaaa 1295
<210> 187
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa14+IgG-Fc1b
<400> 187
Met Ala Pro Ser Ser Thr Leu Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Ile Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Asn Tyr Ser Leu Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 188
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa14+IgG-Fc2a
<400> 188
atggccccat cctcaactct cctcacggtc ctggtgctgc tcagctgcaa tgccatctgc 60
tgtctgggct gcaacctgcc tcagacccac agcctggctc ataccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcataca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcagg agaagaacta cagcctctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcacc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggtg gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctaccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 189
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa14+IgG-Fc2a
<400> 189
Met Ala Pro Ser Ser Thr Leu Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Ile Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Asn Tyr Ser Leu Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 190
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa14+IgG-Fc2b
<400> 190
atggccccat cctcaactct cctcacggtc ctggtgctgc tcagctgcaa tgccatctgc 60
tgtctgggct gcaacctgcc tcagacccac agcctggctc ataccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcataca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcagg agaagaacta cagcctctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcgcc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggta gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 191
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa14+IgG-Fc2b
<400> 191
Met Ala Pro Ser Ser Thr Leu Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Ile Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Asn Tyr Ser Leu Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 192
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa14+IgG-Fc4a
<400> 192
atggccccat cctcaactct cctcacggtc ctggtgctgc tcagctgcaa tgccatctgc 60
tgtctgggct gcaacctgcc tcagacccac agcctggctc ataccagggc cctgaggctc 120
ctggcacatg aggagaatct ctcccttctc ctgcctggac cacagaaggg actttggatc 180
ccctcatgag gcttttgggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcataca ggaggcgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcagg agaagaacta cagcctctgt 480
gcctgggaga tcatcagggc agaagcatag agtcttctct tcctccacaa acctgcaaga 540
cagactcagg aagaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaagggcc 660
cgggccctcg gccttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
ccccaaggtc acgtgcggtg gtagatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccaccca ccgaggagct 1020
gtccaggagc aaagtcacgc taacctgcct ggtcactggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagct cgcggtggac aaggccagct 1200
ggcagcgtgg agacacattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tcttcaagac tccgggtaaa 1290
<210> 193
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa14+IgG-Fc4a
<400> 193
Met Ala Pro Ser Ser Thr Leu Leu Thr Val Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Cys Leu Gly Cys Asn Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Ser Pro His Glu
50 55 60
Ala Phe Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Ile Gln Glu Ala Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Asn Tyr Ser Leu Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Val Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Lys Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 194
<211> 1287
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa15+IgG-Fc1a
<400> 194
atggccccaa cctcagcctt cctcatggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg agaatctccc ctttctcctg cctggaccac agaagggact ttggattccc 180
ccaagaggcc ttggggggca accaggtcca gaaggctcaa gccatggctc tggtgcatga 240
gatgctccag cagcttccag ctcttcagca cagagggctc ggctgctgcc tgggatgaga 300
gcctcctgca ccagttctgc actggactgg atcagcagct cagggacctg gaagcctgtg 360
tcatgcagga ggcggggctg agggaccccc ctgctggagg aggactccat cctggctgtg 420
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 480
tgggagatcg tcagggcaga agtcagaggc cttctcttcc tccacaaacc tgcaagacag 540
actcaggagg aaggagtgag gtggctcagg tggatccggt ggaggcggaa gcggcggtgg 600
aggatcagga acaaagacca aaccaccatg tcccatatgc ccaggctgtg aagtggccgg 660
gccctcggtc ttcatcttcc ctccaaaacc caaggacacc ctcatgatct cccagacccc 720
cgaggtcacg tgcggtggtg gacgtcagca aggagcacgc cgaggtccag ttctcctggt 780
acgtggacgg cgtagaggtg cacacggccg agacgagacc aaaggaggag cagttcaaca 840
gcacctaccg tgtggtcagc tctgcccatc cagcaccagg actggctgaa ggggaaggag 900
ttcaagtgca aggtcaacaa cgtagacctc ccagccccca tcacgaggac catctccaag 960
gctatagggc agagccggga gccgcagtta caccctgccc ccacccgccg aggagctgtc 1020
caggagcaaa gtcaccgtaa cctgcctggt cattggcttc tacccacctg acatccatgt 1080
tgagtggaag agcaacggac agccggagcc aggggaatta ccgcaccacc ccgccccagc 1140
aggacgtgga cgggaccttc ttcctgtaca gcaagctcgc ggtggacaag gcaagatggg 1200
accatggaga aacatttgag tgtgcggtga tgcacgagct ctcacaacca ctacacccag 1260
aagtccatct ccaagactca gggtaaa 1287
<210> 195
<211> 430
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa15+IgG-Fc1a
<400> 195
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Ile Ser Pro
35 40 45
Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu Ala
50 55 60
Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val His
65 70 75 80
Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser Ala
85 90 95
Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu Asp
100 105 110
Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Gly Gly
115 120 125
Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe
130 135 140
His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys Ala
145 150 155 160
Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser Thr
165 170 175
Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly Ser
180 185 190
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys Pro
195 200 205
Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val Phe
210 215 220
Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr Pro
225 230 235 240
Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu Val
245 250 255
Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu Thr
260 265 270
Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser Val
275 280 285
Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys Cys
290 295 300
Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile Ser
305 310 315 320
Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro Ala
325 330 335
Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile Gly
340 345 350
Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln Pro
355 360 365
Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val Asp
370 375 380
Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg Trp
385 390 395 400
Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu His
405 410 415
Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 196
<211> 1292
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa15+IgG-Fc1b
<400> 196
atggccccaa cctcagcctt cctcatggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg agaatctccc ctttctcctg cctggaccac agaagggact ttggattccc 180
ccaagaggcc ttggggggca accaggtcca gaaggctcaa gccatggctc tggtgcatga 240
gatgctccag cagcttccag ctcttcagca cagagggctc ggctgctgcc tgggatgaga 300
gcctcctgca ccagttctgc actggactgg atcagcagct cagggacctg gaagcctgtg 360
tcatgcagga ggcggggctg agggaccccc ctgctggagg aggactccat cctggctgtg 420
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 480
tgggagatcg tcagggcaga agtcagaggc cttctcttcc tccacaaacc tgcaagacag 540
actcaggagg aaggagtgag gtggctcagg tggatccggt ggaggcggaa gcggcggtgg 600
aggatcagga atacaccagc cgcaaacatg tcccatatgc ccaggctgtg aagtggccgg 660
gccctcggtc ttcatcttcc ctccaaaacc caaggacacc ctcatgatct cccagacccc 720
cgaggtcacg tgcgggtggt ggacgtcagc aaggagcacg ccgaggtcca gttctcctgg 780
tacgtggacg gcgtagaggt gcacacggcc gagacgagac caaaggagga gcagttcaac 840
agcacctacc gtgtggtcag ctcctgccca tccagcacca ggactggctg aaggggaagg 900
agttcaagtg caaggtcaac aacgtagacc tcccagcccc catcacgagg accatctcca 960
aggctatagg gcagagccgg gagccgcagt gtacaccctg cccccacccg ccgaggagct 1020
gtccaggagc aaagtcacgc taacctgcct ggtcattggc ttctacccac ctgacatcca 1080
tgttgagtgg aagagcaacg gacagccgga gccaggaaca cataccgcac caccccgccc 1140
cagcaggacg tggacgggac cttcttcctg tacagcaaac tcgcggtgga caaggcaaga 1200
tgggaccatg gagacaaatt tgagtgtgcg gtgatgcacg agctctgcac aaccactaca 1260
cccagaagtc catctccaag actcagggta aa 1292
<210> 197
<211> 430
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa15+IgG-Fc1b
<400> 197
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Ile Ser Pro
35 40 45
Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu Ala
50 55 60
Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val His
65 70 75 80
Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser Ala
85 90 95
Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu Asp
100 105 110
Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Gly Gly
115 120 125
Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe
130 135 140
His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys Ala
145 150 155 160
Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser Thr
165 170 175
Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly Ser
180 185 190
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro Gln
195 200 205
Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val Phe
210 215 220
Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr Pro
225 230 235 240
Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu Val
245 250 255
Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu Thr
260 265 270
Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser Val
275 280 285
Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys Cys
290 295 300
Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile Ser
305 310 315 320
Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro Ala
325 330 335
Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile Gly
340 345 350
Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln Pro
355 360 365
Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val Asp
370 375 380
Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg Trp
385 390 395 400
Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu His
405 410 415
Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 198
<211> 1287
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa15+IgG-Fc2a
<400> 198
atggccccaa cctcagcctt cctcatggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg agaatctccc ctttctcctg cctggaccac agaagggact ttggattccc 180
ccaagaggcc ttggggggca accaggtcca gaaggctcaa gccatggctc tggtgcatga 240
gatgctccag cagcttccag ctcttcagca cagagggctc ggctgctgcc tgggatgaga 300
gcctcctgca ccagttctgc actggactgg atcagcagct cagggacctg gaagcctgtg 360
tcatgcagga ggcggggctg agggaccccc ctgctggagg aggactccat cctggctgtg 420
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 480
tgggagatcg tcagggcaga agtcagaggc cttctcttcc tccacaaacc tgcaagacag 540
actcaggagg aaggagtgag gtggctcagg tggatccggt ggaggcggaa gcggcggtgg 600
aggatcagga acaaagacca aaccaccatg tcccatatgc ccagcctgtg aatcaccagg 660
gccctcggtc ttcatcttcc ctccaaaacc caaggacacc ctcatgatct cccggacacc 720
ccaggtcacg tgcggtggtt gatgtgagcc aggagaaccc ggaggtccag ttctcctggt 780
acgtggacgg cgtagaggtg cacacggccc agacgaggcc aaaggaggag cagttcaaca 840
gcacctaccg cgtggtcagc tctacccatc cagcaccagg actggctgaa cgggaaggag 900
ttcaagtgca aggtcaacaa caaagacctc ccagccccca tcacaaggat catctccaag 960
gccaaagggc agacccggga gccgcagtta caccctgccc ccacacgccg aggagctgtc 1020
caggagcaaa gtcagcataa cctgcctggt cattggcttc tacccacctg acatcgatgt 1080
cgagtggcaa agaaacggac agccggagcc aggggaatta ccgcaccacc ccgccccagc 1140
aggacgtgga cgggacctac ttcctgtaca gcaagttctc ggtggacaag gccagctggc 1200
agggtggagg catattccag tgtgcggtga tgcacgagct ctcacaacca ctacacccag 1260
aagtctatct ccaagactcc gggtaaa 1287
<210> 199
<211> 430
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa15+IgG-Fc2a
<400> 199
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Ile Ser Pro
35 40 45
Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu Ala
50 55 60
Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val His
65 70 75 80
Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser Ala
85 90 95
Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu Asp
100 105 110
Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Gly Gly
115 120 125
Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe
130 135 140
His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys Ala
145 150 155 160
Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser Thr
165 170 175
Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly Ser
180 185 190
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys Pro
195 200 205
Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val Phe
210 215 220
Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro
225 230 235 240
Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu Val
245 250 255
Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln Thr
260 265 270
Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser Val
275 280 285
Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys Cys
290 295 300
Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile Ser
305 310 315 320
Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His Ala
325 330 335
Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile Gly
340 345 350
Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln Pro
355 360 365
Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val Asp
370 375 380
Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser Trp
385 390 395 400
Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu His
405 410 415
Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 200
<211> 1287
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa15+IgG-Fc2b
<400> 200
atggccccaa cctcagcctt cctcatggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg agaatctccc ctttctcctg cctggaccac agaagggact ttggattccc 180
ccaagaggcc ttggggggca accaggtcca gaaggctcaa gccatggctc tggtgcatga 240
gatgctccag cagcttccag ctcttcagca cagagggctc ggctgctgcc tgggatgaga 300
gcctcctgca ccagttctgc actggactgg atcagcagct cagggacctg gaagcctgtg 360
tcatgcagga ggcggggctg agggaccccc ctgctggagg aggactccat cctggctgtg 420
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 480
tgggagatcg tcagggcaga agtcagaggc cttctcttcc tccacaaacc tgcaagacag 540
actcaggagg aaggagtgag gtggctcagg tggatccggt ggaggcggaa gcggcggtgg 600
aggatcagga acaaagacca aaccaccatg tcccatatgc ccagcctgtg aatcgccagg 660
gccctcggtc ttcatcttcc ctccaaaacc caaggacacc ctcatgatct cccggacacc 720
ccaggtcacg tgcggtagtt gatgtgagcc aggagaaccc ggaggtccag ttctcctggt 780
acgtggacgg cgtagaggtg cacacggccc agacgaggcc aaaggaggag cagttcaaca 840
gcacctaccg cgtggtcagc tctgcccatc cagcaccagg actggctgaa cgggaaggag 900
ttcaagtgca aggtcaacaa caaagacctc ccagccccca tcacaaggat catctccaag 960
gccaaagggc agacccggga gccgcagtta caccctgccc ccacacgccg aggagctgtc 1020
caggagcaaa gtcagcataa cctgcctggt cattggcttc tacccacctg acatcgatgt 1080
cgagtggcaa agaaacggac agccggagcc aggggaatta ccgcaccacc ccgccccagc 1140
aggacgtgga cgggacctac ttcctgtaca gcaagttctc ggtggacaag gccagctggc 1200
agggtggagg catattccag tgtgcggtga tgcacgagct ctcacaacca ctacacccag 1260
aagtctatct ccaagactcc gggtaaa 1287
<210> 201
<211> 430
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa15+IgG-Fc2b
<400> 201
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Ile Ser Pro
35 40 45
Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu Ala
50 55 60
Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val His
65 70 75 80
Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser Ala
85 90 95
Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu Asp
100 105 110
Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Gly Gly
115 120 125
Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe
130 135 140
His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys Ala
145 150 155 160
Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser Thr
165 170 175
Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly Ser
180 185 190
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys Pro
195 200 205
Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val Phe
210 215 220
Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro
225 230 235 240
Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu Val
245 250 255
Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln Thr
260 265 270
Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser Val
275 280 285
Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys Cys
290 295 300
Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile Ser
305 310 315 320
Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His Ala
325 330 335
Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile Gly
340 345 350
Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln Pro
355 360 365
Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val Asp
370 375 380
Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser Trp
385 390 395 400
Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu His
405 410 415
Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 202
<211> 1287
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa15+IgG-Fc4a
<400> 202
atggccccaa cctcagcctt cctcatggcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gcgacctgcc tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg agaatctccc ctttctcctg cctggaccac agaagggact ttggattccc 180
ccaagaggcc ttggggggca accaggtcca gaaggctcaa gccatggctc tggtgcatga 240
gatgctccag cagcttccag ctcttcagca cagagggctc ggctgctgcc tgggatgaga 300
gcctcctgca ccagttctgc actggactgg atcagcagct cagggacctg gaagcctgtg 360
tcatgcagga ggcggggctg agggaccccc ctgctggagg aggactccat cctggctgtg 420
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 480
tgggagatcg tcagggcaga agtcagaggc cttctcttcc tccacaaacc tgcaagacag 540
actcaggagg aaggagtgag gtggctcagg tggatccggt ggaggcggaa gcggcggtgg 600
aggatcagga acaaagacca aaccaccatg tcccatatgc ccagcctgtg aagggcccgg 660
gccctcggcc ttcatcttcc ctccaaaacc caaggacacc ctcatgatct cccggacccc 720
caaggtcacg tgcggtggta gatgtgagcc aggagaaccc ggaggtccag ttctcctggt 780
acgtggacgg cgtagaggtg cacacggccc agacgaggcc aaaggaggag cagttcaaca 840
gcacctaccg cgtggtcagc tctgcccatc cagcaccagg actggctgaa cgggaaggag 900
ttcaagtgca aggtcaacaa caaagacctc ccagccccca tcacaaggat catctccaag 960
gccaaagggc agacccggga gccgcagtta caccctgccc ccacccaccg aggagctgtc 1020
caggagcaaa gtcacgctaa cctgcctggt cactggcttc tacccacctg acatcgatgt 1080
cgagtggcaa agaaacggac agccggagcc aggggaatta ccgcaccacc ccgccccagc 1140
aggacgtgga cgggacctac ttcctgtaca gcaagctcgc ggtggacaag gccagctggc 1200
agcgtggaga cacattccag tgtgcggtga tgcacgagct ctcacaacca ctacacccag 1260
aagtccatct tcaagactcc gggtaaa 1287
<210> 203
<211> 430
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa15+IgG-Fc4a
<400> 203
Met Ala Pro Thr Ser Ala Phe Leu Met Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Ile Ser Pro
35 40 45
Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu Ala
50 55 60
Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val His
65 70 75 80
Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser Ala
85 90 95
Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu Asp
100 105 110
Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Ala Gly Gly
115 120 125
Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe
130 135 140
His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys Ala
145 150 155 160
Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser Thr
165 170 175
Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly Ser
180 185 190
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys Pro
195 200 205
Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala Phe
210 215 220
Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro
225 230 235 240
Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu Val
245 250 255
Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln Thr
260 265 270
Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser Val
275 280 285
Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys Cys
290 295 300
Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile Ser
305 310 315 320
Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro Thr
325 330 335
Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr Gly
340 345 350
Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln Pro
355 360 365
Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val Asp
370 375 380
Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser Trp
385 390 395 400
Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu His
405 410 415
Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 204
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa16+IgG-Fc1a
<400> 204
atggccccaa cctcagcctt cttcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacccggt tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggagggctc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcggtg gtggacgtca gcaaggagca cgccgaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg ccgagacgag accaaaggag gagcagttca 840
acagcaccta ccgtgtggtc agctctgccc atccagcacc aggactggct gaaggggaag 900
gagttcaagt gcaaggtcaa caacgtagac ctcccagccc ccatcacgag gaccatctcc 960
aaggctatag ggcagagccg ggagccgcag ttacaccctg cccccacccg ccgaggagct 1020
gtccaggagc aaagtcaccg taacctgcct ggtcattggc ttctacccac ctgacatcca 1080
tgttgagtgg aagagcaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc ttcttcctgt acagcaagct cgcggtggac aaggcaagat 1200
gggaccatgg agaaacattt gagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tctccaagac tcagggtaaa 1290
<210> 205
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa16+IgG-Fc1a
<400> 205
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Pro Val Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Gly Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Val Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Glu Thr Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 206
<211> 1295
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa16+IgG-Fc1b
<400> 206
atggccccaa cctcagcctt cttcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacccggt tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggagggctc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaatacacc agccgcaaac atgtcccata tgcccaggct gtgaagtggc 660
cgggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccagac 720
ccccgaggtc acgtgcgggt ggtggacgtc agcaaggagc acgccgaggt ccagttctcc 780
tggtacgtgg acggcgtaga ggtgcacacg gccgagacga gaccaaagga ggagcagttc 840
aacagcacct accgtgtggt cagctcctgc ccatccagca ccaggactgg ctgaagggga 900
aggagttcaa gtgcaaggtc aacaacgtag acctcccagc ccccatcacg aggaccatct 960
ccaaggctat agggcagagc cgggagccgc agtgtacacc ctgcccccac ccgccgagga 1020
gctgtccagg agcaaagtca cgctaacctg cctggtcatt ggcttctacc cacctgacat 1080
ccatgttgag tggaagagca acggacagcc ggagccagga acacataccg caccaccccg 1140
ccccagcagg acgtggacgg gaccttcttc ctgtacagca aactcgcggt ggacaaggca 1200
agatgggacc atggagacaa atttgagtgt gcggtgatgc acgagctctg cacaaccact 1260
acacccagaa gtccatctcc aagactcagg gtaaa 1295
<210> 207
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa16+IgG-Fc1b
<400> 207
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Pro Val Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Gly Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Ile His Gln Pro
195 200 205
Gln Thr Cys Pro Ile Cys Pro Gly Cys Glu Val Ala Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Gln Thr
225 230 235 240
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Lys Glu His Ala Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Glu
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Lys Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Val Asp Leu Pro Ala Pro Ile Thr Arg Thr Ile
305 310 315 320
Ser Lys Ala Ile Gly Gln Ser Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile His Val Glu Trp Lys Ser Asn Gly Gln
355 360 365
Pro Glu Pro Glu Asn Thr Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Phe Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Arg
385 390 395 400
Trp Asp His Gly Asp Lys Phe Glu Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Gln Gly Lys
420 425 430
<210> 208
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa16+IgG-Fc2a
<400> 208
atggccccaa cctcagcctt cttcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacccggt tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggagggctc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcacc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggtg gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctaccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 209
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa16+IgG-Fc2a
<400> 209
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Pro Val Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Gly Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 210
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa16+IgG-Fc2b
<400> 210
atggccccaa cctcagcctt cttcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacccggt tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggagggctc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaatcgcc 660
agggccctcg gtcttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
accccaggtc acgtgcggta gttgatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccacacg ccgaggagct 1020
gtccaggagc aaagtcagca taacctgcct ggtcattggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagtt ctcggtggac aaggccagct 1200
ggcagggtgg aggcatattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcta tctccaagac tccgggtaaa 1290
<210> 211
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa16+IgG-Fc2b
<400> 211
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Pro Val Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Gly Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Ser Pro Gly Pro Ser Val
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Gln Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro His
325 330 335
Ala Glu Glu Leu Ser Arg Ser Lys Val Ser Ile Thr Cys Leu Val Ile
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Phe Ser Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Gly Gly Gly Ile Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Ser Lys Thr Pro Gly Lys
420 425 430
<210> 212
<211> 1290
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa16+IgG-Fc4a
<400> 212
atggccccaa cctcagcctt cttcacggcc ctggtgctgc tcagctgcaa tgccatctgc 60
tctctgggct gcgacccggt tcagacccac agcctggctc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacg cccctgctgg aggagggctc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcatcagggc agaagcatag agccttctct tcctccacaa acctgcaaga 540
cagactcagg aggaaggagt gaggtggctc aggtggatcc ggtggaggcg gaagcggcgg 600
tggaggatca ggaacaaaga ccaaaccacc atgtcccata tgcccagcct gtgaagggcc 660
cgggccctcg gccttcatct tccctccaaa acccaaggac accctcatga tctcccggac 720
ccccaaggtc acgtgcggtg gtagatgtga gccaggagaa cccggaggtc cagttctcct 780
ggtacgtgga cggcgtagag gtgcacacgg cccagacgag gccaaaggag gagcagttca 840
acagcaccta ccgcgtggtc agctctgccc atccagcacc aggactggct gaacgggaag 900
gagttcaagt gcaaggtcaa caacaaagac ctcccagccc ccatcacaag gatcatctcc 960
aaggccaaag ggcagacccg ggagccgcag ttacaccctg cccccaccca ccgaggagct 1020
gtccaggagc aaagtcacgc taacctgcct ggtcactggc ttctacccac ctgacatcga 1080
tgtcgagtgg caaagaaacg gacagccgga gccaggggaa ttaccgcacc accccgcccc 1140
agcaggacgt ggacgggacc tacttcctgt acagcaagct cgcggtggac aaggccagct 1200
ggcagcgtgg agacacattc cagtgtgcgg tgatgcacga gctctcacaa ccactacacc 1260
cagaagtcca tcttcaagac tccgggtaaa 1290
<210> 213
<211> 431
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa16+IgG-Fc4a
<400> 213
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Pro Val Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Gly Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Ile Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Thr Asn Leu Gln Asp Arg Leu Arg Arg Lys Glu Gly Gly Ser Gly Gly
180 185 190
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Thr Lys Thr Lys
195 200 205
Pro Pro Cys Pro Ile Cys Pro Ala Cys Glu Gly Pro Gly Pro Ser Ala
210 215 220
Phe Ile Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
225 230 235 240
Pro Lys Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asn Pro Glu
245 250 255
Val Gln Phe Ser Trp Tyr Val Asp Gly Val Glu Val His Thr Ala Gln
260 265 270
Thr Arg Pro Lys Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
275 280 285
Val Leu Pro Ile Gln His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys
290 295 300
Cys Lys Val Asn Asn Lys Asp Leu Pro Ala Pro Ile Thr Arg Ile Ile
305 310 315 320
Ser Lys Ala Lys Gly Gln Thr Arg Glu Pro Tyr Thr Leu Pro Pro Pro
325 330 335
Thr Glu Glu Leu Ser Arg Ser Lys Val Thr Leu Thr Cys Leu Val Thr
340 345 350
Gly Phe Tyr Pro Pro Asp Ile Asp Val Glu Trp Gln Arg Asn Gly Gln
355 360 365
Pro Glu Pro Glu Gly Asn Tyr Arg Thr Thr Pro Pro Gln Gln Asp Val
370 375 380
Asp Gly Thr Tyr Phe Leu Tyr Ser Lys Leu Ala Val Asp Lys Ala Ser
385 390 395 400
Trp Gln Arg Gly Asp Thr Phe Gln Cys Ala Val Met His Glu Ala Leu
405 410 415
His Asn His Tyr Thr Gln Lys Ser Ile Phe Lys Thr Pro Gly Lys
420 425 430
<210> 214
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa17+IgG-Fc1a
<400> 214
atggccccaa cctcagcctt cttcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccat agcctggcgc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcggtggtgg 720
acgtcagcaa ggagcacgcc gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccga gacgagacca aaggaggagc agttcaacag cacctaccgt gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaag gggaaggagt tcaagtgcaa ggtcaacaac 900
gtagacctcc cagcccccat cacgaggacc atctccaagg ctatagggca gagccgggag 960
ccgcagttac accctgcccc cacccgccga ggagctgtcc aggagcaaag tcaccgtaac 1020
ctgcctggtc attggcttct acccacctga catccatgtt gagtggaaga gcaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggaccttct 1140
tcctgtacag caagctcgcg gtggacaagg caagatggga ccatggagaa acatttgagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctc caagactcag 1260
ggtaaa 1266
<210> 215
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa17+IgG-Fc1a
<400> 215
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Val Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Glu Thr Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 216
<211> 1271
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa17+IgG-Fc1b
<400> 216
atggccccaa cctcagcctt cttcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccat agcctggcgc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa tacaccagcc 600
gcaaacatgt cccatatgcc caggctgtga agtggccggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccagaccccc gaggtcacgt gcgggtggtg 720
gacgtcagca aggagcacgc cgaggtccag ttctcctggt acgtggacgg cgtagaggtg 780
cacacggccg agacgagacc aaaggaggag cagttcaaca gcacctaccg tgtggtcagc 840
tcctgcccat ccagcaccag gactggctga aggggaagga gttcaagtgc aaggtcaaca 900
acgtagacct cccagccccc atcacgagga ccatctccaa ggctataggg cagagccggg 960
agccgcagtg tacaccctgc ccccacccgc cgaggagctg tccaggagca aagtcacgct 1020
aacctgcctg gtcattggct tctacccacc tgacatccat gttgagtgga agagcaacgg 1080
acagccggag ccaggaacac ataccgcacc accccgcccc agcaggacgt ggacgggacc 1140
ttcttcctgt acagcaaact cgcggtggac aaggcaagat gggaccatgg agacaaattt 1200
gagtgtgcgg tgatgcacga gctctgcaca accactacac ccagaagtcc atctccaaga 1260
ctcagggtaa a 1271
<210> 217
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa17+IgG-Fc1b
<400> 217
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Ile His Gln Pro Gln Thr Cys Pro Ile Cys Pro Gly
195 200 205
Cys Glu Val Ala Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Gln Thr Pro Glu Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Lys Glu His Ala Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Glu Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Lys Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Val Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Thr Ile Ser Lys Ala Ile Gly Gln Ser Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile His
340 345 350
Val Glu Trp Lys Ser Asn Gly Gln Pro Glu Pro Glu Asn Thr Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Phe Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Arg Trp Asp His Gly Asp Lys Phe Glu
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Gln Gly Lys
420
<210> 218
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa17+IgG-Fc2a
<400> 218
atggccccaa cctcagcctt cttcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccat agcctggcgc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcaccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtggttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctacccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 219
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa17+IgG-Fc2a
<400> 219
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 220
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa17+IgG-Fc2b
<400> 220
atggccccaa cctcagcctt cttcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccat agcctggcgc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga atcgccaggg ccctcggtct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggacaccc caggtcacgt gcggtagttg 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacacgccga ggagctgtcc aggagcaaag tcagcataac 1020
ctgcctggtc attggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagttctcg gtggacaagg ccagctggca gggtggaggc atattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtctatctc caagactccg 1260
ggtaaa 1266
<210> 221
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa17+IgG-Fc2b
<400> 221
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Ser Pro Gly Pro Ser Val Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Gln Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro His Ala Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Ser Ile Thr Cys Leu Val Ile Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Phe Ser Val Asp Lys Ala Ser Trp Gln Gly Gly Gly Ile Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Ser Lys Thr Pro Gly Lys
420
<210> 222
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> DNA sequence of interferon recombinant protein INFa17+IgG-Fc4a
<400> 222
atggccccaa cctcagcctt cttcacagcc ctggtgctac tcagctgcaa tgccatctgc 60
tctctgggct gtgacctgcc tcagacccat agcctggcgc acaccagggc cctgaggctc 120
ctggcacatg aggagaatct cccccttctc ctgcctggac cacagaaggg actttggatt 180
cccccaagag gccttggggg gcaaccaggt ccagaaggct caagccatgg ctctggtgca 240
tgagatgctc cagaaccttc cagctcttca gcacagaggg ctcggctgct gcctgggatg 300
agagcctcct gcaccagttc tgcactggac tggatcagca gctcagggac ctggaagcct 360
gtgtcatgca ggaggtgggc tgaagggacc cccctgctgg aggaggactc catcctggct 420
gtgaggaaat acttccacag actcaccctc tatctgcaag agaagagcta cagcccctgt 480
gcctgggaga tcgtcagggc agaagcatag agccttctct tcctccagaa acctgtgagg 540
tggctcaggt ggatccggtg gaggcggaag cggcggtgga ggatcaggaa caaagaccaa 600
accaccatgt cccatatgcc cagcctgtga agggcccggg ccctcggcct tcatcttccc 660
tccaaaaccc aaggacaccc tcatgatctc ccggaccccc aaggtcacgt gcggtggtag 720
atgtgagcca ggagaacccg gaggtccagt tctcctggta cgtggacggc gtagaggtgc 780
acacggccca gacgaggcca aaggaggagc agttcaacag cacctaccgc gtggtcagct 840
ctgcccatcc agcaccagga ctggctgaac gggaaggagt tcaagtgcaa ggtcaacaac 900
aaagacctcc cagcccccat cacaaggatc atctccaagg ccaaagggca gacccgggag 960
ccgcagttac accctgcccc cacccaccga ggagctgtcc aggagcaaag tcacgctaac 1020
ctgcctggtc actggcttct acccacctga catcgatgtc gagtggcaaa gaaacggaca 1080
gccggagcca ggggaattac cgcaccaccc cgccccagca ggacgtggac gggacctact 1140
tcctgtacag caagctcgcg gtggacaagg ccagctggca gcgtggagac acattccagt 1200
gtgcggtgat gcacgagctc tcacaaccac tacacccaga agtccatctt caagactccg 1260
ggtaaa 1266
<210> 223
<211> 423
<212> PRT
<213> Artificial Sequence
<220>
<223> Amino acid sequence of interferon recombinant protein INFa17+IgG-Fc4a
<400> 223
Met Ala Pro Thr Ser Ala Phe Phe Thr Ala Leu Val Leu Leu Ser Cys
1 5 10 15
Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu Pro Gln Thr His Ser Leu
20 25 30
Ala His Thr Arg Ala Leu Arg Leu Leu Ala Gln Met Arg Arg Ile Ser
35 40 45
Pro Phe Ser Cys Leu Asp His Arg Arg Asp Phe Gly Phe Pro Gln Glu
50 55 60
Ala Leu Gly Gly Asn Gln Val Gln Lys Ala Gln Ala Met Ala Leu Val
65 70 75 80
His Glu Met Leu Gln Gln Thr Phe Gln Leu Phe Ser Thr Glu Gly Ser
85 90 95
Ala Ala Ala Trp Asp Glu Ser Leu Leu His Gln Phe Cys Thr Gly Leu
100 105 110
Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys Val Met Gln Glu Val Glu
115 120 125
Gly Thr Pro Leu Leu Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr
130 135 140
Phe His Arg Leu Thr Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys
145 150 155 160
Ala Trp Glu Ile Val Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser
165 170 175
Arg Asn Leu Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
180 185 190
Gly Gly Ser Gly Thr Lys Thr Lys Pro Pro Cys Pro Ile Cys Pro Ala
195 200 205
Cys Glu Gly Pro Gly Pro Ser Ala Phe Ile Phe Pro Pro Lys Pro Lys
210 215 220
Asp Thr Leu Met Ile Ser Arg Thr Pro Lys Val Thr Cys Val Val Val
225 230 235 240
Asp Val Ser Gln Glu Asn Pro Glu Val Gln Phe Ser Trp Tyr Val Asp
245 250 255
Gly Val Glu Val His Thr Ala Gln Thr Arg Pro Lys Glu Glu Gln Phe
260 265 270
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Pro Ile Gln His Gln Asp
275 280 285
Trp Leu Asn Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu
290 295 300
Pro Ala Pro Ile Thr Arg Ile Ile Ser Lys Ala Lys Gly Gln Thr Arg
305 310 315 320
Glu Pro Tyr Thr Leu Pro Pro Pro Thr Glu Glu Leu Ser Arg Ser Lys
325 330 335
Val Thr Leu Thr Cys Leu Val Thr Gly Phe Tyr Pro Pro Asp Ile Asp
340 345 350
Val Glu Trp Gln Arg Asn Gly Gln Pro Glu Pro Glu Gly Asn Tyr Arg
355 360 365
Thr Thr Pro Pro Gln Gln Asp Val Asp Gly Thr Tyr Phe Leu Tyr Ser
370 375 380
Lys Leu Ala Val Asp Lys Ala Ser Trp Gln Arg Gly Asp Thr Phe Gln
385 390 395 400
Cys Ala Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
405 410 415
Ile Phe Lys Thr Pro Gly Lys
420
1
Claims (14)
- 동물 인터페론 및 동물 면역글로불린 Fc 단편을 포함하는 동물용 재조합 융합 인터페론.
- 제1항에 있어서, 동물 인터페론 및 동물 면역글로불린 Fc 단편이 링커에 의해 연결된 동물용 재조합 융합 인터페론.
- 제1항 또는 제2항에 있어서, 동물 인터페론이 아미노산 서열을 포함하고, 아미노산 서열이 SEQ ID NO:2, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 및 47로 구성된 군으로부터 선택된 적어도 하나의 서열인 동물용 재조합 융합 인터페론.
- 제1항 또는 제2항에 있어서, 동물 인터페론이 아미노산 서열을 포함하고, 아미노산 서열이 SEQ ID NO:2, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 및 47로 구성된 군으로부터 선택된 적어도 하나의 서열과 적어도 80%의 상동성을 갖는 동물용 재조합 융합 인터페론.
- 제1항 또는 제2항에 있어서, 동물 면역글로불린 Fc 단편이 아미노산 서열을 포함하고, 아미노산 서열이 SEQ ID NO:4, 49, 51, 53, 및 55로 구성된 군으로부터 선택된 적어도 하나의 서열인 동물용 재조합 융합 인터페론.
- 제1항 또는 제2항에 있어서, 동물 면역글로불린 Fc 단편이 아미노산 서열을 포함하고, 아미노산 서열이 SEQ ID NO:4, 49, 51, 53, 및 55로 구성된 군으로부터 선택된 적어도 하나의 서열과 적어도 80%의 상동성을 갖는 동물용 재조합 융합 인터페론.
- 제2항에 있어서, 링커가 SEQ ID NO:6의 서열을 포함하는 동물용 재조합 융합 인터페론.
- 제2항에 있어서, 링커가 아미노산 서열을 포함하고, 아미노산 서열이 SEQ ID NO:6의 서열과 적어도 80%의 상동성을 갖는 동물용 재조합 융합 인터페론.
- 제2항에 있어서, 동물용 재조합 융합 인터페론이 아미노산 서열을 포함하고, 아미노산 서열이 SEQ ID NO:8, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 및 223으로 구성된 군으로부터 선택되는 동물용 재조합 융합 인터페론.
- 제2항에 있어서, 동물용 재조합 융합 인터페론이 아미노산 서열을 포함하고, 아미노산 서열이 SEQ ID NO:8, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 및 223으로 구성된 군으로부터 선택된 서열과 적어도 80%의 상동성을 갖는 동물용 재조합 융합 인터페론.
- 제1항의 동물용 재조합 융합 인터페론을 인코딩하는 폴리뉴클레오티드.
- 제11항의 폴리뉴클레오티드를 갖는 포유동물 세포를 혈청-함유 배지에서 배양하는 단계;
세포가 안정적으로 성장한 후에 혈청-함유 배지를 혈청-비함유 배지로 대체하는 단계; 및
1 내지 5일마다 혈청-비함유 배지를 수거하고, 새로운 혈청-비함유 배지를 세포에 첨가하는 단계를 포함하는 동물용 재조합 융합 인터페론을 생성시키는 방법. - 제12항에 있어서, 혈청-함유 배지가 약 0.1 내지 10%(v/v)의 혈청을 포함하는 방법.
- 동물용 항바이러스 약제의 제조를 위한 제1항의 동물용 재조합 융합 인터페론의 용도.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210016618.8 | 2012-01-19 | ||
CN201210016618 | 2012-01-19 | ||
PCT/CN2013/070693 WO2013107388A1 (zh) | 2012-01-19 | 2013-01-18 | 干扰素和免疫球蛋白Fc段的融合蛋白 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150002588A true KR20150002588A (ko) | 2015-01-07 |
Family
ID=48798651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20147022960A KR20150002588A (ko) | 2012-01-19 | 2013-01-18 | 인터페론 및 면역글로불린 fc 섹션 융합 단백질 |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR20150002588A (ko) |
CN (2) | CN105001340A (ko) |
BR (1) | BR112014017788A2 (ko) |
PH (1) | PH12014501643A1 (ko) |
WO (1) | WO2013107388A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104292337A (zh) * | 2013-07-17 | 2015-01-21 | 施怀哲维克生物科技股份有限公司 | 猪融合干扰素 |
CN110055272A (zh) * | 2019-04-18 | 2019-07-26 | 西北农林科技大学 | 一种抑制prrs病毒增殖的靶向抗体治疗剂 |
CN113717270A (zh) * | 2020-05-26 | 2021-11-30 | 成都彤琦恩生物科技有限公司 | 一种猪干扰素-α8突变体及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030026779A1 (en) * | 1999-10-15 | 2003-02-06 | Liming Yu | Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc |
US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
CN101967196A (zh) * | 2010-11-10 | 2011-02-09 | 夏志南 | 一种干扰素融合蛋白及其制备和应用 |
-
2013
- 2013-01-18 KR KR20147022960A patent/KR20150002588A/ko active Search and Examination
- 2013-01-18 CN CN201510431529.3A patent/CN105001340A/zh active Pending
- 2013-01-18 BR BR112014017788A patent/BR112014017788A2/pt not_active Application Discontinuation
- 2013-01-18 CN CN201310020072.8A patent/CN103214579B/zh active Active
- 2013-01-18 WO PCT/CN2013/070693 patent/WO2013107388A1/zh active Application Filing
-
2014
- 2014-07-17 PH PH12014501643A patent/PH12014501643A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12014501643A1 (en) | 2014-10-13 |
WO2013107388A1 (zh) | 2013-07-25 |
CN103214579A (zh) | 2013-07-24 |
CN105001340A (zh) | 2015-10-28 |
CN103214579B (zh) | 2015-08-26 |
BR112014017788A2 (pt) | 2017-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11479605B2 (en) | Homodimeric protein constructs | |
KR101808751B1 (ko) | 폰 빌레브란트 인자(vWF)-함유 제제, 및 그와 관련된 방법, 키트 및 용도 | |
CN113230395A (zh) | 一种β冠状病毒抗原、β冠状病毒二联疫苗及其制备方法和应用 | |
CN113527510A (zh) | 融合蛋白分子及其制备方法和用途 | |
JPH05501062A (ja) | Hiv―1のウイルス性コンプレックス抗原に結合する組換え蛋白質 | |
CN110551214A (zh) | 一种人源化抗Periostin单克隆抗体、及其制备方法和应用 | |
EP2582389B1 (en) | High affinity human antibodies to human cytomegalovirus (cmv) gb protein | |
KR20140069222A (ko) | 교차 제시 수지상 세포를 표적으로 하는 백시바디 | |
KR20200144524A (ko) | 신규한 융합 단백질 및 이를 포함하는 암의 예방 또는 치료용 약학적 조성물 | |
CN100586960C (zh) | HAb18GC2单抗和其轻、重链可变区基因及应用 | |
KR20150002588A (ko) | 인터페론 및 면역글로불린 fc 섹션 융합 단백질 | |
CN115916831A (zh) | 包含抗lag-3抗体和il-2的融合蛋白及其用途 | |
WO2022148374A1 (zh) | 抗冠状病毒的全人广谱中和抗体76e1及其应用 | |
CN114630909B (zh) | 环状rna、包含环状rna的疫苗及用于检测新型冠状病毒中和抗体的试剂盒 | |
KR20240019135A (ko) | 작제물과 면역자극 화합물의 공동발현 | |
CN112409484B (zh) | 多功能抗体、其制备及其用途 | |
CN110563841A (zh) | 一种人源化抗Grb2单克隆抗体、及其制备方法和应用 | |
CN111732667B (zh) | 小反刍兽疫病毒基因工程亚单位疫苗 | |
TWI492952B (zh) | 動物融合重組型干擾素 | |
WO2016158546A1 (ja) | ヒトヘルペスウイルス6b抗原組成物 | |
JP2011507552A (ja) | カニクイザルトール様受容体3 | |
KR100808925B1 (ko) | 돼지 lag-3 융합 이뮤노글로블린 | |
CN118043066A (zh) | 构建体和免疫刺激性化合物的共表达 | |
WO1999058676A2 (en) | Semaphorin polypeptides | |
US20030165540A1 (en) | Sentinel virus II |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment |